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Abstract 
There is growing recognition in psychology that wellness is more than the absence of 
disease and distress. Well-being has been defined in numerous ways. Two dominant 
models include Diener, Eunkook, Suh, Lucas & Smith’s (1999) Hedonic model of 
Subjective Well-Being (SWB) and Ryff’s (1989) Eudiamonic model of Psychological 
Well-Being (PWB). There has been insufficient research into positive mental 
processes and well-being in Chronic Fatigue Syndrome (CFS), in contrast to the 
abundance of research emphasising psychopathology and dysfunction. This study’s 
first aim was to examine PWB and SWB and their relationship to symptoms in 
individuals with CFS (N = 60). Participants completed self-report scales of PWB, 
SWB, fatigue, pain, anxiety and depression. The second aim was to compare PWB 
scores in a subgroup of the CFS sample (N = 42) to a matched non-clinical control 
group (N = 42). Correlations between scales of symptoms and well-being were found 
to be complex. Well-being dimensions were largely independent of physical 
symptoms (Pain intensity, Physical Fatigue, Reduced Activity and General Fatigue) 
but strongly related to psychological components of fatigue (Mental Fatigue and 
Reduced Motivation) and psychological distress (Depression and Anxiety). Multiple 
regression analyses indicated that five dimensions of well-being uniquely predicted 
symptomatology in CFS. Compared to the control group, the CFS group scored 
significantly lower on five of Ryff ‘s six PWB dimensions, with particularly marked 
deficits in Personal Growth, Environmental Mastery and Self-Acceptance. No 
significant difference was found between the CFS and control groups on the 
Autonomy subscale. This multi-dimensional assessment of well-being advances our 
understanding of CFS; it highlights the burden of CFS beyond symptoms, challenges 
the over emphasis on maladaptive cognitive and personality traits in previous research 
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and offers several new treatment targets. Future research must investigate whether 
interventions targeting theses well-being deficits can boost the efficacy of symptom-
focused treatments, which currently produce unsatisfactory recovery rates in this 
client group. 
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Chapter 1: Introduction 
 
1.1 Purpose of Research 
There has been an abundance of psychological research investigating 
psychopathology and dysfunction in Chronic Fatigue Syndrome (CFS), whilst very 
few studies have examined positive attributes. A positive psychology approach 
suggests that well-being and recovery from illness are more than just the absence of 
symptoms and should also include the restoration of strengths, happiness and meaning 
in a person’s life (Seligman & Csikszentmihalyi, 2000). Given the unsatisfactory 
recovery rates following symptom-focused treatments in CFS, research identifying 
alternative treatment targets is a clinical priority (Price et al., 2008). The present study 
aims to investigate various aspects of well-being in adults with CFS. A positive 
psychology approach could help us better understand the experience of individuals 
with CFS and challenge the emphasis on maladaptive cognitive and personality traits 
in previous research. A greater understanding of the relationships between symptoms 
and well-being in CFS could help identify new, positive treatment targets that could 
inform the development of less pathologising psychological interventions. 
 
1.2 Chapter Overview 
This chapter will begin by providing an overview of CFS, its diagnostic criteria and a 
critique of previous psychological research into the condition. It will then highlight 
the inadequacy of symptom focused treatment like Cognitive Behavioural Therapy, 
which produce unsatisfactory recovery rates in physical symptoms, psychological 
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distress and quality of life. An argument for the necessity of a positive psychology 
approach in CFS will be given, before defining the constructs of Hedonic and 
Eudiamonic well-being.  Given the striking absence of research examining 
psychological well-being in CFS, literature investigating its relationship to symptoms 
in co-morbid conditions of CFS will be discussed.  The chapter concludes with a 
description of the present study and the research questions it aims to answer. 
 
1.3 Chronic Fatigue Syndrome 
 1.3.1 Classification 
CFS is characterised by a range of symptoms including profound and disabling 
fatigue, sleep difficulties, pain and cognitive impairment (Fukuda et al., 1994). With a 
population prevalence of at least 0.2-2%, depending on the diagnostic criteria and 
study design used, CFS is a relatively common condition,  (Bates et al., 1993; 
Wessely, Chalder, Hirsch, Wallace, & Wright, 1997). It affects four times more 
women than men and the average age of onset is 30 years (Ranjith, 2005). Recovery is 
rare (5–10% achieving total remission) and only palliative treatments exist (Cairns & 
Hotopf, 2005). As a result, most people with the condition experience a chronic 
course of symptoms, which fluctuate in intensity and severity and pose a significant 
challenge to them, their families and the medical profession. 
 
The World Health Organisation (1992) classifies CFS as a neurological illness, 
although its medical aetiology is unknown and no diagnostic test exists. A recent 
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systematic review identified 20 different case definitions of CFS (Brurberg, Fønhus, 
Larun, Flottorp, Malterud, 2014), exposing the lack of medical consensus and 
significant controversy surrounding the condition. The most frequently applied and 
extensively validated diagnostic criteria are that of the Centres for Disease Control 
(CDC; Fukuda et al., 1994), listed in Figure 1. The CDC states that symptoms must 
have been present for six consecutive months, before a diagnosis can be given. In 
comparison, The National Institute of Clinical Excellence (NICE, 2007) recommends 
a diagnostic waiting period of four consecutive months, whilst the International 
Consensus Criteria (Carruthers et al., 2011) asserts that any waiting period is 
unnecessary and potentially damaging. 
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Figure 1: CDC Criteria for a Diagnosis of Chronic Fatigue Syndrome (Fuduka et al., 
1994). 
 
 
 
Centres for Disease Control Criteria: 
 
A case of the chronic fatigue syndrome is defined by the presence of the following:  
1) Clinically evaluated, un- explained, persistent or relapsing chronic fatigue that is of 
new or definite onset (has not been lifelong); is not the result of ongoing exertion; is 
not substantially alleviated by rest; and results in substantial reduction in previous 
levels of occupational, educational, social, or personal activities 
2) The concurrent occurrence of four or more of the following symptoms, all of which 
must have persisted or recurred during 6 or more consecutive months of illness and 
must not have predated the fatigue:  
Self-reported impairment in  
- Short-term memory or concentration severe enough to cause substantial reduction in 
previous levels of occupational, educational, social, or personal activities 
- Sore throat  
- Tender cervical or axillary lymph nodes 
- Muscle pain 
- Multi-joint pain without joint swelling or redness 
- Headaches of a new type, pattern, or severity 
- Unrefreshing sleep 
- Post-exertional malaise lasting more than 24 hours. 
 
3) No clinical evidence of other causes of fatigue: i) organ failure; ii) chronic 
infections; iii) rheumatic and chronic inflammatory diseases; iv) major neurological 
diseases; v) systemic treatment for neoplasms; vi) untreated endocrine diseases; vii) 
primary sleep disorders; viii) obesity (BMI > 40); ix) alcohol/ substance abuse; x) 
reversible causes of fatigue such as medications, infections or major surgery; xi) 
psychiatric conditions e.g. melancholic depression, bipolar disorder, psychosis, eating 
disorder.) 
4) Routine investigations do not suggest a cause for fatigue: FBC, ESR, U&E, LFTs, 
calcium, phosphate, random glucose, thyroid function, celiac serology, urinalysis. 	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A plethora of diagnostic criteria and disparate terminology (Myalgic Encephalopathy 
ME; post-viral fatigue) has hindered CFS research and rendered studies incomparable. 
For patients the effect of medical uncertainty is devastating. Many encounter 
extensive, yet fruitless medical examinations, inconsistent advice, treatment delays 
and skepticism from healthcare providers (Deale & Wessely, 2001). The diagnostic 
label given to patients may even determine their prognosis. After controlling for 
baseline differences, a longitudinal survey found that ME patients showed the worse 
prognosis, followed by CFS patients and then post-viral fatigue patients, who showed 
the most favourable outcomes (Hamilton, Gallagher, Thomas & White, 2005). 
Authors concluded that having a diagnostic label that infers an untreatable 
pathological process (ME) or an unknown cause (CFS) may somehow render the 
patients more helpless in combating their symptoms and disability, as opposed to a 
label that implies a triggering illness (post-viral fatigue). Historically, many 
physicians have not believed in CFS and accused patients of malingering or attributed 
their symptoms to a psychiatric disorder. Reports have since been issued warning 
health professionals that CFS is a genuine illness (Sharpe, 2002) and that inaction due 
to denial or ignorance of the condition is not acceptable (Royal Colleges of 
Physicians, Psychiatrists and General Practitioners, 1996). 
 
 
1.3.2 Co-Morbidity In CFS 
High rates of co-morbidity exist between CFS and other functional disorders. 
Approximately 35%- 75% of individuals with CFS also have fibromyalgia, a chronic 
widespread pain condition (Buchwald & Garrity, 1994; Goldenberg, Simms, Geiger & 
Komaroff, 1990), whilst 63% have irritable bowel syndrome (IBS; 
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Gomborone, Gorard, Dewsnap Libby & Farthing, 1996). Having an additional 
functional syndrome puts a patient at increased risk of depression and psychiatric 
morbidity. Ciccone and Natelson (2003) found that rates of lifetime depression 
increased from 27.4% in the CFS only group to 52.3% in the comorbid CFS and 
fibromyalgia group. There has been some debate as to whether CFS, fibromyalgia and 
IBS are simply different expression of the same thing and it is widely accepted that 
they share many similar clinical features (e.g., they all have an unknown aetiology and 
are frequently accompanied by a significant psychological sequelae).  According to 
Wessely, Nimnuan and Sharpe (1999) the “similarities between them outweigh the 
differences” (p. 936); however, a more recent review of the biological literature 
suggests that there are significant differences in their underlying pathophysiology 
(Abbi & Natelson, 2013).  Based on current evidence, grouping them together as the 
same illness is inappropriate and further exploration of the similarities and differences 
between them is required. Having the three discrete case definitions (CFS, FM, IBS) 
arguably advances the study of medically unexplained illness. It permits comparisons 
to be made of treatment outcomes, prevalence rates and the effects of illness on 
quality of life (Ciccone & Natelson, 2003). Ultimately, there may be important 
differences in the experience and psychological impact of living with chronic fatigue 
(CFS) versus chronic widespread pain (fibromyalgia) versus chronic abdominal pain 
(IBS). 
 
1.3.3 Theories of CFS 
Many potential causal factors of CFS, including immunological, genetic, infectious, 
endocrine, neurological, and psychological, have been examined yet none fully 
explain the diverse array of symptoms reported by patients. Mounting evidence 
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suggests that a complex disease mechanism underlies the condition (Brurberg et al., 
2014). This has been operationalised in the Cognitive Behavioural Therapy (CBT) 
model of CFS, which outlines a plethora of predisposing, precipitating and 
perpetuating factors (Surawy, Hackmann, Hawton & Sharpe, 1995). Factors thought 
to predispose a person to CFS are typically psychological in nature and include a 
history of depression (Abbey, 1996), somatisation (Manu, Matthews & Lane, 1988), 
maladaptive personality traits (Sáez-Francàs et al., 2014) an over active lifestyle (Van 
Houdenhove, Neerinckx, Onghena, Lysens & Vertommen, 2001), parental physical 
abuse (Clark, Goodwin, Stansfield, Hotopf & White, 2011) and an insecure 
attachment style (Noyes et al., 2003; Taylor, Mann, White, & Goldberg, 2000; 
Wearden, Lamberton, Crook, & Walsh, 2004). Common precipitants include viral 
infections and stressful life events (Hatcher & House, 2003; White et al., 2001), 
whereas avoidance of activity, excessive resting, selective attention to symptoms, 
maladaptive illness beliefs and changes to the functioning of the hypothalamus 
pituitary adrenal axis, are hypothesised to maintain CFS (Ray, Jefferies, & Weir, 
1997; Deale, Chalder, & Wessely, 1998; Deary & Chalder, 2010). 
 
1.3.4 Overview of psychological research into CFS 
Previous psychological research into CFS has focused almost exclusively on 
identifying the presence of negative constructs, with a particular emphasis on 
psychological distress, maladaptive personality traits and social dysfunction. 
 
     Psychological Distress 
Surveys and systematic reviews reveal a high prevalence of psychiatric disorders, 
amongst individuals with CFS. Up to 85% of CFS patients identify depressed mood as 
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a primary symptom (Komaroff & Buchwald, 1991) and approximately 65% meet 
lifetime criteria for depression (Abbey & Garfinkel, 1991). Furthermore, 20-56% meet 
criteria for Generalised Anxiety Disorder (GAD; Fischler et al., 1997). Studies 
comparing CFS patients to patients with explainable chronic illnesses, including 
multiple sclerosis, arthritis, and myopathies, consistently document higher rates of 
depression in CFS (Wood, Bentall, Gopfert, & Edwards, 1991; Johnson, DeLuca, & 
Natelson, 1996; Pepper, Krupp, Friedberg, Doscher, & Coyle, 1993). This has led 
some researchers to argue that CFS is an atypical manifestation or somatised 
expression of psychiatric illness (Katon, 1984; Manu, et al., 1988). Biological 
evidence contests this view. Compared to depression, CFS is accompanied by distinct 
abnormalities such as immune system dysfunction (Cho & Stollerman, 1992; Gurwitt 
et al., 1992), brain abnormalities (Gurwitt et al., 1992) and limbic system dysfunction 
(Goldstein, 1992). There is also no strong evidence to suggest that anti-depressant 
medications facilitate recovery in CFS. Rimes & Chalder (2005) reviewed three 
Randomised Controlled Trials (RCTs) of antidepressants (Serotonin and Phenelzine). 
Two of the RCTs (Natelson Cheu, Pareja, Ellis, Policastro & Findley, 1996; 
Vercoulen et al., 1996) revealed no significant effects for any outcomes measured.  
The third trial showed that fluoxetine produced modest improvements in depression 
but had no effect on fatigue (Wearden et al., 1998).  
 
 
Psychological research suggests that CFS patients can be distinguished from 
depressed patients according to their cognitive style; depressed patients’ self schemas 
are dominated by a negative view of the self, whereas CFS patients are principally 
concerned with their ill health (Moss-Morris & Petrie, 2001). According to Abbey and 
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Garfinkel (1991) depression in individuals with CFS is better understood as an 
adjustment reaction to living with a controversial, chronic condition. It is typical for 
individuals with a chronic health condition to grieve about their predicament before 
adapting to it and inevitably some sufferers will go on to experience prolonged 
distress that meets criteria for a psychiatric disorder (Turner & Kelly, 2000). A study 
by Lehman, Lehman, Hemphill, Mandel and Cooper (2002) found that levels of 
depression and anxiety were highest amongst CFS patients whose physician failed to 
legitimatise their illness, suggesting negative responses from medical professionals 
may exacerbate distress and adjustment problems in this population. The majority of 
participants in Lehman et al.’s (2002) study were opportunistically recruited from 
patient-led organisations, raising issues concerning the generalisability of findings. 
Such a sample could be biased in favour of those having had a poor relationship with 
their physician. 
 
     Personality Traits 
Neuroticism is one of the big five personality traits, characterised by emotional 
instability - including feelings of anxiety, depression, anger and envy (Goldberg, 
1990). It is associated with increased stress vulnerability, a dysfunctional, helpless 
coping style and in those with chronic health conditions, greater adjustment problems 
(Flett, Baricza, Gupta, Hewitt, & Endler, 2011; Vollrath & Torgersen, 2000). Several 
studies have documented high levels of neuroticism and low levels of extraversion in 
individuals with CFS, (Blakely et al., 1991; Buckley et al., 1999; Sáez-Francàs et al., 
2014; Taillefer, Kirmayer, Robbins, & Lasry, 2003). As a trait, Watson and 
Pennebaker, (1989) suggest neuroticism predisposes a person to somatopsychic 
distress, which in turn contributes to the likelihood of them experiencing a range of 
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medically unexplained symptoms (De Gucht, Fischler, & Heiser, 2004). Another 
popular hypothesis is that perfectionism is a risk factor for fatigue and CFS. Deary 
and Chalder (2010) highlight that the prevailing stereotype of a CFS patient is one of a 
“burnt-out perfectionist” (p.466).  In support of this Ware and Kleinman (1992) found 
that CFS patients described working tirelessly to achieve the excessively high 
standards they set for themselves. Compared to healthy controls, women with CFS 
have also been documented to have high levels of unhealthy perfectionism, defined as 
excessive concern over mistakes, doubts about actions, parental expectations and 
parental criticism (Deary & Chalder, 2010). 
 
There is some limited evidence suggesting that DSM-IV personality disorders 
(Courjaret, Schotte, Wijnants, Morrkens & Cosyns, 2009; Nater et al., 2010), self-
sacrificing schema (Hambrook, et al., 2011) alexithmyia (conveying difficulties with 
recognising, labelling, and describing emotion; Friedberg & Quick, 2007) and 
negative beliefs about the acceptability of experiencing and expressing negative 
emotions (Hambrook et al., 2011; Rimes & Chalder, 2010), are more prevalent in CFS 
patients compared to the general population; attributes associated with disability and 
poor treatment outcomes. The majority of studies investigating psychopathology in 
CFS samples however have used cross-sectional designs and non-clinical control 
groups (as opposed to other patient groups). As a result, it is not possible to conclude 
that the abnormalities documented are specific to CFS, or that they play a causal role 
in predisposing or perpetuating the condition. Two studies suggest that the personality 
profiles of CFS patients are equivalent if not more favourable than those of patients 
with multiple sclerosis and rheumatoid arthritis, as demonstrated by their scores on 
	  	   20	  
measures of perfectionism, attitudes towards mental illness, defensiveness, social 
desirability, alexithymia and harm avoidance (Christodoulou, Deluca, Johnson, Lange, 
Gaudino, & Natelson, 1999; Wood & Wesseley, 1999). Furthermore, Chubb et al. 
(1999) found no differences between healthy controls and non-depressed CFS patients 
on measures of neuroticism and social desirability. One prospective population study 
conducted in the UK strengthens the evidence base for the aetiological role of 
premorbid psychopathology in CFS, however authors acknowledged that this 
association was partly confounded by comorbid psychopathology (Clark et al., 2011). 
In sum, there is little robust evidence to suggest that CFS patients possess an 
unusually high level of maladaptive personality traits that would predispose them to 
developing their illness. 
 
Impact of CFS on the individual 
The impact of CFS on a person’s social functioning has been documented by both 
quantitative and qualitative research. Findings reveal a sad itinerary of losses, 
including, friendships, support systems and ultimately, a lifestyle, (Anderson & 
Ferrans, 1997; Schoofs, Bambini, Ronning, Bielak & Woehl, 2004). An informative 
mixed-methods study assessed perceived quality of life in CFS using structured 
interviews and questionnaires (Anderson et al., 1997). Findings revealed that 100% of 
participants felt CFS had devastated their social activities and relationships, whilst 
32% stated they had lost most, if not all, of their previous friends. Participants 
described having to frequently cancel social plans due to the unpredictable nature of 
their symptoms and consequently, most remaining friendships were strained or 
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distant. Ninety-five percent of participants described friends’ responses to their illness 
as hurtful and reactions ranged from outright disbelief, to lack of understanding and 
fear of transmission. In terms of participants’ families, all of woman and half of the 
men felt that CFS had negatively impacted on their family life and 55% of the women 
expressed feelings of shame, guilt, or sadness over their dependency on family 
members. The strengths of this study were its high response rate (75%) and mixed 
methods triangulation design, allowing the authors to obtained a rich and robust data 
set. Nevertheless, statements of causality cannot be made, owing to the cross-sectional 
nature of the data. A study by Mayer (2000) found that CFS patients reported 
receiving significantly less social support than healthy controls in the year prior to 
their illness onset. Although retrospective, this implies that individuals’ with CFS may 
have premorbid difficulties with social relationships. 
 
Persons with CFS differ not only in the frequency of their social interactions but also 
in the types of interactions they have. A large study compared 270 individuals with 
CFS to disease-free breast cancer patients, fatigued employees on sick-leave and 
healthy controls (Prins et al., 2004). Findings revealed that individuals with CFS 
reported significantly more negative and problem-focused interactions. Poor 
relationships with family/ friends and negative social interactions predicted fatigue 
severity in CFS participants at baseline and one year follow-up. The majority of 
participants in this study however, had a relatively short illness duration (< 2 years) 
and so findings may not be representative of people who have had CFS for longer.  
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Finally, high levels of unemployment have been documented in individuals with CFS. 
In a systematic review investigating disability, 35 studies (containing 2652 patients) 
reported employment status (Ross, Estok, Frame, Stone, Ludensky, & Levine, 2004). 
Findings revealed that just 42% of participants with CFS were employed, compared to 
90% of controls. Employment was subdivided into full and part-time hours by 16 
studies, illustrating that only 19% of CFS participants were in full-time employment, 
compared to 75% controls. A strength of this review was that the majority of included 
studies (81%) required patients to fulfil CDC (1994) diagnostic criteria for CFS, 
increasing the homogeneity of samples and comparability of results. However, based 
on cross-sectional data one cannot infer causality. A more recent study using data 
from National Outcome Database (N= 2170) found that 50.1% of CFS patients 
reported discontinuing employment because of fatigue-related symptoms (Collin, 
Crawley, May, Sterne, & Hollingworth, 2011).  
 
In sum, individuals who have CFS tend to be markedly disabled. Many are unable to 
work, engage in social activities or maintain relationships. The consequence of this is 
that they feel isolated, alienated, misunderstood and unsupported.  
 
     Investigations of positive constructs in CFS 
In comparison to the abundance of research examining negative mental processes in 
CFS, only three studies have quantitatively assessed positive mental processes and 
their relationship to functioning. Jason, Witter and Harding (2003) examined 
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dispositional optimism, referring to a generalised expectation that good things will 
happen. They found that individuals with CFS (N= 32) had lower levels of optimism 
than healthy controls and that higher levels of optimism were predictive of better 
mental and physical functioning. Findley, Kerns, and Weinberg (1998) examined self-
efficacy (a person’s perceived ability to control their illness or achieve a specific 
outcome) in participants with CFS (N= 68) and found that higher levels of self-
efficacy predicted lower levels of symptoms, disability and distress, even after 
controlling for demographic variables. Similarly, Van-Damme, Crombeza, Van 
Houdenhove, Mariman and Michielsen (2006) examined participants’ (N= 110) 
degree of acceptance of their illness and functional limitations and found that higher 
levels of acceptance were related to lower levels of psychological distress, beyond the 
effects of demographic variables and fatigue severity.  
 
In conclusion, although the evidence is sparse and more methodologically rigorous 
research is required, the findings do suggest that i) individuals with CFS can continue 
to flourish in life despite unremitting physical symptom and ii) that positive factors 
may play a key role in moderating fatigue and distress in this population. A significant 
weakness of these studies is that they have investigated singular concepts, in the 
absence of a theoretical framework of optimal psychological functioning or well-
being.  
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1.3.5 Interventions for CFS  
According to NICE (2007) all patients should have access to a specialist CFS service. 
The reality however, is that over two million people in England don’t. Within the 
National Health Service, CFS service provision is “patchy and inconsistent” and in 
areas where specialist services are available, significant social inequalities in access 
exist (All-Party Parliamentary Group, 2010, p.15; Collin, Sterne, Hollingworth, May 
& Crawley, 2012).  
 
The primary goal of specialist CFS services is early diagnosis and symptom 
management. No specific pharmalogical treatments for CFS exist and drugs are 
simply prescribed for the purpose of managing symptoms. Non-pharmalogical, 
rehabilitative inventions such as Cognitive Behavioural Therapy (CBT) and Graded 
Exercise Therapy (GET) have shown some promise as treatments for CFS (NICE, 
2007). However, several meta-analyses highlight that only a paucity of randomised 
control trials, often containing small sample sizes and non-active comparators, have 
been conducted (Price, Mitchell, Tidy, & Hunot, 2008; NICE, 2007; Whiting et al., 
2001). Dropout rates in GET are also higher than in CBT, suggesting that it may not 
be an acceptable intervention to this client group (Ridsdale, Darbishire & Seed, 2004; 
Wearden et al., 1998). 
 
CBT for CFS targets particular patterns of maladaptive thinking and behaving (such 
as avoidance, rumination and thinking biases) with the aim of reducing their impact 
on physiological processes in the body (Surawy, et al., 1995). It has been shown to 
reduce levels of fatigue and disability in CFS; however only a minority of patients go 
on to make a full recovery after treatment (Price et al., 2008). Quarmby, Rimes, 
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Deale, Wessely and Chalder,  (2007) examined CBT in routine clinical practice and 
reported that post-treatment, 70% of patients still met criteria for excessive fatigue.  
Similarly, in a more recent randomised controlled trials (RCT; N= 641) just 30% of 
participants receiving CBT ceased to meet Oxford diagnostic criteria for CFS and had 
ratings of fatigue and physical function in the normal range, at 52 weeks post-
randomisation (White et al., 2011).  
 
The benefit of CBT for psychiatric symptoms in CFS is questionable too. A 
systematic review of 15 studies with a total of 1043 CFS patients, suggests that CBT’s 
effectiveness at reducing depression, anxiety and psychological distress is uncertain 
(Price et al., 2008). Compared to treatment as usual, CBT was found to have no 
significant effect on depression post-treatment, but did show an advantage at short-
term follow-up. For anxiety, the opposite effect was seen, CBT was significantly 
better than treatment as usual at reducing anxiety at post-treatment but this difference 
was lost at follow up. CBT showed no advantage over treatment as usual at reducing 
overall psychological distress at post-treatment or follow-up. Evidence from a single 
RCT signifies that CBT yields no improvement in cognitive functioning or quality of 
life in CFS patients (O'Dowd et al., 2006). Given the complexity of CFS, coupled with 
the evidence that CBT alone produces unsatisfactory recovery rates in symptoms 
(physical and psychiatric) and quality of life, Price et al. (2008) conclude that studies 
investigating other interventions that can be used alone or in conjunction with CBT to 
increase its efficacy, should be a major research priority.  
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1.4 Positive Psychology and Well-Being 
In the last few decades, positive psychology research has exponentially grown. It is 
shifting the paradigm of psychology away from a preoccupation with illness and the 
worst parts of existence, towards more positive aspects and the question of what it is 
that makes life good. Positive psychology researchers assert that psychology should 
not concern itself solely with the amelioration of psychopathology, weakness and 
dysfunction but also the promotion of strengths, happiness and well-being (Seligman 
& Csikszentmihalyi, 2000). This reflects the growing recognition that just as positive 
affect is not the opposite of negative affect (Cacioppo & Berntson, 1999) well-being is 
not the absence of illness (Ryan & Deci, 2001). In accordance with this view the 
World Health Organisation, defines health as: 
 ‘”A state of complete physical, mental and social well-being and not merely the 
absence of disease or infirmity” (1946, p. 1). 
With an aging population and increasing prevalence of chronic, disabling conditions, 
health care providers are being forced to expand their focus, from an out-dated, 
narrow emphasis on cure and quantity of life, to include the promotion of quality of 
life and well-being (The Institute of Medicine, 2012). When a return to premorbid 
functioning is no longer possible (or very rare as in the case of CFS), the question of 
how to conceive recovery as a treatment objective is pivotal. The Recovery Model 
Approach endorsed by The National Institute for Mental Health England (2005) 
focuses on reducing the impact of chronic illness, as opposed to illness per se. This is 
achieved through the provision of holistic interventions that cultivate self-efficacy, 
hope, empowerment, a positive self-image, self-management skills, social inclusion 
and meaning in life.  
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CBT can be conceptualised as an illness or symptom-focused treatment in that it 
specifically aims to reduce negative mental processes and behaviours. Clinical 
investigations signify however, that the elimination of negative functioning and illness 
does not necessarily give rise to positive functioning and wellness. A study 
investigating the effects of internet-delivered CBT for major depression on future 
thinking found that despite being effective at reducing negative future thinking, CBT 
failed to increase positive future thinking (Andersson, Sarkohi, Karlsson, Bjarehed, & 
Hesser, 2013). This is significant given that depressed individuals differ from healthy 
controls predominantly in their failure to anticipate positive events, as opposed to their 
propensity to anticipate negative events (Bjarehed, Sarkohi & Andersson, 2010). 
Brown (2007) examined affectivity in 606 patients undergoing CBT treatment for a 
variety of axis I disorders, including GAD, social phobia, panic disorder, specific 
phobia and obsessive compulsive disorder. Findings revealed that negative affect 
demonstrated a large treatment effect, whilst positive affect remained remarkably 
stable. Together, these studies suggest that CBT may not target the whole problem and 
provide further support for a positive psychology approach that promotes positive 
functioning in CFS, alongside a reduction of negative functioning.  
 
 
A question central to the field of positive psychology is what constitutes well-being or 
optimal psychological functioning? Ultimately, the way we define well-being 
determines what research variables we measure and how we practice therapeutically. 
To date, there is no consensus on what well-being is. Following a review of the 
literature Ryan and Deci (2001) concluded that it can be broadly categorised 
according to two distinct, yet overlapping theories, one concerned with happiness 
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(Hedonic well-being/ subjective well-being; SWB) and the other concerned with 
human potentials and meaning in life (Eudiamonic well-being/ psychological well-
being; PWB).  There is some debate over the usefulness and validity of splitting well-
being into two distinct constructs and mounting evidence suggests that they are highly 
intertwined and reciprocally related. King and Napa (1998) asked participants to rate 
the components of a good life and found that happiness and meaning were both 
pivotal. The discriminant validity between Hedonic and Eudiamonic measures is large 
enough for them to be considered separate constructs (Waterman, Schwartz, & Conti, 
2008). According to Ryan and Deci (2001) our understanding of well-being will be 
enhanced by measuring it in different ways. Both aspects likely represent assets that 
play an important role in restoring and protecting our mental and physical health. 
Therefore, to provide a holistic, unconstrained understanding of well-being in CFS, 
the present study will utilise SWB and PWB indicators.  
 
1.4.1 Hedonic Theory and Subjective Well-being 
Well-being has long been equated with happiness. Greek philosophers described 
happiness as the highest of all goods and the ultimate motivation for human action 
(Aristotle 350 B.C/ 1925). Hedonic theory suggests that a person has well-being to the 
extent that they feel pleasure, enjoyment and happiness in their life (Kahneman, 
Diener & Schwarz, 1999). The most prolific model of hedonia is Diener, Eunkook, 
Suh, Lucas & Smith’s (1999) tripartite model of subjective well-being (SWB). It is 
concerned with how and why people experience their lives as positive and includes 
affective reactions and cognitive evaluations. SWB defines happiness as a 
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combination of three components: A global evaluation of satisfaction with one’s life, 
the presence of positive affect and the absence of negative affect (Diener, Lucas, Oishi 
& Shuh, 2002). Diener et al., (1999) argue that the components of SWB, although 
closely related, represent three distinct constructs that need to be individually 
understood and researched. SWB can therefore be considered "a general area of 
scientific interest rather than a single specific construct" (Diener et al., 1999; p. 257).  
 
Viewed as the cognitive component of SWB, life satisfaction involves judgments 
regarding fulfilments of one’s goals, expectations, standards and desires. In Diener et 
al.’s (1999) model it is defined as a comparative judgment of one’s circumstances 
against what is deemed to be an appropriate standard; the bigger the discrepancy 
between one’s circumstances and the appropriate standard, the lower one’s life 
satisfaction. Bottom up models stipulate that life satisfaction judgements are domain 
dependent, meaning that they are based on external events, situations and 
demographic variables such as income, health and marriage (Shea, 2013). In contrast, 
top down models infer that a person’s personality and values determine how they 
evaluate their life. Evidence for both models has been found however; a full review of 
this research is beyond the scope of this thesis (see Shea, 2013).  
 
In CFS, appraisals of life satisfaction have received considerable attention. One study 
specifically examined global life satisfaction in a sample of 75 CFS patients, using 
The Manchester Short Assessment of Quality of Life (MANSA; Rakib et al., 2005). 
Findings revealed that CFS patients expressed lower levels of satisfaction with their 
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life as a whole, their financial situation and their leisure activities, than medical 
students, first admission schizophrenia patients and female patients with alcoholism. 
A further seven studies have examined patients’ satisfaction ratings in the domains of 
health and physical, occupational and social functioning (Anderson & Ferrans, 1997; 
Buchwald, Pearlman, Umali, Schmaling & Katon, 1996; Hardt, Buchwald, Wilks, 
Sharpe, Nix & Egle, 2001; Lowry & Pakenham, 2008; Komaroff et al., 1996; Priebe, 
Huxley, Knight & Evans, 1999; Schweitzer, Kelly, Foran, Terry & Whiting, 1995). 
Findings confirm that CFS patients are highly dissatisfied with the quality of their 
lives and the scale of their impairments, which spans a range of physical and mental 
activities, and is equal to, if not greater than that seen in other chronic illness. In sum, 
whilst these studies suggest that life satisfaction is significantly and uniquely affected 
by the experience of CFS, they do not assess affective well-being or several other 
psychological domains that have been implicated in positive functioning and will 
therefore, form the focus of the present study.  
 
Bradburn (1969) was the first to establish positive affect and negative affect as two 
distinct dimensions that vary independently and ought to be measured separately. 
Today they are considered the “dominant dimensions of emotional experience” 
(Watson & Clark, 1994, p.1). Positive affect reflects the extent to which a person feels 
pleasant emotions or moods such as joy, pride contentment and happiness (Diener et 
al., 1999). In contrast, negative affect reflects the extent to which a person feels 
unpleasant emotions such as guilt, anger, sadness and fear (Diener et al., 1999). To 
assess the full range of emotions and feelings that a person might be experiencing, 
Diener et al. (2010) developed a 12-item questionnaire, the Scale of Positive and 
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Negative Experience (SPANE). It includes specific emotions (sad, afraid, joyful, 
angry, happy, contented) and general feelings (positive, negative, good, bad, pleasant, 
unpleasant). Three subscales are calculated from participants’ scores: a scale of 
positive affect (SPANE-P), negative affect (SPANE-N) and balanced affect (SPANE-
B), which is calculated by subtracting the negative score from the positive score. 
According to Diener et al. (2010) the SPANE offers several advantages over the 
Positive and Negative Affect Schedule (PANAS), which has been the most widely 
used measure of affective well-being to date (Watson, Clark, & Tellegen, 1988). 
Firstly, the SPANE reflects all levels of emotional arousal, in comparison to the 
PANAS, which focuses exclusively on high arousal states and also includes items 
such as “strong” and “alert”, which are more akin to physical states than affective 
ones. Secondly, the inclusion of general words allows the SPANE to assess all 
positive and negative feelings, regardless of their specific label, which is more in 
keeping with SWB theory. By listing specific emotions and weighting them all 
identically, the PANAS overlooks the fact that a person may actually feel reasonably 
positive or negative despite not experiencing the full range of emotions listed on the 
scale. Correlational research suggests that the frequency with which a person 
experiences positive affect is more strongly related to other well-being measures such 
as life satisfaction, than intensity with which they feel them (Diener, Sandvik, & 
Pavot, 1991). A third advantage of the SPANE over the PANAS is that it asks 
respondents to report on the frequency with which they experience each feeling (e.g. 
“always”, “sometimes”, “never”), opposed to the intensity of feelings (e.g. “not at 
all”, “extremely”). Finally, by asking the respondent to report on their emotional 
experience in the past four weeks the SPANE avoids capturing short-term mood states 
and incites the respondent to answer based on actual experiences (bottom-up 
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appraisal), as opposed to relying on general self-concept (top-down appraisal).  
Internal consistency for all three scales is good (ranging from 0.81-0.89 across the 
scales), as is temporal stability over a one-month period (0.62-0.68; Diener et al., 
2010) and convergence validity with other measures of happiness (including 
Fordyce’s (1988) single item measure of happiness) and satisfaction with life (the 
Satisfaction with Life Scale; Diener, Emmons, Larsen, & Griffin, 1985). Despite its 
promising psychometric properties, a criticism of the SPANE is that it is yet to be 
validated across cultures and in clinical samples. Normative scores have been 
produced from studies using samples of western college students (N= 468) and further 
research is needed. In defence, Diener et al. (2010) argue that the scale should perform 
well across cultures and societies. It assesses a respondent’s personal appraisal of their 
own feelings based on their own experiences, opposed to pre-defined external criteria, 
which are typically more vulnerable to cultural bias. 
 
Compared to negative affect, namely depression and anxiety, positive affect has been 
grossly under researched in CFS. Three UK studies have previously assessed it but as 
a secondary outcome measure. Using visual analogue scales Wood and Magnello 
(1992) measured diurnal changes in perceptions of energy in a small sample of 36 
participants who had CFS or had recently recovered from it. Findings revealed a 
strong positive correlation (r = 0.70 to 0.80) between high levels of positive affect and 
high levels of mental and physical energy, whilst negative affect was independent of 
energy levels. Wood, Magnello & Sharpe (1992) verified these findings in second 
study (N=37) that employed a modified version of the PANAS (Watson, et al., 1988) 
to measure affect. Finally, Marshall et al. (1996) assessed cognitive function and 
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mood in CFS (N= 27) using the PANAS and found that compared to a large sample of 
college students reported in the literature, CFS patients had extremely low levels of 
positive affect, but relatively normal levels of negative affect. Authors suggest that 
this profile distinguishes CFS patients from those with major depression, who show 
depleted levels of positive affect and elevated levels of negative affect. The 
relationships between symptoms of cognitive impairment and affect were not 
reported. Although these studies provide preliminary evidence for the importance of 
assessing positive affect in CFS, they have several limitations that the present study 
aims to overcome. Specifically, they can be criticised for using small sample sizes, 
flawed measures of affect and for failing to comprehensively assess the relationship 
between affect and symptomatology in CFS.  
 
1.4.2 Eudiamonic Theory and Psychological Well-being 
According to Eudiamonic theory, happiness is not the primary goal of life but rather 
the by-product of a life well lived (Ryff & Singer, 1998). Eudiamonic theorists 
concern themselves with examining what a person is doing in their life, as opposed to 
how it makes them feel. They propose that a person will flourish if they are striving to 
achieve their true potential and engaging themself in purposeful activities. 
Eudiamonic researchers have criticised SWB for simplifying what it means to live a 
good life (Ryff & Singer, 1998) and for not objectifying the types of activities, goals 
and achievements necessary to create happiness (Ryan & Deci, 2001). On the 
contrary, by creating a list of criteria, Eudiamonic researchers can be accused of 
constraining individual definitions of wellness. Sumner (1996) reminds us that well-
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being is only achieved when a life is deemed good by the person living it. In clinical 
psychology, Eudiamonic well-being tends to be privileged, as its focus on life 
processes, as opposed to specific outcomes, offers clearer implications for the 
development of treatments (Fava & Ruini, 2003). 
 
Many theorists have formulated perspectives on Eudiamonic well-being, for instance 
Maslow's (1968) conception of self-actualization, Allport's (1961) formulation of 
maturity and Rogers' (1961) depiction of the fully functioning person. However, few 
plausible assessment procedures have been put forward. Historically, atheoretical 
measures of Eudiamonic well-being have hindered research into the field. To address 
this, Ryff (1989) generated a new, multi-dimensional model of psychological well-
being, which consolidates convergence points in existing Eudiamonic theories from 
several psychological arenas (developmental, humanistic and clinical). According to 
Ryff’s (1989) taxonomy there are six dimensions of positive functioning: Autonomy 
(the ability to be independent and self-determining and not look to others for 
approval); Self-Acceptance (having positive self-regard and acceptance of one’s 
strengths and weaknesses); Environmental Mastery (the ability to choose, control and 
create environments that fit with one’s personal needs and values); Positive 
Relationships with Others (the ability to form warm and trusting interpersonal 
relationships and display empathy and intimacy, towards others); Purpose in Life 
(having goals and a direction in life that contribute to  the belief that one’s life is 
purposefully and meaningful); Personal Growth (an openness to new experience and 
sense that one is continuing to grow and develop over time).  To quantify each 
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dimension, Ryff (1989) devised a 20-item scale (120 items in total) and tested it in a 
large sample (n= 320) of relatively healthy, well-educated respondents. Findings 
indicated that the Psychological Wellbeing Scale had good internal consistency (0.87-
0.93) and re-test reliability coefficients over a 6-week period (0.81-0.88; Ryff, 1989). 
Since then, several more rigorous tests have validated the six-factor model (Cheng & 
Chan, 2005; Ryff & Weaton, 2001; van Dierendonck, 2004; van Dierendonck, Diaz, 
Rodriguez-Carvajal, Blanco & Moreno-Jimenez, 2008), including a study containing a 
large national probability sample of 1108 adults (Ryff & Keyes, 1995).  
 
Critics of the six-factor model of PWB have questioned its multidimensionality, by 
claiming that there is substantial conceptual overlap between the dimensions. In an 
assessment of the scales construct validity Spring and Hausser (2005) analysed data 
from three large surverys —Midlife in the United States, National Survey of Families 
and Households II, and the Wisconsin Longitudinal Study. Findings revealed a very 
strong correlation (r = 0.85) between participants’ scores on the Self-Acceptance and 
Environmental Mastery subscales, leading authors to conclude that they are largely 
measuring the same concept. Further strong correlations have been documented 
between the dimensions of Self-Acceptance and Purpose in Life (0.72) and Purpose in 
Life and Personal Growth (0.72; Ryff, 1989).  This raises doubts about the factorial 
validity of the instrument but also Ryff’s theoretical framework. In defence of such 
criticism, there are several sources of evidence championing distinctiveness. Ryff and 
Keyes (1995) highlight that the six dimensions have distinct age and gender profiles, 
whilst the original validation study (Ryff, 1989) confirms that the subscales have 
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differential patterns of association with other well-being measures. Specifically, 
Affect Balance shows a moderate correlation with Self-Acceptance but much weaker 
links with Purpose in Life. There is also growing evidence that the scales show unique 
profiles in clinical populations and different relationships with symptom measures 
(Mangelli, Gribbin, Büchi, Allard & Sensky, 2002; Nierenberg et al., 2010). 
Ultimately, despite the criticism, Ryff’s work has been ground breaking in the field of 
well-being and highly influential in wider psychology. Her seminal paper has been 
cited in 5114 publications (Ryff, 1989; retrieved from Google Scholar, 07th April 
2015), and the Psychological Well-Being Scale itself, used in more than 500 studies. 
 
1.4.3 Factors Related to Well-Being 
The relationship between several socio-demographic variables has been examined and 
findings suggest that subjective and psychological well-being dimensions vary in 
meaningful ways according to personal characteristics including age, gender, marital 
status and educational attainment. Controlling for these factors in clinical research is 
imperative, as DeNeve (1999) found that individual’s demographics account for 3% 
of the variance in well-being outcomes.  
 
Three cross-sectional, cohort studies suggest the life course trajectory of PWB is 
diverse: Autonomy and Environmental mastery increase from adulthood to old age, 
whilst Purpose in Life and Personal Growth decrease and Positive Relationships with 
Others and Self-Acceptance remain the same (Ryff, 1989; Ryff & Keyes, 1995; Ryff 
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& Singer, 2008). Studies using nationally representative data have verified these life 
course patterns (Ryff, Keyes & Hughes, 2004). A criticism of cross-sectional studies 
however, is that they are confounded by inter- and intra-cohort variation. Springer, 
Pudrovska and Hauser (2011) examined age-related patterns in PWB using data from 
two large longitudinal surveys, each containing three life-course transitions: 
Adulthood to early midlife (aged 32-51 years), early midlife to late midlife (aged 50-
59 years) and late midlife to old age (aged 57-75 years). Findings revealed that with 
the exception of Environmental Mastery, age trends in PWB were not consistent 
across samples or life-course transitions. More variation was observed within age 
periods than between subscales across age or time, thus suggesting that previous 
findings of life course patterns might be best explained by cohort differences. In terms 
of SWB, the average older age profile of SWB is generally positive, with several 
studies indicating that life satisfaction increases with age (Diener & Suh 1998; 
Shmotkin 1990;).  Cross-sectional and longitudinal research examining positive affect 
evidences both gains and losses with age, whilst negative affect appears to decline for 
some and stabilise for others (Diener & Suh 1998; Mroczek & Kolarz 1998; Shmotkin 
1990). 
 
Gender differences have been reported across multiple sets of data, with women 
consistently scoring higher than men on Positive Relations with Others and Personal 
Growth, (Ryff, 1995). In terms of educational attainment a strong positive correlation 
has been documented with all six dimensions of Ryff’s PWB, but most strikingly so 
for Purpose in Life and Personal Growth (Ryff & Singer, 2008). There is now robust 
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evidence to suggest that unemployment leads to a significant deterioration in an 
individual’s well-being, not simply because of the incurred financial losses but also 
because of the loss of the psychological benefits that are associated with work. A job 
is a source of social status and recognition that provides self-respect and self-worth. It 
creates a structure for one’s day, increases opportunities for social interaction, and 
supports and maintains one’s sense of purpose (Darity & Goldsmith, 1996; Shields & 
Wheatley, 2005). Longitudinal and cross-sectional research has linked employment to 
lower mortality, lower psychological distress, higher self-esteem and higher life 
satisfaction (Winefield, Tiggemann, Winefield, 1991; Winefield, Winefield, 
Tiggemann, & Goldney, 1991). In addition to psychological well-being, research has 
also looked at life satisfaction as an indicator of well-being. Relationship status, such 
as being married or being in a stable relationship, has been associated with increased 
life satisfaction (Argle & Martin, 1991; Diener et al., 1999). Burns and Machin (2013) 
speculate that this is due to the increased social support that a partner provides. In 
addition, it is the quality opposed to the quantity of relationships that has been found 
to be most the important factor, with those who have more intimate or high quality 
relationships demonstrating the greatest well-being. In both clinical populations and 
the general population, loneliness has been negatively associated with markers of 
well-being (positive affect and life satisfaction) and positively associated with 
depression (Ames & Roitzsch, 2000; Falcón, Todorova, & Tucker, 2009; Heinrich & 
Gullone, 2006; Lee & Ishii-Kuntz 1987). Importantly in CFS samples, social support 
has been found to moderate health outcomes and reduce illness burden (Saltzstein et 
al., 1998). 
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Research also suggests that evaluations of well-being are influenced by one’s 
personality. In an investigation of the big 5 personality traits, Schmutte and Ryff 
(1997) found that all six PWB dimensions have distinctive personality correlates: 
Self-Acceptance, Environmental Mastery and Purpose in Life were negatively linked 
with Neuroticism and positively linked with Extraversion and Conscientiousness; 
Personal Growth was positively linked with Openness to Experience and 
Extraversion; Positive Relations with Others was positively linked with Agreeableness 
and Extraversion; and Autonomy was negatively linked with Neuroticism. Similarly, 
DeNeve and Cooper (1998) conducted a meta-analysis and reported that extraversion 
and agreeableness were consistently positively associated with SWB, whereas 
neuroticism was consistently negatively associated with it. Diener and Lucas (1999) 
state such findings are intuitive given that extraversion is largely characterised by 
positive affect and neuroticism by negative affect. Other researchers argue that 
affectivity is better conceptualised as a stable trait (individual predispositions to 
certain states) rather than a transient state (fluctuations in mood; Tellegen, 1985; 
Watson & Clark, 1984). 
 
Finally, research has identified biological correlates of well-being. Ryff, Keyes and 
Hughes (2004) found that higher levels of Personal Growth and Purpose in Life were 
associated with better endocrine regulation and lower inflammatory markers in a 
sample of older women. They also documented that higher levels of Environmental 
Mastery were associated with longer periods of REM sleep. Other studies have linked 
higher Purpose in Life to lower levels of cortisol, cardiovascular risk and 
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musculoskeletal symptoms (Lindfors & Lundberg, 2002; Ryff, Singer & Love, 2004). 
Increased social support has been associated with lower blood pressure and stress 
hormones (Uchino, Cacioppo, & Kiecolt-Glaser, 1996), whilst self-enhancing 
thoughts have been linked to lower salivary cortisol and cardiovascular response to a 
laboratory stressor (Taylor, Lerner, Sherman, Sage, & McDowell, 2003). Although it 
is not possible to draw causal conclusions, just as psychological stress has a 
biopsychosocial interaction, these findings infer that psychological well-being could 
enhance the functioning of a number of biological systems that protect against disease 
and promote physical recovery.   
 
1.4.4 Psychological Wellbeing Links With Depression and Chronic Illness 
A broad, multidimensional investigation of well-being has yet to be conducted in 
individuals with CFS, despite mounting evidence that this is a valuable approach in 
healthy individuals and those with depression and other chronic physical health 
conditions such as Fibromyalgia and Rheumatoid Arthritis. Rheumatoid Arthritis is an 
autoimmune disease that causes swelling, stiffness and pain in the joints. Fatigue is a 
frequent and severe complaint of patients, with prevalence rates ranging between 42% 
and 80% depending on the measure used (Repping-Wuts, van Reil & van Achterberg, 
2009). Given the significant diagnostic overlap and high comorbidity between these 
conditions, the well-being profile of these patient-groups may provide a useful 
parallel. Comparing wellbeing in individuals with CFS to individuals with depression 
and fibromyalgia could further add to the debate about whether or not they are a single 
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syndrome. If the well-being profile of CFS were found to be distinct, then it would 
suggest that these conditions have important psychological differences. 
 
Within the well-being literature depression is the most researched mental health 
disorder and there is now robust evidence to suggest that depression arises not only 
from “the presence of the negative”, but also from “the absence of the positive” (Ryff 
& Singer, 1996, p. 21). Several studies have profiled Ryff’s model of PWB in 
depression using clinical and non-clinical samples and findings indicate that 
depression correlates negatively with all six dimensions. In a comparison of depressed 
patients to general population norms, Nierenberg et al., (2010) found that depressed 
individuals scored significantly lower in the domains of Environmental Mastery and 
Self-Acceptance (two standard deviations below the population mean), and lower in 
Purpose in Life and Positive Relations with Others than norms (one standard deviation 
below the mean). In the domains of Personal Growth and Autonomy however, they 
scored within the normal range. In an attempt to control for extraneous variables 
Edmondson and MacLeod (2014) repeated this study but this time comparing 
clinically depressed participants (N= 26) to matched controls. Findings confirmed that 
well-being in depressed individuals is most depleted in the domains of Environmental 
Mastery and Self-Acceptance.  Overall, PWB research highlights the need for 
depression treatments that focus not only on alleviating psychopathology but also on 
promoting well-being; in particular, rebuilding individuals’ sense of control over their 
environment and fostering a more positive self-attitude (Edmondson & MacLeod, 
2014). 
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Mangelli et al. (2002) examined Ryff’s psychological well-being dimensions in 
patients with rheumatoid arthritis. Findings revealed that well-being was largely 
independent of disease variables (disease activity, pain and functioning) and more 
closely related to psychological distress. Compared to a large American community 
sample (Ryff, Lee, Essex & Schmutte, 1994) patients reported significantly lower 
well-being scores across all six dimensions and showed the most marked impairment 
in Personal Growth and Purpose in Life. This is a distinctly different pattern of 
deficits to that observed in depressed samples. Schleicher, Alonso, & Shirtcliff (2005) 
investigated Ryff’s model of PWB in a sample of 57 women with fibromyalgia. 
Findings showed psychological well-being was independent of pain but strongly 
related to self-reported disability. Unfortunately, psychological distress was not 
measured. Compared to two matched groups, one of healthy controls and the other of 
women with rheumatoid arthritis, the fibromyalgia group reported the lowest overall 
PWB and demonstrated significantly greater deficits from the control group mean in 
Environmental Mastery, Self-Acceptance, Positive Relations with Others and Purpose 
in Life, and to a lesser extent Personal Growth.  Their level of Autonomy fell within 
the normal range. Due to the cross-sectional nature of these studies it is not possible to 
draw causal conclusions and the relationship between well-being, disability and 
psychological distress is most likely bidirectional. Findings do however, allude to the 
presence of condition-specific deficits in PWB. They also concur that increasing 
meaningful activity and promoting well-being should be the focus of treatments for 
chronic physical conditions, opposed to reducing physical symptoms per se.  
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1.5 The Present Study  
CFS is a poorly understood condition, with no known cure and only palliative 
treatment options. Previous psychological research into CFS has focused almost 
exclusively on the identification of negative criteria. Yet, therapies such as CBT, 
which focus on reducing negative constructs, produce unsatisfactory recovery rates in 
physical and psychiatric symptoms in this patient group.  Finding ways to enhance the 
efficacy of existing treatments is a clinical priority. Previous research examining 
psychological well-being in other mental and physical health disorders signifies that it 
could equally advance our understanding of CFS. The present study addressed a major 
gap in the literature described above by conducting a theoretically informed, multi-
dimensional investigation of well-being in adults with CFS. Building such a profile 
helps us better understand the experiences of people with CFS, identify new treatment 
targets and distinguish CFS from its co-morbid partners. 
 
The present study firstly examined the relationship between measures of well-being 
and measures of physical symptoms and psychological distress in a sample of adults 
with CFS. Where significant relationships were found, the study then went on to 
investigate whether well-being scores predicted symptoms scores in CFS. No previous 
research has considered CFS’s relationship to Ryff’s dimensions of PWB. Secondly, it 
examined Ryff’s (1989) six domains of PWB in a group of CFS participants, by 
directly comparing their scores to that of a matched, non-clinical control group. More 
information is needed about the profile of well-being in individuals currently suffering 
from CFS so that treatments can be specifically tailored to their needs. Control group 
data was not available for the SPANE, as the two previous studies from which the 
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control data was taken did not include the measure. CFS participants SPANE scores 
were therefore, compared to Diener et al.’s (2010) normative sample. It was predicted 
that well-being dimensions would be related to symptom measures in CFS participants 
and that, compared to non-clinical controls, CFS participants would score lower on all 
measures of well-being. There were however, no grounds for making strong 
predictions. 
 
To summarise the study had two hypotheses: 
Hypothesis 1: CFS participants’ self-reported scores on two measures of wellbeing 
(SPANE and PWB) will be significantly related to their self-reported scores on 
measures of symptoms (the Multi-dimensional Fatigue Inventory and the Pain Visual 
Analogue Scale) and psychological distress (the Hospital Anxiety and Depression 
Scale). Differential relationships between different aspects of well-being and different 
aspects of CFS were of major interest but there was no basis for making strong 
predictions. 
 
Hypothesis 2:  Self-reported ratings of current PWB will be significantly lower in the 
CFS group than the Control group. Differential impairments on the different 
psychological well-being scales were of significant interest; however again there was 
no basis for making strong predictions. 
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Chapter 2: Method 
 
2.1 Ethical Approval 
Ethical approval was obtained from the East of Scotland Research Ethics Committee 
in April 2014 (Appendix I and II). This study was also reviewed and approved by the 
Royal Holloway, University of London Ethics Committee. Permission was gained 
from the Research and Development (R&D) departments at Lincolnshire Partnership 
NHS Foundation Trust and University College London Hospitals NHS Foundation 
Trust (see Appendices III and IV for letters confirming ethical approval). 
 	  
2.2 Design 
A cross sectional, correlational design was used for hypothesis one. Participants were 
administered self-report questionnaires, which assessed symptoms and several 
domains of well-being. The independent variables were symptoms of fatigue, pain, 
anxiety and depression. The dependent variables were the dimensions of PWB (Ryff, 
1989), Positive Affect and Negative Affect. An independent samples design was used 
for hypothesis two, to compare the CFS group to a normative community sample on 
self-reported PWB. On self-reported Positive Affect and Negative Affect 
 
 
2.3 Power Calculation 
The number of participants required was calculated by taking the smallest (0.29) and 
largest  (0.61) effect sizes found in a correlational study examining the relationships 
between Ryff’s six dimensions of PWB and fatigue interference in daily activities, in 
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females with fibromyalgia (Schleicher et al., 2005). In order to conduct correlations 
coefficients, with alpha set to 0.05 and power set to 0.8 (Cohen, 1988), it was 
calculated that the current study required a sample of 29 participants to detect a large 
effect size and 84 for a medium effect size. The total number of CFS participants 
included in this study was 60; therefore a large effect size was attained for hypothesis 
one. 
 
A medium effect size was predicted based on previous findings showing a medium to 
large effect size between clinically depressed and non-clinical participants for self-
reported psychological well-being (Edmondson & MacLeod, 2014). With alpha set to 
0.05 and power set to 0.8 (Cohen, 1988) the current study required a sample of 26 
participants in each group for independent t-tests. The aim however, was not only to 
test significance of difference but the varying magnitude of differences for the 
different subscales; therefore a substantially larger sample was recruited. The total 
number of participants included in each group in this study was 42; therefore, a small 
effect size was attained for hypothesis two. 
 
 
2.4 Sample 
2.4.1 Clinical Participants 
Sixty-two participants with a diagnosis of Chronic Fatigue Syndrome were recruited 
to this study: 39 participants were recruited from two CFS services (one based in 
Lincolnshire and one based in London) and 23 participants were recruited from either 
CFS/ ME support groups, online forums or because they approached the researcher 
directly having seen the study registration on clinicaltrial.gov. Two participants did 
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not meet threshold for severe fatigue, as defined by having a score of 13 or above on 
the General Fatigue subscale or a score of 10 or above on the Reduced Activity 
subscale of the Multidimensional Fatigue Inventory (Reeves et al., 2005). They were 
therefore, excluded from the study leaving a final sample of 60 participants for 
analysis. 
 
The CFS Group consisted of 12 males and 48 females. The mean age was 40.50 years 
(SD = 14.94) with an age range of 18 to 70 years old. Fifty-eight participants 
identified as White British, one participant identified as White Irish and one 
participant identified as Black British. Twenty-two percent stated they had a co-
morbid diagnosis of fibromyalgia. The mean number of years with CFS was 8.08 (SD 
= 7.38; minimum = 0.5, maximum = 30) and the mean time taken to receive a 
diagnosis of CFS from the onset of symptoms was 3.83 years (SD = 4.39). 37.6% of 
participants had previously received treatment for CFS, whilst 63.3% had no history 
of previous treatment. Of the 38 included participants recruited from CFS services, 23 
had been assessed by the service and were on the waiting list to start treatment. The 
other 15 were currently receiving treatment and the mean number of treatment 
sessions received was 7.52 (SD = 4.32; minimum = 1, maximum = 20).  
 
Inclusion criteria for the CFS group were participants must have been over 18 years 
old, living in the United Kingdom and able to read and write fluent English. CFS 
participants recruited from services were required to have a diagnosis of CFS 
confirmed by a physician and a clinical assessment at their current CFS service. CFS 
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participants at all stages of treatment were invited to take part. Participants not 
recruited from a service were asked to confirm that a physician or general practioner 
had given them a diagnosis of CFS. Co-morbid disorders (other than fibromyalgia) 
were not recorded or controlled for. Scores on the Multi-Dimensional Fatigue 
Inventory (MFI-20; Smets, Garssen, Bonke & Haes, 1995) confirmed that all 60 
participants in the final sample were currently experiencing severe fatigue. 
 
2.4.2 Control Participants 
Data for non-clinical, control participants were obtained from two previous doctoral 
thesis studies into psychological well-being (Blackburn, 2014; Edmondson, 2012). 
There were a total of 25 control participants in each study, who were recruited from 
Gumtree, online forums and community settings, such as libraries, community centres 
and job centres.  All control participants completed a demographics questionnaire and 
the 54-item Ryff Scale of Psychological Well-Being (Ryff, 1989; Sewell, Hauser, 
Springer, & Hauser, 2004). 
 
Inclusion criteria for controls in Edmondson’s (2012) study were (1) not currently 
experiencing or seeking treatment for any mental health difficulties; (2) being aged 
between 18 and 65; (3) at the time of testing scoring below the clinical cut off (< 10) 
on the Patient Health Questionnaire (PHQ-9; Spitzer, Kroenke & Williams, 1999); (4) 
at the time of testing scoring below the clinical cut-off (< 8) on the Generalised 
Anxiety Disorder Scale, a self-report measure of anxiety symptoms (GAD-7; Spitzer, 
Kroenke, Williams & Lowe, 2006). Inclusion criteria for controls in Blackburn’s 
(2014) study were (1) not currently experiencing or seeking treatment for any mental 
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health difficulties and (2) at the time of testing scoring below the cut-off (<7) for 
Borderline Personality Disorder symptoms on the McLean Screening Instrument for 
BPD (MSI-BPD, Zanarini, Frankenburg, Hennen & Silk, 2003). Control group mean 
scores were in the non-clinical range on the PHQ-9 (<5) and the GAD-7 (<5), 
indicating no difficulties with depression or anxiety. 
 
The Control group for the current study contained a total of 42 participants, 23 from 
Blackburn’s (2014) study and 19 from Edmondson’s (2012) study.  Starting with CFS 
Participant 1 and working consecutively through the list, each CFS participant was 
matched to a Control participant by finding the closest age (within 5 years), gender 
(female vs. male), ethnicity (white vs. non-white), employment status (unemployed 
vs. not unemployed) and marital status (in a relationship vs. not in a relationship) 
match from either sample. The 12 CFS participants that could not be matched were 
either older, in a relationship or unemployed.  The eight Control participants that 
could not be matched were either male or non-white. All participants that could not be 
matched were excluded. The mean age of the Control group was 34.93 (SD = 11.26); 
69% of Control participants were female and 31% male. Statistical analyses (reported 
in the results section) indicated that there were no significant differences between the 
two groups on any of the matched demographic variables. 
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2.5 Measures 
2.5.1 Demographics Questionnaire 
A questionnaire was designed specifically for this study to gather data about 
participants’ age, gender, ethnicity, level of education, employment status, 
relationship status, number of years with CFS, time taken (from onset of symptoms) to 
receive a diagnosis, previous treatment, number of treatment sessions with current 
CFS service and comorbid fibromyalgia (see Appendix VII for full scale).  
 
2.5.2 The Multidimensional Fatigue Inventory (MFI-20; Smets, et al., 1995)  
The MFI-20 was first developed by a Dutch research group as a tool to 
comprehensively assess the impact of fatigue (see Appendix VII for full scale). It has 
been translated into many languages and validated in patients with CFS, cancer and 
depression (Smets, et al., 1995; Chung, Yu, Yung, Yeung, Ng & Ho, 2014). It is 
comprised of 20-items, divided equally into five scales: General Fatigue, Physical 
Fatigue, Mental Fatigue, Reduced Activity, and Reduced Motivation. General Fatigue 
includes generalised statements about fatigue and decreased functioning for example, 
“I feel tired” and “I feel fit”. Physical Fatigue concerns physical sensations related to 
fatigue, for example “Physically I can take on a lot” and “Physically I feel I am in a 
bad condition”. Mental Fatigue refers to cognitive functioning, including 
concentration difficulties, for example “I can concentrate well” and “My thoughts 
easily wander”. Reduced Activity describes the influence of fatigue on activity levels, 
for example “I feel very active” and “I get little done”. Reduced Motivation relates to 
lack of motivation for initiating activity, for example “I dread having to do things” 
and “I have a lot of plans”. Participants rate each statement according to how they 
	  	   51	  
have been feeling recently, using a five-point Likert scale running from agreement 
with the accompanying statement "yes, that is true" to disagreement "no, that is not 
true". Positively worded items are reverse scored. Higher scores indicate more fatigue. 
The MFI-20 has been shown to have good internal consistency in a large CFS sample 
(N= 357), with relatively good Cronbach’s alpha coefficients for General Fatigue 
(0.83), Physical Fatigue (0.85), Mental Fatigue (0.91) and Reduced Motivation (0.82) 
and an adequate alpha coefficient for Reduced Activity (0.79; Smets et al., 1995). The 
author does not recommend summarising the five subscales to produce a total fatigue 
score. 
 
The Centre for Disease Control and Prevention’s  (CDC; Fuduka et al., 1994) case 
definition of Chronic Fatigue Syndrome uses the MFI-20 to assess fatigue. Severe 
fatigue is defined either as a score of 13 or greater on the MFI general fatigue subscale 
or a score of 10 or greater on the reduced activity subscale (Reeves et al., 2005). 
 
2.5.3 The Pain Visual Analog Scale (VAS; McCormack, Horne & Sheather, 1988) 
This widely used questionnaire assesses subjective perception of pain based on a 10 
cm horizontal line (0 cm= no pain, 10 cm= pain as bad as it could be; see Appendix 
VII for full scale). Participants mark the line at the point they feel represents their 
current pain intensity. The VAS score is determined by measuring in millimetres from 
the left hand end of the line to the point that the patient marks. It is quick, concise and 
easy to administer and score. Bigatti and Cronan (2002) evaluated several pain 
instruments and concluded that in patients with Fibromyalgia the VAS is the most 
useful. It also showed the highest correlation with measures of physical function, 
fatigue and stiffness. In Fibromyalgia patients, a cut-off score of 48.5 mm has been 
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found to give a sensitivity of 80% and a specificity of 80% (Marques, Assumpção, 
Matsutani, Pereira & Lage, 2008).  
 
Cut-off scores were not specifically used in the present study. However, based on the 
distribution of VAS pain scores in a sample of postsurgical patients (knee 
replacement, hysterectomy, or laparoscopic myomectomy) the following cut points 
have been recommended: No pain (0 – 4 mm), mild pain (5– 44 mm), moderate pain 
(45–74 mm) and severe pain (75–100 mm; Jensen, Chen & Brugger 2003).  
 
 2.5.4 The Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 
1983)  
The HADS is a brief clinical measure used as a screening tool and severity measure 
for anxiety and depression in medical and surgical outpatients (see Appendix VII for 
full scale). All items referring to symptoms that may have a physical cause such as 
dizziness, headaches, insomnia and fatigue, have been excluded. For each statement 
participants must select one out of four possible answers, which best reflects how they 
are currently feeling. The HADS contains two 7-item scales, one for anxiety (HADS-
A) and one for depression (HADS-D), both with scores ranging from 0 to 21. A higher 
score indicates higher anxiety or depression and scores for each subscale can be 
categorised as follows: Normal (0-7), mild (8-10), moderate (11-15), and severe (16-
21; Snaith & Zigmond, 1994). Example anxiety items include: “I feel tense or wound 
up” and “I get sudden feelings of panic”. Example depression items include: “I have 
lost interest in my appearance” and “I feel cheerful”. HADS has been used extensively 
and has demonstrated good reliability and validity. In a review of 71 papers using the 
HADS, Bjelland, Dahl, Haug and Neckelmann (2002) concluded it has good internal 
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consistency with a mean alpha of 0.83 for HADS-A and 0.82 for HADS-D. It also has 
good test-retest reliability over a three-week period (HADS-A = 0.89, HADS-D = 
0.86; Spinhoven, Ormel, Sloekers, & Kempen, 1997) and good validity (Bjelland et 
al., 2002). As a screening instrument, a cut-off score of 8 on both scales has been 
found to achieve the optimal balance between sensitivity (80%) and specificity (80%; 
Bjelland et al., 2002).  
 
2.5.5 Ryff Psychological Well-Being Scale (PWB; Ryff, 1989) 
The PWB scale is a theoretically grounded instrument designed to measure six 
dimensions of psychological well-being: Autonomy, environmental mastery, personal 
growth, purpose in life, positive relations with others, and self-acceptance. 
Participants are required to read positively and negatively worded statements and rate 
them on a scale of 1 to 6 (1 = strong disagreement; 6 = strong agreement) according to 
how accurately they reflect their current life (see Appendix VII for full scale). A total 
is calculated for each dimension with a score range of 9 to 54. Table 1 provides Ryff 
and Keyes’s (1995) definition of a high and low score in each dimension. Self-
acceptance concerns having a positive self-regard. Example items include “In general, 
I feel confident and positive about myself” and “I like most aspects of my 
personality”. Positive relations with others refers to whether one has warm, satisfying, 
trusting relationships with others. Example items include “Most people see me as 
loving and affectionate” and “I enjoy personal and mutual conversations with family 
members or friends”. Environmental mastery refers to having a sense of competence 
over one’s environment and day-to-day tasks. Example items include “In general, I 
feel I am in charge of the situation in which I live” and “I am quite good at managing 
the many responsibilities of my daily life”. Autonomy refers to the ability to be 
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independent and self-determining and not look to others for approval. Example items 
include “I tend to worry about what other people think of me” and “Being happy with 
myself is more important to me than having others approve of me”. Personal growth 
refers to an openness to new experiences and having a sense that one is expanding 
over time. Example items include “I don’t want to try new ways of doing things - my 
life is fine the way it was” and “I think it was important to have new experiences that 
challenge how you think about yourself and the world”. Lastly, purpose in life refers 
to having aims and goals in life and example items include “I don’t have a good sense 
of what it is I’m trying to accomplish in life” and “I enjoy making plans for the future 
and working to make them a reality”. 
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Table 1. 
Categories of Psychological Well-Being as described by Ryff and Keyes (1995, 
p.1072) 
 
Self-acceptance 
High scorer:  Possesses a positive attitude toward the self; acknowledges and accepts multiple 
aspects of self, including good and bad qualities; feels positive about past life. 
Low scorer:  Feels dissatisfied with self; is disappointed with what has occurred with past life; 
is troubled about certain personal qualities; wishes to be different than what he or she is. 
Positive relations with others 
High scorer:  Has warm, satisfying, trusting relationships with others; is concerned about the 
welfare of others; capable of strong empathy, affection, and intimacy; understands give and 
take of human relationships. 
Low scorer:  Has few close, trusting relationships with others; finds it difficult to be warm, 
open, and concerned about others; is isolated and frustrated in interpersonal relationships; not 
willing to make compromises to sustain important ties with others. 
Autonomy 
High scorer:  Is self-determining and independent; able to resist social pressures to think and 
act in certain ways; regulates behavior from within; evaluates self by personal standards.  
Low scorer:  Is concerned about the expectations and evaluations of others; relies on 
judgments of others to make important decisions; conforms to social pressures to think and act 
in certain ways. 
Environmental mastery 
High scorer:  Has a sense of mastery and competence in managing the environment; controls 
complex array of external activities; makes effective use of surrounding opportunities; able to 
choose or create contexts suitable to personal needs and values. 
Low scorer:  Has difficulty managing everyday affairs; feels unable to change or improve 
surrounding context; is unaware of surrounding opportunities; lacks sense of control over 
external world. 
Purpose in life 
High scorer:  Has goals in life and a sense of directedness; feels there is meaning to present 
and past life; holds beliefs that give life purpose; has aims and objectives for living. 
Low scorer:  Lacks a sense of meaning in life; has few goals or aims, lacks sense of direction; 
does not see purpose of past life; has no outlook or beliefs that give life meaning. 
Personal growth 
High scorer:  Has a feeling of continued development; sees self as growing and expanding; is 
open to new experiences; has sense of realizing his or her potential; sees improvement in self 
and behavior over time; is changing in ways that reflect more self-knowledge and 
effectiveness. 
Low scorer:  Has a sense of personal stagnation; lacks sense of improvement or expansion 
over time; feels bored and uninterested with life; feels unable to develop new attitudes or 
behaviors. 
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The PWB scale has demonstrated good internal consistency across all six scales 
(alpha range = 0.86–0.93), and good test-retest reliability over a 6-week period (range 
= 0.81–0.88; Ryff, 1989). In terms of its convergent validity the PWB scale has been 
found to correlate positively with other measures of positive functioning (i.e., life 
satisfaction, affect balance, self-esteem, the belief that you have control over events in 
your life, internal control and morale), with coefficients ranging from 0.25 to 0.73 
(Ryff, 1989). Similarly, significant negative correlations have been found between the 
PWB scale and measures of negative functioning (i.e. negative affect, depression, the 
belief that other people have control over events in your life and the belief that chance 
affects your experiences or outcomes) with coefficients ranging from -0.30 to  -0.60 
(Ryff, 1989). 
 
The present study used the 54-item version of the scale. This version is a very widely 
used alternative to the original 78-item scale and demonstrates good psychometric 
properties (Sewell, Hauser, Springer & Hauser, 2004). The 54-item version was used 
for this study because the original version was deemed to long to administer to 
severely fatigued participants and the 18-item version is not recommended for 
research, owing to its poorer internal consistency of subscales (Springer & Hauser, 
2006). 
 
2.5.6 The Scale of Positive and Negative Experience (SPANE; Diener et al., 2010)  
The SPANE is a brief 12-item scale (see Appendix VII for full scale). It has six items 
corresponding to positive emotions including “joyful”, “good”, “pleasant” and 
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“contented” and six items corresponding to negative emotions including “afraid”, 
“angry”, “bad” and “negative”. Participants must rate how much they have 
experienced each emotion in the past four weeks using a 5-point scale ranging from   
“very rarely or never” and to  “very often or always”. The positive and negative scales 
are scored separately and each range from 6 to 30. The two scores can also be 
combined as a scale of balanced affect by subtracting the negative emotion score from 
the positive emotion score. Internal consistency is good (ranging from 0.81-0.89 
across the scales), as is temporal stability (0.62-0.68; Diener et al., 2010). The SPANE 
has performed well in terms of convergent validity with other measures of emotion, 
well-being, happiness and life satisfaction (Diener et al., 2010). 
 
2.6 Recruitment 
Participants were recruited from two CFS services, one based in Lincolnshire and one 
based in London. The Lincolnshire service consists of a small multi-disciplinary team 
of five clinicians (psychologist, occupational therapy, physiotherapist, rehabilitation 
worker and assistant psychologist). The team serves the entire county, providing a 
range of evidenced based therapies to children and adults with CFS. All referrals must 
have been medically screened for differential diagnosis and the referrer assumes that 
the patient fulfils the criteria for CFS in line with NICE (2007) guidance. All 
clinicians were involved in recruiting participants for the current study.   
 
The Royal London Hospital for Integrated Medicine (RLHIM) is the largest public-
sector provider of integrated medicine in Europe and offers conventional and 
complementary treatments for a wide range of conditions. The CFS service consists of 
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a small multi-disciplinary team of five conventionally trained clinicians (a consultant 
physician, an occupational therapist, a physiotherapist, a dietician and a CBT 
therapist). The consultant physician carries out all initial assessments and a diagnosis 
of CFS is made on the basis of a detailed clinical assessment and tests excluding other 
possible causes of fatigue. The consultant physician and occupational therapist were 
involved in recruiting participants for the current study.   
 
Through outpatient clinics, both services offer therapeutic groups and individual 
therapy including components of activity management, stress management, relaxation 
techniques, sleep hygiene, dietary advice, Graded Exercise Therapy and CBT. In 
addition to this, the RLHIM offers acupuncture and homeopathy. 
 
CFS/ ME support groups were identified through social media sites and the ME 
Association website (www.meassociation.org.uk). 
 
 
2.7 Procedure 
Recruitment took place between June 2014 and January 2015. Clinicians in both 
services were informed of the study inclusion criteria and asked to identify and 
approach patients who met the criteria to take part. Eligible CFS participants were 
given a written information sheet (see Appendix V) and clinicians verbally explained 
the study to them, using a statement written by the researcher. Those interested in 
taking part were given a consent form (see Appendix VI) and questionnaire pack to 
take away and complete (see Appendix VII). It was stressed that participation was 
voluntary and that they could leave the study at any time. Participants returned the 
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completed questionnaire and consent form to the researcher using a prepaid, self-
addressed envelope.  
 
CFS participants from support groups were recruited by advertising the study on 
social media sites and emailing support groups listed on the ME Association’s 
website. Participants were asked to email the researcher if they were interested in 
finding out more about the study or taking part. Those who contacted the researcher 
either in response to seeing the study posted on a support group or registered on 
clinicaltrials.gov, were then emailed an information sheet (see Appendix V) and asked 
to provide a postal address if they wished to take part, so that a questionnaire pack and 
consent form could be sent to them. Consent forms and completed questionnaires 
were returned to the researcher using prepaid, self-addressed envelopes. If participants 
wanted further information or had any concerns, the information sheet contained the 
researchers contact details. It also contained the contact details of their trust’s Patient 
Advice and Liaison Service (if recruited from a service) and the Samaritans, if they 
were distressed. On the consent form participants were asked if they would like to 
receive a summary of the results and their contact details were obtained for this 
purpose. 
 
All CFS participants completed the measures in the following order: Demographics 
questionnaire, SPANE, VAS, MFI-20, HADS, and PWB scale. All control 
participants had completed a demographics questionnaire and the PWB scale and 
these were used in the current study. 
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Chapter 3. Results 
Chapter Overview 
This chapter is divided into the sections listed below. Because the correlational 
analyses were the main part of this study they will be presented first, followed by the 
group comparison. Section A examines the relationship between symptomatology and 
wellbeing in CFS, using data from the whole CFS sample (N= 60).  Regression 
analysis is used to examine how multiple facets of well-being correlate jointly and 
independently with a particular symptom measure. Section B examines the profile of 
psychological well-being (PWB) in CFS and compares data from a subgroup of the 
CFS sample (N= 42) to a matched, non-clinical Control group (N= 42). 
3.1 Data Entry 
3.2 Section A 
3.2.1 Data screening 
3.2.2 Participant demographics 
3.2.3 Analyses of self-reported symptoms 
3.2.4 Analyses of self-reported wellbeing  
3.2.5 Hypothesis 1  
3.2.6 Regression Analyses 
3.3 Section B 
3.3.1 Data screening 
3.3.2 Participant demographics 
3.3.3 Hypothesis 2 
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Throughout the chapter, where Levene’s test of homogeneity of variance was 
significant on t-tests, appropriate alternatives were reported. Similarly, where 
Mauchley’s test of sphericity was significant on repeated measure ANOVAs, Huynh-
Feldt values were reported. To control for Type 1 error when conducting multiple 
correlations, a conservative significance value of .01 was used.  
 
3.1 Data Entry 
 Participants’ data were entered into spreadsheets and analysed using IBM SPSS 
Statistical Data Editor version 21. All data were explored for missing data and normal 
distribution. Data were missing for two CFS participants on the single item VAS pain 
scale and for one CFS participant on the entire SPANE scale; this missing data was 
treated as missing. Two CFS participants missed a single item on the Self-Acceptance 
subscale of The Ryff Psychological Well-being categories; their mean scores across 
this subscale were used as substitutions. Skewness and Kurtosis were calculated and 
considered within normal distribution if z-scores were below 2.58 (Field, 2013). 
Outliers that were more than three standard deviations from the mean were 
Winsorised. 
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3.2 Section A 
3.2.1 Data Screening for the CFS Sample (N = 60) 
The HADS-A, HADS-D, VAS, SPANE-POS, SPANE-NEG and participant age for 
the CFS sample were within normal distribution limits and there were no outliers. 
Internal consistencies were calculated for all the scales listed above (except the single-
item VAS) and were shown to be good (Cohen α > 0.8; see Table 2). 
 
The Ryff Psychological Well-being categories (Positive Relationships with Others, 
Environmental Mastery, Personal Growth, Self-Acceptance, Purpose in Life and 
Autonomy) were all within normal distribution limits; one outlier was winsorised in 
the Positive Relationships with Others category. Internal consistencies were tested for 
the six subscales and were all shown to be good (Cohen α > 0.8; see Table 2). 
  
Three subscales on the Multi-dimensional Fatigue Scale (MFI-20) were all 
significantly negatively skewed: General Fatigue (z = -3.69), Physical Fatigue (z =     -
4.25) and Mental Fatigue (z = -3.71). Transformations were performed, which brought 
the data into normal distribution limits and there were no outliers. The Reduced 
Activity and the Reduced Motivation subscales were within normal distribution limits 
and there were no outliers. Internal consistencies were tested for the five MFI-20 
subscales (see Table 2). General Fatigue was below .7 suggesting weaker internal 
consistency than the other subscales; however, at .66 it was close enough to the 
standard cut-off to be used with caution. Previous research based on larger sample of 
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adults with CFS (N=357; Smets et al., 1995) suggests that the internal consistency of 
the General Fatigue subscale is good (0.83). 
 
Table 2.  
Cronbach alphas for the internal consistency of all scales in the CFS sample (N= 60) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scale Subscale Cronbach alpha 
MFI-20 General Fatigue .66 
Physical Fatigue .79 
Mental Fatigue .85 
Reduced Activity .85 
Reduced Motivation .71 
HADS Anxiety .88 
Depression .83 
PWB Autonomy .87 
Environmental Mastery .82 
Positive Relationships with Others .86 
Personal Growth .82 
Purpose in Life .81 
Self Acceptance .85 
SPANE Positive Affect .91 
Negative Affect .85 
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3.2.2 Participants’ Demographics 
Participants’ demographics are reported in Table 3. The majority of participants were 
White British females. The mean number of years with CFS was 8.08 (SD = 7.38; 
minimum = 0.5, maximum = 30) and the mean time taken to receive a diagnosis of 
CFS from the onset of symptoms was 3.83 years (SD = 4.39). Only 21.7% of 
participants had a co-morbid diagnosis of fibromyalgia, which is lower than reported 
in previous studies (35%- 75%; Buchwald & Garrity, 1994; Goldenberg, et al., 1990). 
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Table 3.  
Participant characteristics for the CFS sample 
Demographic Variables CFS 
(N= 60) 
Gender 
     N Female (%) 
     N Male (%) 
 
48 (80%) 
12 (20 %) 
Age (years) 
  Mean (SD) 
 
40.50 (18.81) 
Ethnicity 
     N White British (%) 
     N White Irish (%) 
     N Black British (%) 
 
58 (96.7%) 
  1 (1.7%) 
  1 (1.7%) 
Relationship Status 
    N Single (%) 
    N In a relationship (%) 
    N Married/ Living with a partner (%) 
    N Divorced (%) 
 
22 (36.7%) 
  4 (6.7%) 
29 (48.3%) 
  5 (8.3%)  
Employment Status 
    N Unemployed (%) 
    N Student (%) 
    N Employed Full-time (%) 
    N Employed Part-time (%) 
    N Retired (%) 
Number of hours worked (of those in employment)  
Mean (SD) 
 
25 (41.7%)  
  6 (10.0%) 
  8 (13.3%)  
14 (23.3%)  
  7 (11.7%)  
 
26.98 (11.15) 
Highest Educational Attainment 
    N University degree/ professional qualification (%) 
    N College/ vocational training (%) 
    N A levels (%) 
    N GCSEs  (%) 
    N No qualifications (%) 
    N Missing (%) 
 
24 (40.0%)  
11 (18.3%)  
  7 (11.7%) 
14 (23.3%)  
  3 (5.0%)  
  1 (1.7%) 
Treatment Stage 
     N In a service: Assessment stage (%) 
     N In a service: In treatment (%) 
     N Not in a service (%) 
Number of treatment sessions (of those in treatment) 
Mean SD 
 
23 (38.3%) 
23 (38.3%) 
14 (23.3%) 
 
7.52 (4.32) 
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3.2.3 Analyses of Self-Reported Symptoms 
The mean scores on the three symptoms measures (MFI-20, VAS, HADS) are 
displayed in Table 4. On the General Fatigue subscale 98.3% of participants scored 
above the cut off score (12) for severe fatigue. On the Reduced Activity subscale 
78.3% participants scored above the cut off score (9) for severe fatigue. Participants’ 
mean Mental Fatigue score was comparable to that reported in a previous study by 
Capuron et al. (2006), which found CFS patients exhibited significantly greater MFI 
Mental Fatigue scores (Mean= 14.1, SD= 4.2) than a matched, non-fatigued control 
group (Mean= 6.0, SD= 2.0; t=12.5, p <0.0001). The mean score on the VAS was 
4.63 cm (SD = 2.60). This was below the cut-off score for fibromyalgia patients (4.85) 
and indicates mild pain (Jensen et al., 2003).  However, 44.8% of participants scored 
above this cut-off score. The mean scores on the two HADS subscales were above the 
clinical cut-off scores (7) indicating that the CFS sample on the whole had mild 
depression and anxiety (Bjelland et al., 2002; Snaith & Zigmond, 1994). This finding 
was consistent with HADS depression and anxiety scores reported in previous CFS 
research (Rimes & Chalder, 2010). The proportion of participants scoring above the 
HADS anxiety cut-off score (7) was 65%. The proportion of participants scoring 
above the HADS depression cut-off score (7) was also 65%. 
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Table 4. 
Mean Symptom scores for the CFS sample (N= 60) 
Scale Subscale Mean SD 
 
MFI-20 General Fatigue 17.98 2.12 
Physical Fatigue 16.95 3.37 
Mental Fatigue 15.45 3.85 
Reduced Activity 14.38 4.28 
Reduced motivation 
 
12.92 3.74 
VAS1 Pain 
 
4.63 2.60 
HADS Anxiety 9.65 4.75 
 
Depression 9.02 4.10 
1N= 58 
 
A series of Pearson correlations were utilised to evaluate bivariate relationships 
between symptom variables. Given the number of correlations being performed, a 
conservative significance value of .01 was used to reduce the risk of Type I error. 
 
Correlations between physical symptoms for the CFS sample are shown in Table 5. A 
high level of inter-correlation was found between the five fatigue subscales, with the 
exception of General Fatigue and Mental Fatigue, which showed no significant 
relationship. The strongest correlations were between Physical Fatigue and Reduced 
Activity and General Fatigue and Physical Fatigue.  Pain was not significantly related 
to any of the fatigue subscales.  
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Table 5 
Correlations between physical symptoms for the CFS sample (N = 60) 
 
 General 
Fatigue 
Physical 
Fatigue 
Mental 
Fatigue 
Reduced 
Activity 
Reduced 
Motivation 
Pain1 
 
 
General 
Fatigue 
- .665* 
(p< .001) 
.239 
(p= .066) 
.425** 
(p= .001) 
.492** 
(p< .001) 
.299* 
(p= .022) 
 
Physical 
Fatigue 
 
 - .345** 
(p= .007) 
.716** 
(p< .001) 
.411** 
(p= .001) 
.200 
(p= .132) 
Mental 
Fatigue 
 
  - .455** 
(p< .001) 
.364** 
(p= .004) 
.223 
(p= .092) 
Reduced 
Activity 
 
   - .515** 
(p< .001) 
.297* 
(p = .024) 
Reduced 
Motivation 
    - .131 
(p= .327) 
1 N= 58 
* Correlation is significant at the 0.05 level (2-tailed) 
** Correlation is significant at the 0.01 level (2-tailed) 
 
 
Correlations between physical symptoms and symptoms of psychological distress for 
the CFS sample are shown in Table 6. Depression showed a very high degree of 
correlation with all five fatigue subscales, which was especially pronounced for 
Reduced Motivation and Mental Fatigue. No significant relationship was found 
between Depression and Pain. Anxiety was not significantly related to any measures 
of physical symptoms. However, high levels of Anxiety were associated with high 
levels of Depression (r(58) = .340, p= .008). 
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Table 6 
Pearson correlations between physical and psychiatric symptoms for the CFS sample 
(N= 60) 
HADS General 
Fatigue 
Physical 
Fatigue 
Mental 
Fatigue 
Reduced 
Activity 
Reduced 
Motivation 
Pain1 
Anxiety 
 
0.134 
(p = .306) 
-0.045 
(p = .735) 
 
0.291 
(p = .024)* 
-0.022 
(p = .870) 
0.179 
(p = .170) 
0.183 
(p = .168) 
Depression 0.347** 
(p = .007) 
0.343** 
(p = .007) 
0.579** 
(p < .001) 
0.435** 
(p = .001) 
0.727** 
(p < .001) 
0.323* 
(p = .014) 
1 N= 58 
* Correlation is significant at the 0.05 level (2-tailed) 
** Correlation is significant at the 0.01 level (2-tailed) 
 
 
3.2.4 Analyses of Self-Reported Well-Being  
The mean scores on the two well-being measures (PWB and SPANE) are displayed in 
Table 7. According to Diener et al.’s (2009) normative data, the CFS sample mean for 
Positive Affect fell on the 18th percentile, indicating that 82% of the normed sample 
scored above this. For Negative Affect, the CFS sample mean fell on 85th percentile, 
indicating that only 15% of the normed sample scored above this. Therefore, on the 
whole the CFS sample scored low in Positive Affect and high in Negative Affect. 
There are no published norms for the PWB scale, as it is known to vary by age and 
culture, hence the rationale of creating a matched control group constructed from 
previous studies. 
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Table 7. 
Total well-being scores for the CFS sample (N= 60) 
Wellbeing Subscale 
 
Mean SD 
PWB Autonomy 37.48 9.54 
Environmental Mastery 30.72 8.68 
Positive Relationships with Others 39.18 7.14 
Personal Growth 34.48 8.34 
Purpose in Life 36.20 9.33 
Self Acceptance 
 
31.29 9.59 
SPANE1 Positive Affect 17.71 4.72 
Negative Affect 18.75 4.33 
1 N= 59 
 
 
Correlations between well-being variables for the CFS sample are shown in Table 8. 
On the whole, PWB variables and SWB variables were highly inter-correlated. The 
most striking correlations found were between Environmental Mastery and Self-
Acceptance; Environmental Mastery and Personal Growth; and Purpose in Life and 
Personal Growth. Autonomy showed the weakest correlations with the other PWB 
variables, with only one reaching significance: Autonomy and Self-Acceptance. There 
were also some small to moderate correlations across the SWB and PWB variables, 
the most striking being between Negative Affect and Self Acceptance; Negative 
Affect and Environmental Mastery; and Positive Affect and Self-Acceptance. No 
significant relationship was found between Autonomy and Positive Affect; Positive 
Relations with Others and Positive Affect; and Positive Relations with Others and 
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Negative Affect. The relationships between SWB and PWB dimensions supports 
previous research suggesting they are highly intertwined and reciprocally related. The 
partial overlap nevertheless suggests that they are not synonymous and measuring 
both therefore enhances the broad understanding of wellbeing in CFS. 
 
Table 8 
Correlations between the dimensions of well-being for the CFS sample (N = 60) 
 
 EM PR PG PL SA PA1 NA1 
AU 
 
 
.311* 
(p = .016) 
.277* 
(p = .032) 
.221 
(p = .089) 
.182 
(p = .164) 
.436** 
(p < .001) 
.145 
(p = .272) 
-.405** 
(p = .001) 
 
EM 
 
 
- .337** 
(p = .008) 
.681** 
(p < .001) 
.542** 
(p < .001) 
.768** 
(p < .001) 
.556** 
(p < .001) 
-.572** 
(p < .001) 
PR 
 
 - .592** 
(p < .001) 
 
.504** 
(p < .001) 
.405** 
(p = .001) 
.271* 
(p = .038) 
-.244 
(p = .063) 
PG 
 
  - .741** 
(p <.001) 
.620** 
(p < .001) 
.409** 
(p = .001) 
 
-.340** 
(p = .009) 
 
PL 
 
   - .675** 
(p < .001) 
.438** 
(p < .001) 
-.357** 
(p < .001) 
 
SA     - .571** 
(p < .001) 
-.579** 
(p < .001) 
 
PA1 
 
 
      
- 
-.614** 
(p < .001) 
NA1 
 
      - 
 
Notes: AU = Autonomy, EM = Environmental Mastery, PR = Positive Relations with Others, PL = 
Purpose in Life, PG = Personal Growth, SA = Self-Acceptance, PA = Positive Affect, NA = 
Negative Affect, 1 N= 59, * Correlation is significant at the 0.05 level (2-tailed), ** Correlation is 
significant at the 0.01 level (2-tailed) 
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Pearson r correlations indicated that well-being variables were not significantly 
related to participants’ age, number of years with CFS and time (years) taken to 
receive a diagnosis of CFS from the onset of symptoms (see Table 9). To examine the 
influence of participants’ stage of treatment, a Group (Assessment vs. in treatment vs. 
not in a service) X well-being (Positive Affect, Negative Affect, Environmental 
Mastery, Positive Relations with Others, Purpose in Life, Personal Growth, Autonomy 
and Self-Acceptance) MANOVA was carried out. No main effect of stage of 
treatment was found at the .05 significant level (F(14, 102) = 1.264, p = .243).  
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Table 9 
Correlations between the dimensions of well-being and demographic variables for the 
CFS sample (N = 60) 
 
 Age Years with 
CFS 
Years taken to receive 
a diagnosis of CFS 
from the onset of 
symptoms 
 
AU .330* 
(p = .016) 
 
.061 
(p = .644) 
.013 
(p = .924) 
EM .104 
(p = .429) 
 
.036 
(p = .787) 
.203 
(p = .120) 
PR .025 
(p = .849) 
 
.010 
(p = .938) 
.038 
(p = .774) 
PG -.020 
(p = .878) 
 
-.006 
(p = .962) 
.102 
(p = .438) 
PL .019 
(p = .887) 
 
-.021 
(p = .874) 
.131 
(p = .318) 
SA .147 
(p = .261) 
 
.139 
(p = .288) 
.284* 
(p = .028) 
PA1 -.145 
(p = .275) 
 
.057 
(p = .668) 
.137 
(p = .302) 
NA1 -.114 
(p = .389) 
 
-.032 
(p = .809) 
-.107 
(p = .422) 
Notes: AU = Autonomy, EM = Environmental Mastery, PR = Positive Relations 
with Others, PL = Purpose in Life, PG = Personal Growth, SA = Self-Acceptance, 
PA = Positive Affect, NA = Negative Affect, 1 N= 59, * Correlation is significant 
at the 0.05 level (2-tailed) 
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3.2.5 Hypothesis 1: CFS participants’ self-reported scores on the two measures of 
wellbeing (SPANE and PWB) will be significantly related to their scores on 
measures of symptoms (MFI-20 and VAS) and psychological distress (HADS). 
 
A series of Pearson correlations were utilised to evaluate bivariate relationships 
between wellbeing variables and symptom variables (see Tables 10 and 11). Given the 
number of correlations being performed, a conservative significance value of .01 was 
used to reduce the risk of Type I error. No significant correlations were found between 
Autonomy and the eight symptom measures. In contrast, a high score on 
Environmental Mastery was significantly associated with a low score of all symptom 
measures, particularly psychological distress (Anxiety and Depression). High levels of 
Positive Relations with Others were associated with low levels of Reduced Motivation 
and Depression. High levels of Personal Growth were associated with low levels of 
Mental Fatigue, Reduced Motivation, and Depression. Lastly, high levels of Purpose 
in Life were associated with low levels of Reduced Motivation and Depression, whilst 
high levels of Self-Acceptance were associated with low levels of Mental Fatigue, 
Reduced Motivation, Anxiety and Depression. 
 
In terms of SWB, those high in Positive Affect scored low in General Fatigue, 
Reduced Motivation, Anxiety and most strikingly Depression; whilst those high in 
Negative Affect scored high in Reduced Motivation, Depression and particularly 
Anxiety.  
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Table 10 
Pearson correlations between symptoms and PWB for the CFS sample (N= 60) 
 AU EM PR PG PL SA 
Physical Symptoms 
GF 
 
-.124 
(p = .346) 
 
-.380** 
(p = .003) 
-.273* 
(p = .035) 
-.191 
(p = .144) 
-.194 
(p = .137) 
-.281* 
(p = .031) 
PF 
 
.023 
(p = .864) 
 
-.440** 
(p < .001) 
-.225 
(p = .084) 
-.180 
(p = .168) 
-.198 
(p = .129) 
-.252 
(p = .052) 
MF 
 
-.306* 
(p = .017) 
 
-.464** 
(p < .001) 
-.282* 
(p = .029) 
-.456** 
(p < .001) 
-.314* 
(p = .014) 
-.466** 
(p < .001) 
RA 
 
-.022 
(p = .867) 
 
-.497** 
(p < .001) 
-.148 
(p = .259) 
-.308* 
(p = .017) 
-.163 
(p = .212) 
-.292* 
(p = .024) 
RM -.260* 
(p = .045) 
-.423** 
(p = .001) 
-.464** 
(p < .001) 
-.491** 
(p < .001) 
-.433** 
(p = .001) 
-.415** 
(p = .001) 
 
Pain1 -.231 
(p = .081) 
-.349** 
(p = .007) 
-.155 
(p = .247) 
-.244 
(p = .065) 
-.239 
(p = .071) 
-.214 
(p = .107) 
 
Psychological Distress 
Anx 
 
 
-.538** 
(p < .001) 
-.505** 
(p < .001) 
-.180 
(p = .169) 
-.261* 
(p = .044) 
-.241 
(p = .063) 
-.595** 
(p < .001) 
Dep -.317* 
(p = .013) 
-.594** 
(p < .001) 
-.363** 
(p = .004) 
-.581** 
(p < .001) 
-.614** 
(p < .001) 
-.643** 
(p < .001) 
Notes: AU = Autonomy, EM = Environmental Mastery, PR = Positive Relations 
with Others, PL = Purpose in Life, PG = Personal Growth, SA = Self-Acceptance, 
Anx = Anxiety, Dep = Depression, GF = General Fatigue, PF = Physical Fatigue, 
MF = Mental Fatigue, RA = Reduced Activity, RM = Reduced Motivation,  
1 N= 58, * Correlation is significant at the 0.05 level (2-tailed), ** Correlation is 
significant at the 0.01 level (2-tailed) 
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Table 11 
Pearson correlations between symptoms and SWB for the CFS sample (N= 60) 
 Positive Affect2 Negative Affect2 
 
Physical Symptoms 
General Fatigue 
 
-0.405** 
(p = .007) 
0.251 
(p = .055) 
Physical Fatigue 
 
-0.308* 
(p = .018) 
0.156 
(p = .237) 
Mental Fatigue 
 
-0.279* 
(p = .032) 
0.286* 
(p = .028) 
Reduced Activity 
 
-0.317* 
(p = .014) 
0.151 
(p = .254) 
Reduced Motivation -0.448** 
(p < .001) 
 
0.386** 
(p = .003) 
Pain1 -0.115 
(p = .392) 
 
0.208 
(p = .117) 
Psychological Distress 
Anxiety 
 
-0.400** 
(p = .002) 
0.724** 
(p < .001) 
Depression -0.622** 
(p < .001) 
0.457** 
(p < .001) 
Notes: 1 N= 58, 2 N= 59, * Correlation is significant at the 0.05 level 
(2-tailed), ** Correlation is significant at the 0.01 level (2-tailed) 
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3.2.6. Regression Analyses 
Do CFS Participants’ Scores on Well-Being Measures Predict Their Scores on 
Symptoms Measures? 
Regression analyses examine relationships between variables and cannot establish 
causality. Multiple regression was utilised in the present study to examine 1) the 
relationship between different facets of well-being together and a specific symptom 
and 2) how the different facets of well-being related to a particular symptom when 
they were controlled for each other.   
.   
 
3.2.6.1 Demographic Predictors 
Before examining the predictive power of the well-being variables, the predictive 
power of several demographics variables were computed to check whether they would 
need to be taken into account. A conservative significance value of .01 was used for 
consistency. 
 
Pearson r correlations indicated that participant age, number of years with CFS and 
years taken (from onset of symptoms) to receive a diagnosis of CFS, were not 
significantly related to any of the symptom measures (General Fatigue, Physical 
Fatigue, Mental Fatigue, Reduced Activity, Reduced Motivation, Pain, Anxiety and 
Depression; see Appendix VIII). Relationship status was collapsed to two categories: 
In a relationship vs. not in a relationship. Independent sample t-tests revealed no 
significant difference in symptom severity between groups (see Appendix IX). 
Employment status was also collapsed into two categories: unemployed vs. not 
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unemployed. Independent sample t-tests revealed no significant difference in 
symptom severity between groups (see Appendix X). 
 
To examine the influence of participants’ stage of treatment, a Group (Assessment vs. 
in treatment vs. not in a service) X Symptom (General Fatigue, Physical Fatigue, 
Mental Fatigue, Reduced Activity, Reduced Motivation, Pain, Anxiety and 
Depression) MANOVA was carried out. A main effect of stage of treatment was 
found at the .05 significance level (F(16, 98) = 1.792, p = .043). All univariate 
ANOVAs were non-significant at the .05 level with the exception of Reduced Activity 
(F(2, 55) = 4.017, p = .024; see Appendix XI for non-significant results). Post hoc t-
tests revealed that CFS participants currently receiving treatment were significantly 
more active (Mean = 12.35, SD = 3.601) than those recruited at the assessment stage 
(Mean = 15.43, SD = 4.315; t(44) = 2.634, p = .012) and those not in services (Mean 
= 16.00, SD = 4.169; t(35) = 2.819, p = .008). No significant difference in activity 
levels was found between participants at the assessment stage and those not in 
services (t(35) = .391, p = .698). 
 
3.2.6.2 Well-being Predictors 
A series of multiple regression analyses were conducted to establish whether well-
being variables predicted physical symptoms and symptoms of psychological distress 
in CFS participants. All correlations between well-being dimensions and symptoms 
found to be significant at the .01 level were included in the regression. All symptoms 
were examined independently; however, the researcher was aware that they were 
highly correlated and therefore, dependent.  
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Three diagnostic tests were completed for each regression model. All assumptions 
were met and the models were considered to be generalisable and a good fit of the 
observed data. Cook’s distances were all less than one, indicating that there were no 
significant outliers (Cook & Weisberg, 1982). Variance Inflation Factors were all less 
than 10, indicating acceptable multicollinearity (Myers, 1990). Standardised residuals 
indicated that the models were an acceptable fit of the sample data (95% of z scores 
were between -1.96 and +1.96, 99% of scores were between -2.58 and +2.58 and 
99.9% were between -3.29 and +3.29). 
 
3.2.6.3 General Fatigue  
A standard multiple regression was performed with General Fatigue as the dependent 
variable and Environmental Mastery and Positive Affect, as independent variables. 
The model accounted for a significant amount of variance in General Fatigue (R2 = 
.219, Adjusted R2 = .191, F(2, 56) = 7.857, p = .001). The partial regression 
coefficients showed that none of predictors made a unique contribution to General 
Fatigue: Environmental Mastery (t(58) = 1.995, p = .051) and Positive Affect (t(58) = 
1.740, p = .087). Therefore, although the model showed a significant relationship to 
General Fatigue, this was not carried uniquely by either of the wellbeing predictors. 
 
3.2.6.4 Mental Fatigue 
A standard multiple regression was performed with Mental Fatigue as the dependent 
variable and Environmental Mastery, Personal Growth, and Self Acceptance, as 
independent variables. The model accounted for a significant amount of variance in 
Mental Fatigue (R2 = .270, Adjusted R2 = .231, F(3, 56) = 6.915, p < .001). However, 
the partial regression coefficients showed that none of predictors made a unique 
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contribution to Mental Fatigue: Environmental Mastery (t(58) = .757, p = .452), 
Personal Growth (t(58) = 1.398, p = .168) and Self Acceptance (t(58) = 1.180, p = 
.243). 
 
3.2.6.5 Reduced Activity 
A hierarchical multiple regression was performed with Reduced Activity as the 
dependent variable and treatment stage and Environmental Mastery as independent 
variables. Treatment stage was collapsed from three levels (assessment vs. in 
treatment vs. not in a service) into two levels (in treatment vs. not in treatment). The 
aim was to see what the combined predictive power of these variables was and also to 
determine the extent to which Environmental Mastery accounted for variance in 
Reduced Activity Levels, after the effects of treatment stage had been accounted for. 
Therefore, treatment stage was entered as the first step in a hierarchical regression in 
order to partial out any contribution to Reduced Activity levels. Treatment stage 
explained a significant amount of variance in Reduced Activity Levels  (R2 = .143, 
Adjusted R2 = .129, F(1, 58) = 9.704, p =.003). More importantly the predictor 
variable at step 2 (Environmental Mastery) contributed to a significant increase in 
variance from 14.3% to 30.3%, adjusted R2 = 0.279, a change that was highly 
significant (F(1, 57) = 13.083, p < .001). In the final equation, Environmental Mastery 
(B = -.207, β = -.420, t(58) = 3.617, p = .001) and to a lesser extent treatment stage (B 
= 2.169, β = .249, t(58) = 2.140, p = .037) made significant unique contributions to 
explaining Reduced Activity levels. 
 
 
 
	  	   81	  
3.2.6.6 Reduced Motivation 
A standard multiple regression was performed with Reduced Motivation as the 
dependent variable and Environmental Mastery, Positive Relations with Others, 
Personal Growth, Purpose in Life, Self Acceptance, Positive Affect and Negative 
Affect as independent variables. The model accounted for a significant amount of  
variance in Reduced Motivation  (R2 = .371, Adjusted R2 = .285, F(7, 51) = 4.296, p = 
.001). The partial regression coefficients showed that only Positive Relations with 
Others (B = -.157, β = -.299, t(58) = 2.026, p = .048) made an independent 
contribution to Reduced Motivation. Environmental Mastery (t(53) = .206, p = .837), 
Personal Growth (t(53) = .725, p = .472), Purpose in Life (t(53) = .101, p = .920), Self 
Acceptance (t(53) = .297, p = .767), Positive Affect (t(53) = 1.527 p = .133) and 
Negative Affect (t(53) = .798, p = .429) did not. Overall, the model showed a 
significant relationship to Reduced Motivation, the only unique predictor of which 
was Positive Relations with Others. 
 
3.2.6.7 Depression 
A standard multiple regression was performed with Depression as the dependent 
variable and Environmental Mastery, Positive Relations, Personal Growth, Purpose in 
Life, Self-Acceptance, Positive Affect and Negative Affect as independent variables. 
These seven variables accounted for a significant amount of variance in Depression 
(R2 = .558, Adjusted R2 = .498, (F(7, 51) = 9.207, p < .001). The partial regression 
coefficients showed that Positive Affect (B = -.299, β = -.351, t(53) = 2.756, p = .008)  
made an independent contribution to Depression. However, the other predictors were 
not independently associated with Depression: Environmental Mastery (t(53) = .471, p 
= .640), Positive Relationships with Others (t(53) = .410, p = .684), Personal Growth 
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(t(53) = .534, p = .596), Purpose in Life (t(53) = 1.154 p = .254), Self Acceptance 
(t(53) = 1.098, p = .277) and Negative Affect (t(53) = .185, p = .854). Therefore, the 
model showed a significant relationship to Depression, the only unique predictor of 
which was Positive Affect.  
 
3.2.6.8 Anxiety 
A standard multiple regression was performed with Anxiety as the dependent variable 
and Autonomy, Environmental Mastery, Self Acceptance, Positive Affect and 
Negative Affect as independent variables. These five variables accounted for a 
significant amount of variance in Anxiety (R2 = .632, Adjusted R2 = .597; F(5, 53) =  
18.172, p <.001;). The partial regression coefficients showed that Autonomy (B = -
.108, β = -.217, t(55) = 2.205, p = .032) and Negative Affect (B = .623, β = .564, t(55) 
= 4.693, p < .001) made significant, unique contributions to Anxiety. However, 
Environmental Mastery (t(55) = .010, p = .992), Self Acceptance (t(55) = 1.779, p = 
.081) and Positive Affect (t(55) = 1.069, p = .290) were not independently associated 
with Anxiety. Therefore, the model showed a significant relationship to Anxiety, the 
only unique predictors of which were Negative Affect and to a lesser extent 
Autonomy. 
 
 
A summary of the regression analyses is presented in Table 12. The 0.05 column is 
shown for completeness; however, 0.01 was used as the significance level. All 
regression models were significant. In terms of physical aspects of fatigue (physical 
fatigue and reduced activity) and pain intensity, Environmental Mastery was found to 
be a unique predictor: A high level of Environmental Mastery predicted a low level of 
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pain intensity, physical fatigue and Reduced Activity. Reduced Motivation, a 
psychological aspect of fatigue was strongly related to all aspects of well-being and 
uniquely predicted by Positive Relations with Others: A high level of Positive 
Relations with Others predicted a low level of Reduced Motivation. In terms of 
predicting psychological distress, a high level of Positive Affect uniquely predicted a 
low level of Depression and a low level of Negative Affect and to a lesser extent a 
high level of Autonomy, predicted a low level of Anxiety. 
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Table 12.  
     Summary of regression analyses 
 
 
 
 
 
Symptom        Significant Correlation Variance 
Explained by 
Model (%) 
Unique 
Predictor in 
Model 
 
.05 .01 
 
General Fatigue 
 
EM, PR, SA 
PA 
 
 
EM 
PA 
 
21.9 
 
- 
Physical Fatigue EM 
PA 
 
EM 19.4 EM 
Mental Fatigue AU, EM, PR, PG, 
PL, SA 
PA, NA 
 
EM, PG, SA 27.0 - 
Pain EM 
 
EM 12.2 EM 
Reduced Activity EM, PG, SA 
PA 
 
EM 
 
30.3 EM 
Treatment stage 
Reduced 
Motivation 
AU, EM, PR, PG, 
PL, SA 
PA, NA 
 
EM, PR, PG, PL, 
SA 
PA, NA 
37.1 PR 
Depression AU, EM, PR, PG, 
PL, SA 
PA, NA 
 
EM, PR, PG, PL, 
SA 
PA, NA 
55.8 PA 
Anxiety AU, EM, PG, SA 
PA, NA 
 
AU, EM, SA  
PA, NA 
63.2 NA 
AU 
Notes: AU = Autonomy, EM = Environmental Mastery, PR = Positive Relations with Others, PL 
= Purpose in Life, PG = Personal Growth, SA = Self-Acceptance, PA = Positive Affect, NA = 
Negative Affect. 
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3.3 Section B 
The data for non-clinical, control participants was obtained from two previous 
doctoral thesis studies into psychological well-being (Blackburn, 2014; Edmondson, 
2012). A total of 50 Control participants were available to match with the CFS 
participants. Forty-two Control participants were successfully selected to match forty-
two CFS participants on the basis of age, gender (female vs. male), ethnicity (white 
vs. non-white), employment status (unemployed vs. not unemployed) and marital 
status (in a relationship vs. not in a relationship). This left 8 control participants and 
18 CFS participants who were unmatched and therefore, excluded. 
 
3.3.1 Data Screening 
In the CFS group (N = 42) the six PWB were all within normal distribution limits and 
there were no outliers. In the Control group, five of the PWB categories 
(Environmental Mastery, Personal Growth, Self-Acceptance, Purpose in Life and 
Autonomy) were within normal distribution limits and there were no outliers.  The 
Positive Relations with Others category was significantly negatively skewed (z = -
3.54) in the Control Group. Therefore, transformations were carried out for both 
groups, which resulted in them being normally distributed.  
 
3.3.2 Participant Demographics 
Demographics for the two groups are displayed in Table 13. The mean age for the 
Control group (N = 42) was 34.93 years (SD = 11.26). The mean age for the CFS 
group (N= 42) was 36.13 years (SD = 13.11). Independent sample t-test indicated that 
the two groups did not differ significantly in mean age (t(82) = 0.449, p = .654). 
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Current employment status was collapsed to unemployed/ not unemployed; both 
groups had 16 participants who were unemployed and 26 participants who were not 
unemployed. 
 
Chi-square tests were carried out on the other demographic categories (Gender, 
Ethnicity and Relationship Status). Results showed that Gender (X2(1) = 0.233, p = 
.629) did not differ significantly between the Control group and the CFS group. 
Ethnicity was collapsed to white/ non-white and there was no significant difference 
between the two groups (X2(1) = 3.111, p = .078). Relationship status was collapsed 
to in a relationship/ not in a relationship and there was no significant difference 
between groups (X2(1) = 1.730, p = .188). 
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Table 13.  
Participant Characteristics for the CFS and Control group 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.3 Hypothesis 2: Ratings of Current PWB will be Significantly Lower in the 
CFS Group than the Control group 
In order to examine group differences in PWB variables a Group (CFS group vs. 
Control group) X PWB (Positive Relations with Others, Environmental Mastery, 
Personal Growth, Self-Acceptance, Purpose in Life, and Autonomy) mixed model 
ANOVA was conducted. Huynh-Feldt was used because Mauchly’s test of sphericity 
was significant. A significant main effect of PWB was found (F(2.96, 242.86) = 
183.89, p<.001), suggesting that the six PWB category scores differed significantly 
from each other. There was also a significant main effect for Group (F(1,82) = 130.39, 
Demographic Variables CFS Group 
(N= 42) 
Control Group 
(N= 42) 
 
Gender 
     N Female (%) 
     N Male (%) 
 
31 (73.8%) 
11 (26.2 %) 
 
29 (69.0%) 
13 (31.0%) 
Age (years) 
     Mean (SD) 
 
36.13 (13.11). 
 
34.93 (11.26) 
Ethnicity 
     N White (%) 
     N Non-White (%) 
 
40 (95.2%) 
  2 (4.8%) 
 
35 (83.3%) 
  7 (16.7%) 
Relationship Status 
     N In a relationship (%) 
     N Not in a relationship (%) 
 
22 (52.4%) 
 20 (47.6%) 
 
16 (38.1%) 
 26 (61.9%) 
Employment Status 
     N Unemployed (%) 
     N Not Unemployed 
 
16 (38.1%)  
  26 (61.9%) 
 
16 (38.1%)  
  26 (61.9%) 
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p<.001), where the Control Group had a higher PWB score than the CFS  Subgroup. 
The interaction of Group and PWB category was significant (F(2.96, 242.86) = 22.76, 
p<.001), indicating that the difference between the CFS  group and the Control group 
varied across PWB variables.  
 
Post hoc Fisher’s protected t-tests compared the CFS group and Control group on the 
PWB variables (see Table 14 for means). The CFS group scored significantly lower 
(more negative) than the Control group on Environmental Mastery, Positive 
Relationships with Others, Personal Growth, Purpose in Life and Self-Acceptance. 
There was no significant difference between the two groups on Autonomy.  
Table 14 
Means and standard deviations of the self-report scales of PWB for the CFS and 
Control groups and significance of difference between the groups. 
 
PWB Category CFS  
Mean (SD) 
 
Control  
Mean (SD) 
t(82) p 
Autonomy 36.52 (8.86) 
 
39.52 (8.92) 1.55  .130 
Environmental Mastery 30.10 (7.83) 42.57 (6.59) 
 
7.90 <.001* 
Positive Relations  38.24 (6.98) 45.05 (8.02) 
 
3.29  .002* 
Personal Growth 34.52 (7.96) 46.31 (5.79) 
 
7.76 <.001* 
Purpose in Life 35.95 (9.64) 42.83 (6.60) 
 
3.82 <.001* 
Self Acceptance 30.16 (8.90) 41.69 (6.92) 
 
6.63 <.001* 
*Difference significant at the 0.01 significance level (2 tailed) 
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Therefore, there was partial support for hypothesis 2. As predicted the CFS group 
scored significantly lower than the Control group on five of the six PWB subscales. 
There was no significant difference between the CFS and Control group in their scores 
on the Autonomy subscale of PWB.  
 
To profile the PWB of the CFS group, a comparison was made using the Control 
group scores as baseline scores for each dimension of PWB. Each CFS participant’s 
score for a dimension was calculated as the distance from the Control group (baseline) 
mean and divided by the Control group standard deviation, to produce a set of 
standardised scores.  The CFS group scores shown in Figure 1 therefore, represent 
standard deviations from the Control group mean.  
 
The CFS group scored below the Control group mean on all six dimensions. Personal 
Growth was more than two standard deviations from the Control group mean; 
Environmental Mastery and Self Acceptance were more than 1.5 standard deviations 
from the Control group mean; Purpose in Life was over one standard deviation from 
the Control group mean; Positive Relationships with Others was over 0.5 standard 
deviations from the Control group mean; Autonomy was the nearest dimensions to the 
Control group mean, at less than 0.5 standard deviations below it. 
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Figure 2: Psychological well-being profile of the CFS group relative to the Control 
group baseline (where units represent standard deviations of CFS group scores from 
control group mean). 
 
A repeated measures ANOVA showed a main effect of CFS group profile scores 
(F(3.98,163) = 22.93, p < .001). Post hoc Fisher’s protected paired-samples t-tests 
compared the CFS group’s category profile scores to each other. Nine significant 
differences were found (see Table 15). Personal Growth, Environmental Mastery and 
Self-Acceptance were significantly lower than the other three variables, and did not 
differ significantly from each other. To summarise, the CFS group had the largest 
deficits in Personal Growth, Environmental Mastery and Self-Acceptance and to a 
lesser extent Purpose in Life and Positive Relations with Others. Their level of 
Autonomy was comparable to that of the Control group and therefore fell within 
normal limits. 
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Table 15 
Mean differences between the Ryff Psychological Well-being Profile scores for the 
CFS group. 
 Autonomy Environ
-mental 
Mastery 
Positive 
Relations 
 
 
Personal 
Growth 
Purpose 
in Life 
Self-
Acceptance 
Autonomy 
 
 
- < .001* .014 < .001* .012 .001* 
Environ-
mental 
Mastery 
 
 - < .001* .351 < .001* .107 
Positive 
Relations 
 
  -   < 
.001* 
.332  < .001* 
Personal 
Growth 
 
   -  < .001*   .047 
Purpose in 
Life 
 
    - .001* 
Self-
Acceptance 
     - 
* Mean difference significant at the 0.01 significance level (2 tailed) 
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Chapter 4: Discussion 
 
Chapter Overview 
Previous psychological research into CFS has focused almost exclusively on the 
identification of negative mental processes, whilst positive mental processes have 
been relatively ignored. In patients with CFS, therapies that focus on reducing 
negative criteria, such as CBT, produce unsatisfactory recovery rates in symptoms 
relating to fatigue and psychological distress. Finding ways to enhance the efficacy of 
existing treatments is a clinical priority (Price et al, 2008). Research into related 
conditions like chronic pain, rheumatoid arthritis and depression suggests that 
individuals who maintain positive affect and psychological well-being, experience 
less distress and disability. Therefore, the present study attempted to focus on positive 
psychological functioning and the relationship it may have to symptoms of fatigue, 
pain and psychological distress in CFS. This is the first reported study to conduct a 
theoretically informed, multi-dimensional investigation of well-being in adults with 
CFS, incorporating both aspects of Psychological Well-Being  (as operationally 
defined by Ryff, 1989), and Subjective Well-Being (as operationally defined by 
Diener et al., 2010). It was suggested that building a profile of well-being would help 
us better understand the experiences of people with CFS, identify new treatment 
targets and distinguish CFS from its co-morbid partners. 
 
The first objective was to examine the relationships between symptomatology and 
dimensions of psychological and subjective well-being in CFS. It was predicted that 
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participants’ self-reported scores on two measures of wellbeing (SPANE and PWB) 
would be significantly related to their self-reported scores on measures of symptoms 
(Fatigue, Pain) and psychological distress (Anxiety, Depression). Where relationships 
were found to be significant at the 0.01 level, the second objective was to examine 
whether participants’ scores on well-being variables could predict their scores on 
measures of symptoms and psychological distress. The third objective was to examine 
the profile of psychological well-being in CFS participants. It was predicted that the 
CFS group would report significantly lower scores on Ryff’s six dimensions of 
psychological well-being, than a matched, non-clinical Control group.  
 
This chapter will begin by providing a summary of the study’s findings. Although an 
examination of group differences in well-being between the CFS and Control groups 
was not the main part of the study and was presented second in the results, it will be 
presented here first for coherence. The relationships between measures of 
symptomatology and well-being will then be examined second. Findings will be 
interpreted in light of existing research, before discussing the limitations of the study, 
its clinical implications and suggestions for future research.  
 
4.1 Summary of Findings 
As was expected from the CFS population, the sample in the present study was 
predominantly female and contained participants with a wide range of ages and 
durations of CFS. Fatigue was measured using the Multi-dimensional Fatigue 
Inventory, which comprehensively assesses physical and psychological components of 
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fatigue. All CFS participants included in the study met criteria for severe fatigue. Only 
21.7% of participants had a co-morbid diagnosis of fibromyalgia, which was lower 
than reported in previous research (35%- 75%; Buchwald & Garrity, 1994; 
Goldenberg et al., 1990). Pain was measured using the Pain Visual Analogue Scale 
and on average, the CFS group scored below the cut-off for fibromyalgia, indicating 
mild pain. Psychological distress was measured using the Hospital Anxiety and 
Depression Scale. Approximately two thirds of the sample scored above the cut off for 
clinically significant anxiety and depression, which is consistent with rates of 
psychological distress reported in existing CFS research (Bell, 1991; Taerk Toner, 
Salit, Garfinkel & Ozersky, 1987). Participants’ scores across the five fatigue 
subscales were highly correlated, in particular Physical Fatigue and Reduced Activity. 
No relationship was found between General Fatigue and Mental Fatigue. Strong 
bivariate relationships were found between Depression and the Fatigue dimensions, in 
particular Reduced Motivation and Mental Fatigue. No significant bivariate 
relationships were found between Fatigue, Pain and Anxiety. Compared to Diener et 
al.’s (2010) normative sample, the CFS sample reported high levels of Negative 
Affect and low levels of Positive Affect, indicating that they were low in SWB. This 
contests Marshall et al.’s (1996) previous finding that CFS patients’ had relatively 
normal levels of negative affect. PWB dimensions were strongly inter-correlated, in 
particular Environmental Mastery and Self-Acceptance; Environmental Mastery and 
Personal Growth; and Purpose in Life and Personal Growth. SWB dimensions showed 
the strongest relationships to Environmental Mastery and Self Acceptance. Well-being 
variables were not related to demographic variables. 
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A subgroup of the CFS sample was matched on demographics (age, gender, ethnicity, 
relationship status and employment status) to a non-clinical Control group and there 
were no significant differences between groups. Successful matching of these factors 
was deemed to be a significant strength of the present study, as previous research 
suggests they can affect well-being (Diener et al., 1999; Ryff, 1995; Ryff & Singer, 
2008). Compared to the Control group, the CFS group reported significantly lower 
psychological well-being scores on five of Ryff ‘s six dimensions (Environmental 
Mastery, Positive Relations with Others, Personal Growth, Purpose in Life, and Self-
Acceptance). There was no significant difference found between the CFS and Control 
groups’ scores on the Autonomy subscale. This provided partial support for the 
present study’s second hypothesis, which predicted that the CFS group would show 
deficits across all domains of psychological well-being. The greatest deficits observed 
in the CFS group from the Control group mean were Personal Growth (being open to 
new experiences and considering the self as growing and expanding over time), 
Environmental Mastery (being able to choose and create environments that meet ones 
specific needs), and Self-Acceptance (being able to positively evaluate oneself and 
one’s past life, acknowledging the presence of good and bad qualities in the self), and 
to a lesser extent Purpose in Life (having goals, intentions and a sense of direction 
which contributes to the feeling that life is meaningful) and Positive Relations with 
Others (having warm and trusting interactions). Their level of Autonomy (being able 
to evaluate oneself according to personal standards and not look to others for 
approval) was comparable to that of the Control group and thus, within normal limits.  
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Correlational analyses revealed that in CFS, well-being dimensions were largely 
independent of physical symptoms, namely levels of Pain intensity, Physical Fatigue 
(referring to physical sensations related to fatigue), Reduced Activity (referring to the 
influence of fatigue on activity levels) and General Fatigue (referring to general 
aspects of fatigue and impaired functioning). The exceptions were Environmental 
Mastery, which showed a moderate, negative association with all physical symptoms 
and Positive Affect, which showed a moderate, negative association with General 
Fatigue. 
 
In comparison to physical symptoms, well-being in CFS showed a much greater 
association with the presence of psychological components of fatigue and 
psychological distress, namely Mental Fatigue, Reduced Motivation, Anxiety and 
Depression. The presence of Depression and Reduced Motivation (for initiating 
activity) were related to low levels of all well being dimensions, with the exception of 
Autonomy. The presence of Mental Fatigue was independent of SWB but moderately 
associated with low levels of three PWB dimensions: Self-Acceptance, Environmental 
Mastery and Personal Growth. The presence of Anxiety was related to low levels of 
SWB and three PWB dimensions: Autonomy, Self-Acceptance, and Environmental 
Mastery. 
 
A series of multiple regression analyses were conducted to establish whether well-
being variables predicted symptoms in CFS participants. Environmental Mastery 
uniquely predicted lower levels of Physical Fatigue (explaining 19% of the variance), 
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Reduced Activity (explaining 30% of the variance when entered into a model with 
treatment stage), and Pain (explaining 12% of the variance). Environmental Mastery 
and Positive Affect together predicted lower levels of General Fatigue (explaining 
22% of the variance). Environmental Mastery, Self Acceptance and Personal Growth 
predicted lower levels of Mental Fatigue (explaining 27% of the variance). A model 
containing all the well-being variables (except Autonomy) was found to predict lower 
levels of Reduced Motivation (explaining 37% of variance), which was uniquely 
carried by Positive Relations with Others and; lower levels of Depression (explaining 
56% of variance), which was uniquely carried by Positive Affect. Finally, a model 
containing Autonomy, Environmental Mastery, Self Acceptance, Positive Affect and 
Negative Affect predicted lower levels of Anxiety (explaining 63% of the variance); 
an effect that was uniquely carried by Negative Affect and to a lesser extent 
Autonomy. 
 
In summary, partial support was found for hypothesis 1. In CFS, psychological 
components of fatigue and psychological distress were significantly related to several 
aspects of well-being. Reduced Activity levels and physical symptoms of fatigue and 
pain however, were largely independent of well-being dimensions. 
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4.2 Interpretations of Findings 
4.2.1 CFS and Psychological Well-being 
As previously stated, the CFS group had significantly lower psychological well-being 
scores than the Control group across all dimensions, with the exception of Autonomy, 
where their level was within normal limits. This highlights the burden of CFS beyond 
symptoms and is consistent with research associating CFS with reduced emotional 
health, life satisfaction, social functioning and occupational functioning (Collin, et al., 
2011; Rakib, et al., 2005; Schoofs et al., 2004). It also supports previous findings on 
Ryff psychological well-being scores in other physical and mental health disorders, 
where clinical participants have consistently reported lower levels of psychological 
well-being than the general population (Mangelli et al., 2002; Nierenberg et al., 2010; 
Schleicher, et al., 2005). The pattern of deficits however, varies between conditions. 
Compared to other physical health (fibromyalgia) and mental health (depression and 
borderline personality disorder) conditions the CFS group in the present study 
demonstrated a distinct pattern of deficits, with the greatest differences observed 
between the CFS and Control group means in Environmental Mastery, Personal 
Growth and Self-Acceptance. In comparison, fibromyalgia (Schleicher, et al., 2005), 
depressed (Edmondson, 2012) and borderline personality disorder (Blackburn, 2014) 
participants showed the greatest difference from their control group means in 
Environmental Mastery, Self Acceptance and Positive relations with Others. This 
suggests that there maybe fundamental differences in the experience and impact of 
living with CFS. However, further research directly comparing matched samples of 
CFS participants to participants with fibromyalgia, depression or borderline 
personality disorder is required to verify such conclusions.   
	  	   99	  
To provide a context for the magnitude of deficits in the CFS group, the psychological 
well-being profiles of Edmonson and MacLeod’s (2014) depressed sample and 
Blackburn’s (2014) Borderline Personality Disorder (BPD) sample are shown in 
Figure 3. Unfortunately, no other studies have examined the profile of PWB in CFS, 
fibromyalgia or rheumatoid arthritis, where the six psychological well-being 
dimension scores in the Control Group act as a baseline for comparison and the 
clinical groups’ standard deviation differences to these mean baseline scores are 
explored. As a result, Mangelli et al.’s (2002) rheumatoid arthritis sample and 
Schleicher et al.’s (2005) fibromyalgia sample could not be included in Figure 3. 
Edmonson and MacLeod (2014) profiled PWB in depression, controlling for 
confounding factors by comparing patients to a matched non-clinical control group. 
Given the high co-morbidity between CFS and depression, and that 65% of CFS 
participants in the current study scored above the clinical cut-off for depression, 
depressed patients were considered the next reasonable alternative for comparison. 
Individuals with BPD typically experience difficulties with impulsivity, managing 
their emotions, unstable images of self and unstable interpersonal relationships (DSM-
5; American Psychiatric Association, 2013). There is some limited evidence to 
suggest that compared to the general population, personality disorders are more 
prevalent in CFS patients (Henderson & Tannock, 2004; Johnson, DeLuca, Natelson, 
1996; Nater et al., 2010). Reported rates of BPD in CFS range from 1.8% to 17% 
(Johnson et al., 1996). It was therefore considered that the profile of PWB in BPD 
patients would also make an interesting comparison.  
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Figure 3: Psychological well-being profile of the present study’s CFS group 
compared to Edmondson & MacLeod’s (2014) depressed group and Blackburn’s 
(2014) BPD group (where units represent standard deviations of patient group scores 
from their control group mean).	  
	  
Edmondson and MacLeod (2014) compared 26 patients with depression to 26 non-
clinical controls. Depressed patients ranged in age from 18 – 60 years (Mean= 38.85, 
SD  = 10.91) and were mostly female (65%), White British (65%), and not in a 
relationship (58%). Blackburn (2014) compared 24 patients with Borderline 
Personality Disorder (BPD) who were currently receiving treatment to 24 non-clinical 
controls. BPD participants ranged in age from 18 – 60 years (M = 34.46, SD = 8.31) 
and were mostly female (63%), White British (54%), and not in a relationship (75%). 
In comparison to both samples, the CFS group were similar in age (Mean = 36.13, SD 
= 13.11) and had more participants that were female (73.8%), White British (95.2%) 
and in a relationship (47.6% were not in a relationship). In the present study the 
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greatest differences in the CFS group’s psychological well-being dimensions from 
their control group mean were in Personal Growth, Environmental Mastery and Self-
Acceptance, which were all close to two standard deviations from the Control group 
mean. Out of the other three dimensions, Purpose in Life and Positive Relationships 
with Others were close to one standard deviation from the Control group mean, 
whereas Autonomy was less than 0.5 standard deviations below it and within normal 
limits. Compared to the Depressed group, the CFS group had smaller deficits from 
their Control group mean across all dimensions of well-being, except Personal 
Growth, where they showed a deficit approximately 0.7 standard deviations larger. 
The largest differences between the Depressed and CFS groups were in the 
dimensions of Environmental Mastery and Self Acceptance (with the Depression 
group showing a deficit from their control baseline close to one standard deviation 
larger).  Compared to the BPD group, the CFS group showed smaller deficits from 
their Control Group mean in four PWB dimensions (Environmental Mastery, 
Autonomy, Self-Acceptance and Positive relations with Others) but larger deficits in 
Personal Growth and Purpose in Life. The greatest differences between the CFS and 
BPD group’s deficits were in Personal Growth and Purpose in Life (with the CFS 
group showing a deficit from their control baseline approximately one standard 
deviation larger).  
 
Caution must be taken when drawing conclusions, as the statistical significance of the 
reported differences are unknown and the groups were not matched on demographic 
variables. Any differences could be attributable to confounding factors and further 
research is needed to verify the findings.  
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Difficulties in Environmental Mastery  (managing everyday affairs) and Personal 
Growth (a sense that one is growing and expanding) maybe explained by the CFS’s 
groups varied and fluctuating symptoms. Sufferers experience unpredictable good 
days and bad days, a lack of understanding about the nature of their medically 
unexplained illness and disbelief from professionals. This may make it hard for them 
to create an environment that can accommodate their needs and many report feelings 
of helplessness and a loss of control (Anderson & Ferrans, 1997; Clarke & James, 
2003). Complaints of cognitive impairment are significant. Previous research suggests 
that 85-95% of people with CFS self-report cognitive difficulties (Grafman, 1994; 
Komaroff & Buchwald, 1991). Symptoms include impaired memory, attention, 
concentration, word-finding difficulties, processing speed and mental exhaustion 
(Shanks, Jason, Evans, & Brown, 2013). Compared to the Control group, the presence 
of cognitive impairment in the CFS group may make it harder for them to complete 
day-to-day tasks, problem solve challenges and learn new skills (difficulties 
associated with reduced Environmental Mastery and Personal Growth). 
 
 
Without a clear explanation for their symptoms, individuals with CFS have been 
found to develop maladaptive illness beliefs and avoidant coping strategies, which 
may also be associated with reduced Environmental Mastery and Personal Growth. 
Catastrophic interpretations of illness and fear avoidance are common in CFS, and 
result in patients avoiding new activities and ways of doing things, for the fear that 
they will exacerbate symptoms (Moss-Morris, Petrie & Weinman, 1996). Several 
researchers have associated maladaptive illness beliefs with increased helplessness, 
distress, disability, reduced activity levels (Moss-Morris & Chalder, 2003; Moss-
	  	   103	  
Morris, 2005) and failures to embrace new directions and interests (Gray &Fosey, 
2003). Over time, a restricted range and number of activities and a cognitive 
perception of oneself as unable to master even the most basic tasks, may gives rise to 
feelings of personal stagnation and boredom (associated with reduced Personal 
Growth). Furthermore, excessive rest and sedentary behaviour can lead to physical 
deconditioning and body sensitivity (Hotopf, Noah & Wessely, 1996); potentially 
adding to the loss of mastery, self-confidence and growth reported by the CFS group. 
 
 
A diagnosis of a chronic illness can drastically impact how a person views their life, 
self and future. Bury (1982) named this impact biographical disruption and it may be 
particularly relevant to explaining low levels of Self-Acceptance in the CFS group. 
Adjustment to living with a chronic illness presents an intense psychological 
challenge, as a person is confronted with the task of incorporating this new limitation 
into their sense of self and corresponding goals and beliefs. With regard to CFS, 
biographical disruption could ensue following an abrupt, unwanted transition from an 
active, lifestyle to one that necessitates rest and a more sedentary existence (Asbring, 
2001). Neuroticism and perfectionism may also contribute to the low levels of self-
acceptance reported by the CFS group. Cross-sectional evidence suggests that high 
levels of these personality dimensions exacerbate adjustment problems, because 
modifying rigid, pre-morbid high standards presents a further challenge (Baricza, et 
al., 2011; Shanmugasegaram et al., 2014). A negative discrepancy between who one 
currently is and who one used to be (past self), would like to be (ideal self) or ought to 
be (ought self) is likely to result in feelings of disappointment and personal 
dissatisfaction (associated with low levels of Self-Acceptance; Goossens et al., 2010). 
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The present study is the first study to quantitatively measure Self-Acceptance in CFS. 
A paucity of qualitative studies using small sample sizes have examined self-
perception in CFS. Consistent with the present study, they document a disrupted sense 
of identity and competence (Gray & Fossey, 2003), a lost sense of self (Edwards, 
Thompson & Blair, 2007), low levels of self-esteem and a powerful longing for a life 
lived earlier (Asbring, 2000). The contested, illegitimate status of CFS may also 
impact on patients’ degree of Self-Acceptance, especially if they are left feeling 
responsible for their illness.  Travers and Lawler (2008) found that doubt from others 
about the reality of CFS and the legitimacy of their impairments shattered patients’ 
perceptions of themselves as experts of their own lives. Individual dialogues of self 
dissatisfaction and discrepancy captured in interview studies provide powerful support 
for the reduced levels of Self-Acceptance reported in the present study’s CFS group: 
“I feel like I’m the ugly twin that has nothing to offer….. I think probably the 
foremost thing would be that I just feel like I’m so different” (Travers & Lawler, 
2008; p. 319).  
 
The substantial reduction in previous levels of occupational, educational, social, and 
personal functioning associated with a diagnosis of CFS, may be responsible for 
reported impairments in several domains of psychological well-being. In support of 
this Gray and Fossey (2003) found that CFS participants regarded activity as the key 
to maintaining well-being, fostering a sense of enjoyment, purpose and control, and 
utilising their capacities. Engagement in employment and education has been 
associated with higher levels of well-being in all of Ryff’s dimensions, particularly 
Purpose in Life and Personal Growth (Ryff & Singer, 2008). An unwanted loss of role 
at home or work can lead to a loss of routine, social status, identity, sense of purpose, 
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and financial security (Shields & Wheatley, 2005). It can also put a strain on 
relationships. In support of this, Andersen & Ferrans (1997) found that 100% of 
participants described CFS as having devastated their social activities and 
relationships. The physical limitations imposed by CFS may make it harder for 
individuals to participate in the types of activities necessary to build satisfactory 
relationships and maintain relational obligations. In sum, reduced functioning may 
explain the CFS groups’ lower scores in the PWB domains of Environmental Mastery, 
Purpose in Life, Positive Relations with Others, Self-Acceptance and Personal 
Growth, compared to the general population.  
 
Interpersonal difficulties have been documented in individuals with CFS. Research 
suggests that CFS patients are highly sensitive to criticism and rejection and tend to 
experience other people as unavailable, disrespectful and negatively interfering (Taerk 
& Gnam, 1994; Vandenbergen, Vanheule, Rosseel , Desmet & Verhaeghe, 2009). A 
small number of studies have retrospectively linked CFS to childhood trauma, 
victimisation starting in childhood and exposure to adverse parenting (Clark et al., 
2011; Fisher  & Chalder, 2003; Van Houdenhove, et al 2001). Compared to the 
general population, higher rates of insecure attachment styles, particularly a fearful 
attachment style have been found in those with medically unexplained conditions 
(Noyes et al., 2003; Taylor, Mann, White, & Goldberg, 2000; Wearden, Lamberton, 
Crook & Walsh, 2005).  A fearful attachment style is characterised by a fear of 
intimacy, low trust of others and low self esteem (Bartholomew & Horowitz, 1991); 
qualities consistent with Ryff’s (1989) definition of low levels of Positive Relations 
with Others. Importantly, it has been linked to higher levels of self-reported 
interpersonal problems and lower levels of satisfaction with medical care (Noyes et 
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al., 2003). Attachment theory presents an interesting framework for understanding 
interpersonal behaviour in patients with medically unexplained conditions however; 
most studies so far have been cross-sectional investigations of adults. Longitudinal 
studies of young children are required to validate results. As previously discussed, 
individuals with CFS frequently describe experiencing a lack of empathy and 
understanding from health professionals. Consistent with this, medical practioners 
report scepticism of the diagnosis and feelings of impatience during consultations with 
patients (Deale &Wessely, 2001). Negative interactions with health professionals, 
along with conflicting advice, inappropriate tests and accusations of malingering 
likely exacerbate feeling of rejection and criticism in CFS patients, contributing to the 
reduced levels Positive Relations with Others reported in the CFS group. 
 
As previously stated, the CFS group showed significantly smaller (but still 
substantial) deficits in Purpose in Life and Positive Relations with Others, compared 
to their levels of Environmental Mastery, Self-Acceptance and Personal Growth. This 
is a pattern similar to that found in Nierenberg et al.’s (2010) study of PWB in patients 
with minor depression, except patients with minor depression showed no deficit in 
Personal Growth. Nierenberg et al.’s (2010) interprets the relative preservation of a 
sense of purpose coupled with feeling unable to achieve that purpose because of the 
lack of Environmental Mastery, as a risk factor for developing a ruminative, learned-
helplessness style of thinking and persistent sense of failure, associated with 
depression. Similarly, the far greater deficit in levels of Self-Acceptance in contrast to 
Positive Relations with Others in CFS, may reflect the finding that individuals with 
CFS feel shame and guilt over their dependency on friends and family (Anderson & 
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Ferrans, 1997) and perhaps a corresponding sense of gratitude to those who 
understand their condition and offer them support (Nierenberg et al., 2010).  
 
According to Ryff’s taxonomy, Autonomy refers to one’s ability to be independent 
and self-determining and not look to others for approval. The present study found that 
that Autonomy was preserved in CFS. This contradicts existing research suggesting 
that individuals with the condition are unassertive and overly accommodating 
(Vandenbergen, Vanheule,  Rosseel, Desmet &Verhaeghe, 2009). It also disputes the 
stereotypical portrayal of individuals with CFS as seekers of approval and 
reassurance. Nevertheless, in the presence of perfectionism, autonomy, independence 
and social disconnection can represent a defence against underlying attachment needs 
(e.g. a wish to be accepted, cared for, loved and recognised; Chen, Hewitt, Flett, 
Cassels, Birch & Blasberg, 2012). 
 
 
4.2.2 The Relationship Between Well-Being and Symptomatology in CFS 
As previously stated, the present study found that levels of pain intensity and physical 
components of fatigue (namely physical sensations of fatigue and the impact of 
fatigue on activity levels) were largely independent of well-being dimensions in 
participants with CFS. Of the eight well-being dimensions examined only one, 
Environmental Mastery, showed a consistent negative association with physical 
symptoms. In contrast, psychological components of fatigue (Mental Fatigue and 
Reduced Motivation) and distress (Anxiety and Depression) were strongly related to 
several dimensions of wellbeing. An important limitation of the present study is its 
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cross-sectional design; it does not permit inferences about causality to be made and it 
is likely that the relationships between well-being and symptomatology are reciprocal. 
Consistent with other studies of psychological well-being in individuals with chronic 
conditions, what may be causing low levels of well-being in CFS then is largely 
psychological factors and the impact of chronic illness more generally, as opposed to 
fatigue itself. 
 
No studies have examined the relationship between symptoms and psychological 
well-being in CFS. To help interpret the lack of association found between physical 
symptoms and well-being in CFS, findings are compared to psychological well-being 
research conducted in other chronic health conditions, specifically chronic pain and 
rheumatoid arthritis. On the whole, findings from the present study replicate those 
reported in chronic pain patients, where several studies have reliably demonstrated 
that pain intensity is independent of psychological well-being. In women with 
fibromyalgia, Schleicher et al. (2005) and Hubera, Sumana, Biasib and Carlia, (2008) 
found that PWB was associated with less disability but not pain per se. Similarly, in 
patients with rheumatoid arthritis Mangelli, et al. (2002) found that three disease 
variables (pain, disease activity and limitations in daily activities) were unrelated to 
PWB dimensions. The only exception was a small negative association between levels 
of Environmental Mastery and limitations in daily activities. On the basis of such 
findings, researchers have concluded that pain and arthritic disease only lead to 
debilitating distress in the presence of other physical and psychological features. 
Reducing pain or arthritic behaviour rather than physical sensations per se is the 
recommended treatment target (Schleicher et al., 2005; Hubera et al., 2008).  
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In contrast to the research on patients with rheumatoid arthritis and fibromyalgia, the 
present study found a consistent, moderate relationship between Environmental 
Mastery and disease variables in CFS, with higher levels of Environmental Mastery 
predicting a small amount of variance in lower levels of physical symptoms (pain, 
physical fatigue and general fatigue) and a moderate amount of variance in Reduced 
Activity levels. The emergence of this scale as a predictor is particularly poignant 
given CFS patients’ tendency to report little control over their condition. It is also 
consistent with Findley et al.’s  (1998) findings that greater self- efficacy predicted 
lower levels of symptoms, disability and distress in CFS, even after controlling for 
demographic variables. Together with the present study this suggests that treatments 
that focus on promoting individuals’ sense of control and choice, as well as their 
ability to make may effective use of surrounding opportunities, may be particularly 
beneficial for this client group.  
 
In the present study Positive Affect was significantly related to all five fatigue 
subscales at the <0.05 significance level; however only its relationship with General 
Fatigue and Reduced Motivation reached significance at the <0.01 level. The General 
Fatigue subscale on the Multi-dimensional Fatigue Inventory, consists of four 
generalised statements about one’s physical state and functioning: “I feel fit”, “I feel 
tired”, “I am rested” and “I tire easily”. The moderate, negative association found 
between General Fatigue and Positive Affect supports Wood et al.’s (1992, 1996) 
previous findings. His interpretation is that both constructs may contribute to a more 
general affective state, which he describes as “feeling good” (Wood et al., 1992; p. 
198). However, it could also indicate that similarly to pain, fatigue is best defined as a 
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physiological and emotional state. The Broaden-and-Build Theory (Fredrickson, 1998, 
2001; Fredrickson & Joiner, 2002) has been successfully tested in a range of 
observational, experimental and clinical studies. It proposes that in contrast to 
Negative Affect, which leads to cognitive narrowing, Positive Affect functions to 
expand the scope of attention, cognition and behavioural choices. Positive Affect may 
enhance CFS participants’ general appraisal of their fitness, by facilitating their ability 
to access a wider range of ideas and sensory information. Finally, the significant 
bivariate correlations found between Positive Affect and General Fatigue, Reduced 
Motivation and psychological distress supports research into chronic pain, where 
Positive Affect has been extensively researched and there is robust evidence to 
suggest that it acts as a source of resilience against symptoms (Finan & Garland, 
2015). 
 
Mental Fatigue in the present study refers to participants’ self-reported cognitive 
functioning and statements such as “I have difficulties concentrating” and “My 
thoughts easily wander” represent a high score on this scale. Although CFS patients 
commonly report symptoms of cognitive dysfunction, objective studies confirming 
their presence are mixed. This discrepancy could be due to the heterogeneity of 
presenting symptoms found in different samples. Capuron (2006) investigated the 
relationship between subjective complaints of mental fatigue in CFS participants and 
performance on objective neuropsychological tests and findings revealed a strong 
concordance. A large body of research evidences the negative effects of psychological 
distress, primarily depression on cognitive functioning (Veiel, 1997). However, the 
present study is the first to examine the relationship between cognitive functioning 
and psychological and subjective wellbeing, using Ryff’s (1989) scale of 
	  	   111	  
psychological well-being and Diener et al.’s (2010) scale of positive and negative 
affect. Findings revealed that lower levels of Self Acceptance (meaning one feels 
dissatisfied with self, is disappointed with what has occurred with past life, is troubled 
about certain personal qualities, wishes to be different than what he or she is), 
Environmental Mastery (meaning one has difficulty managing everyday affairs, feels 
unable to change or improve surrounding context, is unaware of surrounding 
opportunities, lacks sense of control over external world) and Personal Growth 
(meaning one has a sense of personal stagnation lacks sense of improvement or 
expansion over time, feels bored and uninterested with life, feels unable to develop 
new attitudes or behaviors) predicted higher levels of Mental Fatigue.  
 
The relationship between Mental Fatigue and Self-Acceptance, Personal Growth and 
Environmental Mastery is most likely bi-directional. As previously discussed, 
cognitive difficulties such as poor attention and memory may make it hard for 
individuals with CFS to problem solve challenges and learn new skills, leading to a 
loss of mastery over everyday affairs and opportunities for personal growth. Mental 
aptitude is predictive of educational and occupational achievement (Schmidt & 
Hunter, 2004; Spinath, Spinath, Harlaar, & Plomin, 2006) and is therefore, likely to be 
imperative to an individuals’ sense of self. Prior to getting ill, scientific researchers 
characterises CFS patients as conscientious, hardworking perfectionists (van Geelen, 
Sinnema, Hermans, & Kuis, 2007). Consequently, unexplained symptoms of cognitive 
dysfunction may be especially threatening to their values, sense self and identity. 
Frequent mistakes and reduced performance at work or socially is likely to result in 
increased self-criticism and feelings of dissatisfaction and inadequacy (associated with 
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low Self-Acceptance). Nevertheless, it is also conceivable that constantly doubting, 
criticising and scrutinising one’s self and one’s performance is mentally exhausting. 
In support of this Austin, Mitchell and Goodwin (2001) hypothesises that cognitive 
impairment in depression is the result of patients selective attention to and 
catastrophic interpretation of, perceived failures. Given the extra effort required to 
complete cognitive tasks, CFS patients may withdraw from challenging or novel 
activities that are necessary for a sense of mastery and growth. Over time this lack of 
stimulation will likely exacerbate feelings of reduced motivation and apathy. Austin et 
al.’s (2001) second hypothesis is that reduced motivation is the cause of cognitive 
impairment in depressed patients.  A review of neuropsychological functioning in 
CFS concludes that symptoms of cognitive impairment can only partly be explained 
by the presence of depression and anxiety (Michiels & Cluydts, 2001). The present 
study advances our understanding of cognitive impairment in CFS, as it suggests that 
it may result from a loss of positive elements, not simply the presence of negative, and 
infers a specific route for intervention.  
 
In the present study, Reduced Motivation for engaging in activity was negatively 
related to all aspects of SWB and PWB, with the exception of Autonomy. Well-being 
variables predicted a large amount of variance in levels of Reduced Motivation, which 
was uniquely carried by Positive Relations with Others. This confirms previous 
findings indicating that perceived social support is an important predictor of 
symptoms, illness burden and health outcomes in CFS (Saltzstein et al., 1998). 
Furthermore, it emphasises the importance of the quality of patients’ interactions, as 
opposed to simply the quantity of interactions or the breadth of their social network 
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(Prins et al., 2004). The relationship between Reduced Motivation and Positive 
Relations with Others is again probably bi-directional. Debilitating symptoms and 
reduced energy levels make people with CFS less able to engage in activity, which in 
turn may make them less motivated too. Most activities are socially orientated, as 
result those with CFS are likely to become isolated from the types of activities 
necessary to build and maintain satisfactory relationships with other people. On the 
other hand, difficulties with getting others to recognise and respect that CFS is a 
legitimate illness may de-motivate patients, making them more ambivalent about 
engaging in social or therapeutic activities. A systemic approach that focuses on 
enhancing levels of empathy, understanding and encouragement in the wider network 
of people surrounding CFS patients, might help motivate them to re-engage with life. 
In support of this, two recent papers propose that the first step towards change should 
be addressing negative attitudes in medical students and GPs, so that CFS patients feel 
validated, listened to and thus, more receptive to recommended management 
strategies such as pacing and graded exercise therapy (Bayliss et al., 2014; Stenhoff, 
Sadreddini, Peters, & Wearden, 2013). 
 
As previously stated, psychological distress in CFS showed a large association with 
well-being factors. This supports findings from previous research, indicating that 
SWB and PWB have a stronger relationship to psychological health than to physical 
health (Mangelli et al., 2002). This is not surprising given their closer correspondence. 
However in terms of correlations, the partial overlap of these constructs confirms that 
the presence of well-being is not synonymous with the absence of distress (Fava & 
Sonino, 2000; Heszen-Niejodek, Gottschalk, & Januszek, 1999; Rafanelli et al., 2000; 
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Ryff & Singer, 2000). The present study found that Depression was strongly 
associated with Self-Acceptance (r= -0.64), Positive Affect (r= -0.62) and Purpose in 
Life  (r= -0.61); moderately associated with Environmental Mastery (r= -0.59), 
Personal Growth (r= -0.58) and Negative Affect (r= 0.46) and; weakly associated with 
Positive Relations with Others (r= -0.36). Positive Affect however, was the only 
unique predictor of depression. This is the first study to demonstrate that depression 
and anxiety in CFS are associated not only with the presence of negative constructs 
such as negative beliefs about emotion (Rimes & Chalder, 2010) and self-critical 
perfectionism (Luyten et al., 2011) but also the absence of the positive constructs. 
Importantly, the well-being dimensions identified in the present study offer several 
new targets for the treatment of distress in CFS. The findings replicate investigations 
of subjective wellbeing in depressed patients and support researchers’ characterisation 
of depression as the loss of positive affect. Cummin (2010) suggests that when 
homeostasis fails due to the overwhelming nature of an aversive challenge, people 
lose contact with positive affect and negative affect prevails. If this condition becomes 
chronic, then people are thought to have clinical depression. Compared to PWB 
research in other conditions, depression in CFS showed a much stronger relationship 
to low levels of PWB. In patients with affective disorders, Rafanelli et al. (2000) 
found Environmental Mastery (r= - 0.58, p < .01) to be the only dimension 
significantly related to depression; whereas in a sample of participants with moderate 
to severe depression, Edmondson (2012) found Personal Growth (r= -0.43, p = .028) 
was the only dimension that showed a significant correlation with depression scores. 
In Nierenberg et al.’s study (2010) of participants with minor depression, correlations 
between depression symptom severity and the six PWB dimensions were all very low 
(r = −0.06 to – 0.29). Lastly, in patients with rheumatoid arthritis, depression showed 
	  	   115	  
a strong relationship to Environmental Mastery (rs = -0.64, p < .0001), but a weak to 
moderate relationship with the other five dimensions (rs = -0.26 to -0.48; Mangelli et 
al., 2002).  
 
In comparison to depression, the present study found that anxiety in CFS was strongly 
associated with Negative Affect (r= 0.72) and moderately associated with Autonomy 
(r= -0.54). Like depression, it was also associated with Environmental Mastery (r= -
0.51) and Positive Affect (r= -0.40). All other dimensions were unrelated to anxiety, 
suggesting each disorder has a somewhat distinct relationship to well-being in CFS. 
Findings go against previous research in mental health disorders, suggesting Anxiety 
is only significantly related to Environmental Mastery (r = -0.57, p < .01) in patients 
with affective disorders (Rafanelli et al., 2000) and unrelated to all psychological 
well-being dimensions in patients with moderate to severe clinical depression 
(Edmondson, 2012). In patients with rheumatoid arthritis Mangeli et al. (2002) found 
anxiety showed a small to moderate association (rs = -0.23 to -0.57) with all 
dimensions of psychological well-being. In the present study Anxiety was uniquely 
predicted by an increase in Negative Affect and a decrease in Autonomy (being able 
to evaluate oneself according to personal standards and not look to others for 
approval). Existing research suggests that being in a state of anxiety can make a 
person more threat focused, indecisive, intolerant of uncertainty, and more likely to 
seek reassurance and approval from others (Dugas, Buhr, & Ladouceu, 2005; 
Salkovskis, 1991). One explanation for the present study’s findings is that high levels 
of Negative Affect lead to cognitive narrowing, which in turn makes a person more 
likely to interpreting stimuli as threatening and dangerous (Fredrickson, 1998, 2001). 
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In support of this, greater levels of distress have been associated with catastrophic 
interpretations of illness in CFS (Moss-Morris et al., 1996). A study by Parfitt & Pates 
(1999) suggests that in the general population, higher levels of self-confidence are 
associated with lower levels of anxiety. Although this finding is correlational, it seems 
reasonable to speculate that having conviction in the validity of one’s illness and 
opinions (qualities associated with Ryff & Keyes (1995) definition of Autonomy) 
could make CFS patients less anxious in response to social threats such as stigma and 
disbelief from others.  
 
In sum, low levels of PWB and SWB broadly (opposed to specific facets) appear to be 
a pertinent risk factor for psychological distress and reduced motivation in CFS 
patients. 
 
4.3 Clinical Implications 
A number of the findings from the present study have relevant theoretical and clinical 
implications. Firstly, findings from the present study highlight that compared to the 
general population individuals with CFS have lower levels of Hedonic and 
Eudiamonic well-being. This challenges i) the over emphasis on maladaptive 
cognitive and personality traits in past research and ii) the premise of current 
treatments like CBT that focus largely on the removal of negative mental processes. 
Importantly, it gives a more balanced perspective and offers several new treatment 
targets that are less pathologising. 
 
 
	  	   117	  
The present study found that well-being was largely independent of physical 
symptoms but a significant predictor of psychological symptoms and distress in CFS. 
This supports the notion that impairments in well-being domains represent 
vulnerability factors for mood disorders and adjustment problems (Mangelli et al., 
2002; Wood & Joseph, 2010). On this basis, researchers may wish to consider shifting 
the paradigm of psychological treatments for CFS away from an exclusive focus on 
symptom reduction, towards the enhancement of strength, happiness and virtue 
(Seligman & Csikszentmihalyi, 2000). Well-being therapy (WBT) is a short-term 
psychotherapeutic strategy that offers one possible alternative or adjunct to CBT 
(Fava & Ruini, 2003). It uses techniques such as self-monitoring of moments and 
feelings of well-being (opposed to distress) and optimal engagement in pleasant 
activities, to improving the patients’ levels of happiness and psychological well-being 
across Ryff’s (1989) six dimensions. When compared to standard CBT or used as an 
adjunct, WBT has been found to be more effective at reducing residual symptoms of 
depression and anxiety and enhancing psychological well-being at post-treatment and 
follow-up (Fava, 1998a, 1998b; Fava, Rafanelli, Ottolini, Ruini, Cazzaro, & Grandi, 
2001). Furthermore, Ruini et al. (2009) found that in addition to enhancing Personal 
Growth, WBT can reduce somatisation.  
 
Solution focused therapy, in a similar manner to WBT, helps individuals to identify 
positive exceptions to psychological distress, disability and life problems, by focusing 
on solution building rather than problem solving. It is a short-term, goal orientated 
therapy that is based on the philosophy that clients are the experts in their own lives 
(MacDonald, 2011). Specific techniques include helping the client to create a 
problem-free vision for their future and identify strengths, resources and existing 
	  	   118	  
skills that will assist them in reaching their goal (MacDonald, 2011). Although 
solution focused therapy is an under-researched area, there is preliminary evidence to 
suggest that solution focused therapy is an effective and acceptable intervention for 
patients with long-term physical health conditions (Carr, Smith & Simm, 2014; Viner, 
Christie, Taylor, & Hey, 2003). One recent randomised controlled trial (N= 98) of 
solution focused therapy for patients with fatigued inflammatory bowel disease, 
indicates that compared to treatment as usual, it has a significant beneficial effect on 
quality of life and fatigue severity (Vogelaar et al., 2013). 
 
The dominant outcome measures employed by CFS services and clinical trials are 
questionnaires assessing symptomatology and psychopathology. Moos (1977) argues 
that despite the many physical, cognitive, and emotional challenges associated with 
chronic illness, individuals can continue to lead happy, fulfilling and virtuous lives. 
As a result, recovery from such conditions should not simply be conceived as the 
resolution of physical and psychiatric symptoms but rather the restoration of well-
being. Including the Ryff (1989) Psychological Well-being Scale and Diener et al.’s 
(2010) Scale of Positive and Negative Emotions as outcome measures could broaden 
our understanding of the effectiveness of CFS treatments. 
 
Given the profile of psychological well-being found in CFS, clinical services may 
wish to priorities ways of promoting Environmental Mastery, Personal Growth and 
Self-Acceptance specifically. The emergence of Environmental Mastery as a unique 
predictor of physical symptoms and activity levels supports the use of treatments such 
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as pacing and graded exercise therapy in CFS. The aim of pacing is to help patients 
adapt to their illness and break boom bust cycles of activity that exacerbate physical 
symptoms. Organising their day into balanced, sustainable periods of activity and rest, 
makes symptoms more predictable and optimises activity levels; giving patients 
improved self-confidence and a greater sense of stability and control over their illness. 
The PACE trial (White et al., 2011) demonstrated that interventions that encourage an 
initial stabilisation of activity levels, followed by gradual increases or changes in 
activity in line with planned treatment goals, are more effective at reducing CFS 
symptoms than specialist medical care alone. That said, gaining control over 
uncontrollable symptoms is not always possible and treatments that help CFS patients 
accept their limitations may be equally important. Research with chronic pain patients 
suggests that attempts to control uncontrollable pain can intensify feelings of 
frustration, distress and hypervigilance for symptoms (McCracken, Eccleston & Bell, 
2005). Whereas, giving up control strategies and accepting pain has been linked to 
better adjustment and reduced distress and disability (McCracken, Carson, Eccleston 
& Keefe, 2004). In qualitative studies, CFS participants frequently cite acceptance of 
their illness and limitations as a fundamental first step in recovery (Dickson, Knussen 
& Flowers, 2008). Furthermore, as discussed in Chapter 1, cross-sectional evidence 
suggests that higher levels of acceptance may protective against the occurrence of 
psychological distress in CFS (Van-Dammea et al., 2006). 
 
Ryff and Keyes (1995) define Personal Growth as being open to new experiences and 
having a sense of oneself as fulfilling one’s potential and developing over time. The 
significant deficit in this dimension in the CFS group suggests that because of their 
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symptoms and low energy levels they may not be in a position to be able to have new 
experiences that are essential for growth. It could be that individuals with CFS 
become so focused on their illness that it is hard for them to see past it or 
compartmentalise it, so that they can connect with other areas of their life. As a 
treatment strategy for enhancing feelings of Personal Growth and psychological well-
being more generally, several researchers recommend goal setting and attainment 
(Fava & Ruin, 2003; MacLeod, 2010; MacLeod,	  Coates	  &	  Hetherton,	  2008; Sheldon, 
Kasser, Smith & Share, 2002). Top down theorists hypothesise that goal attainment 
creates positive changes in one’s self-concept (as one re-evaluates their capabilities) 
and life circumstances (as new opportunities or relationships are gained), inducing 
large shifts in one’s growth related judgments (Sheldon et al., 2002). In antithesis, 
bottom up theorists suggest that progressing towards a goal results in small fulfilling 
experiences, which over time accrue to influence growth related appraisals (Sheldon 
et al., 2002). CBT incorporates elements of goal attainment, however, goals tend to be 
short-term and treatment focused. Research suggests that the greatest gains in well-
being and personality integration are attained when individuals pursue goals related to 
their underlying values and interests (Sheldon & Kasser, 1998; Deci & Ryan, 1991).  
 
Acceptance and Commitment Therapy (ACT) is a third-wave CBT intervention that 
can be broadly classified as having a well-being focus owing to its concern above and 
beyond the removal of symptoms. ACT aims to help people accept their difficulties 
and reconnect with what they truly value, as a way of providing direction and meaning 
in life (Hayes, 2004). Once armed with the awareness of their most deeply cherished 
values, people are asked to identify a life domain that is high priority for change and 
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set realistic short-term and long-term goals. Compared to treatment-based goals, 
value-based goals are longstanding, meaningful and personal, and if achieved, should 
bring patients a greater sense of happiness, fulfillment and growth. ACT is an 
effective intervention for long-term conditions. A systematic review of 14 studies (9 
RCTs and 5 controlled studies) suggests that when compared against any comparator 
(active or wait-list control) ACT for chronic pain demonstrates small positive effects 
for pain, depression, anxiety, physical well-being and quality of life (Veehof, Oskama, 
Schreurs, & Bohlmeije, 2011). Together with the present study’s findings, this 
suggests that ACT may also benefit those with CFS. 
 
Having a healthy attitude towards oneself can be conceptualised in several different 
ways including self-acceptance (Ryff, 1989), self-esteem (Rosenberg, Schooler, 
Schoenbach & Rosenberg, 1995) and self-compassion (Gilbert, 2000, 2009; Gilbert & 
Proctet, 2006). The past decade has seen a rapid increase in therapies designed to 
enhance a positive self-attitude. The practice of mindfulness involves focusing one’s 
attention on the present moment, in an attempt to gain a balanced, non-judgmental, 
observer-like perspective of one’s internal state (Kabat-Zinn, 1994). There is evidence 
to suggest that regular practice of mindfulness enhances numerous positive 
psychological processes including happiness, self-acceptance, personal growth, and 
positive affectivity (Brown & Ryan, 2003). As a result, it could be used to target low 
levels of these variables found in CFS in the present study. Mindfulness based 
interventions have shown efficacy in various psychological disorders and medical 
conditions such as depression, anxiety, chronic pain and cancer (Chiesa, Anselmi & 
Serretti, 2014). A paucity of studies have investigated mindfulness-based 
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interventions in CFS: Three exploratory studies (Surawy, Roberts & Silver, 2005), 
one uncontrolled study (Stubhaug & Kvale, 2010), one controlled study (Sampalli, 
Berlasso, Fox & Petter, 2009) and one pilot RCT (Rimes & Wingrove, 2013). Despite 
clear weakness in their design, these studies provide preliminary evidence for the 
effectiveness of mindfulness at improving fatigue, pain, distress, functioning, quality 
of life, maladaptive illness beliefs and most importantly self-compassion in 
individuals with CFS. 
 
Compassion focused therapy may offer a second means of enhancing levels of Self-
Acceptance in CFS patients. Compassion Focused Therapy was specifically designed 
for people with high shame and self-criticism (Gilbert, 2000, 2009). Through the use 
of strategies such as compassionate imagery and behaviour, it helps individuals to 
develop an internal compassionate relationship with themselves and appreciate their 
efforts, as opposed to simply focusing on whether or not they achieve their goals. 
Compassion Focused Therapy has yet to be tested in CFS. However, as an adjunct to 
CBT it has proven to be clinically effective at reducing levels of self-criticism in 
psychosis (Braehler, Gumley, Harper, Wallace, & Gilbert, 2013), eating disorders 
(Gale, Gilbert, Read, Goss, 2014), personality disorders (Lucre & Corten, 2013), 
trauma (Beaumont, Galpin & Jenkins, 2012) and brain injury (Ashworth, Gracey & 
Gilbert, 2011).  
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4.4 Limitations  
There are several limitations to the present study that should be considered when 
evaluating the findings. Firstly, CFS is a highly heterogeneous condition that is 
notoriously difficult and controversial to diagnoses. Before diagnosing CFS, a 
physician is required to exclude other possible causes of fatigue by completing a 
comprehensive assessment including a physical examination and blood tests. There is 
dispute over whether a diagnostic waiting period is necessary, with the International 
Consensus Criteria (Carruthers et al., 2011) recommending no diagnostic waiting 
period and the Centres for Disease Control (CDC; Fukuda et al., 1994) recommending 
six months. In the present study 38 participants had a CFS diagnosis confirmed by a 
clinical service, however 22 participants were recruited from outside of services, 
through CFS support groups and online advertisements. As a result, it is not possible 
to conclude whether their symptoms were attributable to an explanatory condition or 
CFS. All participants were asked to confirm that a physician or General Practioner 
had given their diagnosis and the Multi-dimensional Fatigue Inventory was used to 
screen out those who did not meet criteria for severe fatigue. In the present study, 
participants’ self-reported time taken to receive a diagnosis from the onset of 
symptoms ranged from 1 month to 18 years, which is representative of the diverse 
array of diagnostic experiences in the CFS population. Correlational analyses 
indicated that symptom severity was independent of number of years with CFS and 
time taken to receive a diagnosis. The scope of the present study and the training 
requirements necessary to diagnose CFS meant that it was not viable to conduct 
diagnostic interviews. If replicated in the future, the inclusion of a full diagnostic 
interview, may make findings more generalisable to people suffering from CFS.  It is 
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also worth noting that the majority of participants in the present study were White 
British and female. Although this is representative of the UK CFS population, 
findings may not be as generalisable to men or patients from other cultures or 
ethnicities.  
 
Participants were asked to complete the questionnaires in their own time and return 
them by post to the researcher. This ensured very fatigued participants were able to 
complete the questionnaires in a paced manner and respond whenever they could. It 
also reduced the risk of interviewer bias, meaning participants may have been more 
likely to respond honestly. However, with self-completion questionnaires and postal 
returns there are often several limitations too. Typically there is low response rate, as 
there is no real pressure for participants to complete or return the questionnaire. It can 
also bias the sample, for example in favour of those who were more functional or 
more interested in psychological concepts. As a result, findings may not be 
generalisable to CFS patients who are more severely fatigued, bedbound or who find 
psychological research into CFS stigmatising. Furthermore, there is no way of 
verifying whether the right person actually completed the questionnaire or whether 
they fully understood the questions being asked.  
 
A third consideration is the involvement of CFS participants in different services and 
treatments. Participants in the present study were recruited from two CFS services 
based in different counties and offering slightly different treatment packages. 
Specifically, the London based service offered homeopathic treatments alongside 
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routine care. Eight participants recruited from support groups or online advertisements 
also identified themselves as currently receiving treatment from a CFS service. In 
terms of recruitment, there was no limitation as to participants’ stage of treatment and 
all clients with a diagnosis of CFS were eligible to take part. Twenty-three 
participants had been assessed by a service and were on the waiting list to start 
treatment. Another 15 were currently receiving treatment and the number of treatment 
sessions received ranged from one to twenty (mean = 7.52). Treatment programmes 
aim to help participants understand their condition and learn strategies to manage 
physical symptoms (e.g. pacing) and stress. Consequently, they could impact on a 
person’s well-being. Being engaged in a service may enhance a participants’ well-
being, for the virtue that it offers the prospect of support and improvement in one’s 
condition. Those in treatment could also be biased in their reporting of symptoms and 
well-being. If they are concerned about being perceived as a ‘good patient’, meaning 
someone who has followed his or her treatment plan and done well, then they may 
report lower symptoms and higher well-being. To protect against this type of reporting 
bias, participants in the present study returned the completed questionnaires directly to 
the researcher (not their clinician) and were informed that all data would be 
anonomyised. MANOVAs were computed to examine the effect of treatment stage 
(Assessment vs. in treatment vs. not in a service) on symptoms and well-being and 
results found no significant differences between group on well-being variables and 
seven out of eight symptom variables  (see results section). This supports findings 
from research in routine clinical practice indicating that 70% of CFS patients still met 
criteria for excessive fatigue after receiving CBT (Quarmby et al., 2007). The only 
exception was a positive effect of treatment on activity levels, with participants 
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currently receiving treatment reporting greater levels of activity than those at the 
assessment stage or not in a service.  
 
A fourth consideration is that the present study examined the relationship between 
self-rated measures of well-being and symptoms and did not include objective 
measures of disease. Self-rated measures of health are known to reflect one’s actual 
physical condition but also one’s degree of emotional adjustment (Hooker & Siegler, 
1992). A review of activity levels in patients with chronic fatigue and pain found 
different results depending on whether studies employed subjective or objective 
measures of activity, indicating a discrepancy between the methods (van Weering, 
Vollenbroek-Hutten, Kotte & Hermens, 2007). A further study directly compared 
objective and subjective methods and findings revealed that in patients with lower 
back pain, self-reported activity levels were relatively inaccurate when compared to 
objective measurements (Van Weering, Vollenbroek-Hutten & Hermens, 2011). 
Thirty percent of participants were found to underestimate their activity levels, whilst 
fourteen percent over-estimated them. One means of controlling for this discrepancy 
in the present study would be to replicate it with the inclusion of objective and 
subjective measures. For instance, including a cognitive assessment as an objective 
measure of symptoms of Mental Fatigue; exercise duration (measuring muscle 
endurance), as an objective measure of Physical Fatigue; a pedometer, as an objective 
measure of Activity Levels and lastly, dolorimetry evaluation or palpitation of tender 
points as an objective measure of Pain symptoms.  
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A further limitation is that control participants in the present study were obtained from 
two existing doctoral projects, with different inclusion criteria and information. 
Controls, were successfully matched to CFS participants on important demographics 
such as age, gender, ethnicity, employment status and relationship status. 
Furthermore, Edmondson (2012) and Blackburn (2014) screened control participants 
for mental health disorders and scores on self-report measures of anxiety and 
depression confirmed their non-clinical status. Symptoms of fatigue and pain 
however, were not measured in control participants. Similarly, explainable chronic 
conditions were not assessed, for example asthma or diabetes. As a result, it is not 
possible to confirm that control participants in the present study did not have a chronic 
health condition or levels of fatigue and pain in the clinical range. Further research 
and replication of the present study’s novel results controlling for explainable chronic 
health conditions and symptoms of CFS in the control sample is required. Another 
limitation pertaining to the control data is that it was historical (2 – 4 years old) and 
thus, between group difference could be confounded by socio-economic changes or 
other extraneous variables. Twelve CFS and eight control participants were also 
excluded because they could not be matched, potentially introducing selection bias.  
 
Co-morbidity between depression and CFS has previously been discussed. Comparing 
the profile of well-being in the CFS group to that of depressed participants in 
Edmondson and MacLeod’s (2014) study proved interesting. It potentially highlights 
important differences between the conditions that could further add to the debate 
about whether or not they are a single syndrome. The groups however, were not 
matched on demographic variables or symptoms of anxiety and depression and so 
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further research is needed to validate the findings. Controlling for symptoms of 
anxiety and depression could help answer the question of whether well-being deficits 
in the present study are related to the diagnosis of CFS or merely due to clients having 
some level of anxiety or depression. Similarly, a chronic illness control group would 
help identify whether the group differences are a result of CFS or the experience of 
chronic illness more generally. 
 
Within the context of the present study’s correlational design, it is not possible to 
establish causal conclusions. Relationships between well-being and symptom 
variables are most likely bi-directional and Schleicher et al., (2005) remind us that it 
would be presumptuous to think that all disabled individuals should or could maintain 
a positive attitude in the face of severe disability. Findings need replication in a 
longitudinal study. Nevertheless, they do suggest that maintaining well-being could 
potentially influence the disease course of CFS and protect against the risk of mood 
disorders (Fischler et al., 1997; Komaroff & Buchwald, 1991).  
 
A final limitation of the present study is that it conducted multiple comparisons, 
increasing the risk of Type 1 error (findings of false "significance"). To protect against 
this, a more stringent statistical significance criterion was adopted throughout the 
analyses (p < .01). A classic criticism of p-value adjustments is that they are too 
conservative, meaning that they raise the risk of type II errors (false negatives; Feise, 
2002). If you lower the alpha level and maintain the beta level then a study loses 
power. With alpha set to 0.01 and power set to 0.8, the present study remained 
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adequately powered to detect large effect sizes. However, if replicated with a larger 
sample size, allowing small and medium effect sizes to be detected, some of the non-
significant correlational findings may be significant. Alternative strategies to p-value 
adjustments when conducting multiple comparisons, include selecting a primary 
outcome measure or creating a composite score consisting of a combination of 
variables. As previously stated CFS is a highly heterogeneous condition with multiple 
manifestations. No presentation dominates and different people are impacted in 
different ways. Consequently, there is no obvious way to select a primary symptom. 
Furthermore, authors of the Multi-dimensional Fatigue Inventory (Smets, et al., 1995) 
and the Ryff Psychological Well-being Scale (Ryff, 1989) advise against summarising 
the subscales to create a composite score.  
 
4.5 Future Research 
A number of research suggestions were made when discussing the limitations such as 
replicating the study using a full diagnostic assessment, objective symptom measures, 
a larger sample size and a depression comparison group. Research comparing the 
profile of well-being in CFS to matched groups of participants with fibromyalgia and 
IBS would add to the debate about whether or not there are important differences in 
the experience and psychological impact of living with these conditions. However, 
longitudinal research is required to establish whether lower levels of subjective and 
psychological well-being are the cause or consequence of CFS. 
 
This is the first study to examine well-being in CFS and consider its relationship to 
disease variables and psychological distress. The results identify several new 
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treatment targets. Services would initially benefit from research investigating how 
effective current treatments (CBT, pacing, graded exercise therapy) are at enhancing 
well-being in CFS, by assessing participants’ well-being before and after treatment. 
Then studies examining the efficacy of suggested alternative treatments that have 
more positive content (Well-being Therapy, Solution Focused Therapy, Acceptance 
and Commitment Therapy, Mindfulness and Compassion Focused Therapy) should be 
a major research priority. Used alone or in conjunction with CBT it may be that they 
are not only more effective at enhancing well-being but also at reducing symptoms. 
 
4.6 Conclusion 
The present study aimed to explore subjective and psychological well-being in adults 
with Chronic Fatigue Syndrome. It was hypothesised that well-being would be 
significantly related to symptomatology in CFS and that individuals with CFS would 
report significantly lower psychological well-being across Ryff’s six dimensions than 
a group of matched, non-clinical controls. As this was the first study to conduct a 
theoretically driven, multi-dimensional investigating of well-being in CFS and its 
relationship to symptoms, there were no grounds for making strong predictions. 
Correlational analyses revealed that in CFS, well-being dimensions were largely 
independent of physical symptoms (Pain intensity, Physical Fatigue, Reduced Activity 
and General Fatigue) but strongly related to psychological components of fatigue 
(Mental Fatigue and Reduced Motivation) and psychological distress (Depression and 
Anxiety). The exceptions were Environmental Mastery, which showed a consistent, 
moderate association with low levels of all physical symptoms and Positive Affect, 
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which was related to low levels of General Fatigue. Participants’ scores on well-being 
dimensions were also found to predict their scores on symptom measures. Five well-
being dimensions were identified as unique predictors of symptomatology. Regression 
models containing SWB and PWB dimensions explained a particularly large amount 
of variance in psychological distress.  Hypothesis 1 in the present study was therefore 
partially supported. In line with previous investigations of well-being in chronic 
health conditions, findings suggest that what may be causing low levels of well-being 
in CFS is largely psychological factors and the general impact of living with a chronic 
illness. Future research comparing levels of well-being in CFS participants to that of 
participants with explainable medical conditions is required to investigate the possible 
effects of CFS’s contested status. 
 
Results also showed that the CFS group had lower psychological well-being than the 
Control group on five of Ryff ‘s six dimensions (Environmental Mastery, Positive 
Relations with Others, Personal Growth, Purpose in Life, and Self-Acceptance). No 
significant difference was found between the CFS and Control groups on the 
Autonomy subscale. Therefore, hypothesis 2 was partially supported. The greatest 
differences observed between the CFS and Control group means were in Personal 
Growth, Environmental Mastery and Self-Acceptance. This is a unique pattern of 
deficits to that documented in individuals with depression and fibromyalgia, 
suggesting that there maybe fundamental differences in the experience and impact of 
living with these conditions. 
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Despite the present study’s limitations and the need for further research, findings give 
further support for the theory that psychological wellness is more than the absence of 
distress and physical illness.  What is more, findings advance our understanding of 
CFS, challenge the over emphasis on maladaptive cognitive and personality traits in 
past research and offer several new treatment targets. Future research must continue to 
investigate whether interventions targeting well-being enhancement, can boost the 
efficacy of symptom-focused treatments, which currently produce unsatisfactory 
recovery rates in CFS. 
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Appendix I: NHS Ethics Approval Letter 
-  
 
 
EoSRES 
 
 
                         Research Ethics Service 
 
East of Scotland Research Ethics Service (EoSRES) REC 1 
      Tayside Medical Sciences Centre (TASC) 
Residency Block C, Level 3 
Ninewells Hospital & Medical School 
George Pirie Way 
Dundee  DD1 9SY 
 
 
Miss Hannah Jackson 
Trainee Clinical Psychologist 
Camden & Islington NHS Foundation Trust 
Royal Holloway University, Department of Clinical 
Psychology   
Egham Hill 
Egham  
TW20 0EX 
 
 
Date: 18 April 2014 
Your Ref:  
Our Ref: LR/14/ES/0053 
Enquiries to: Mrs Lorraine Reilly 
Direct Line: 01382 383878 
Email: eosres.tayside@nhs.net 
 
Dear Miss Jackson 
 
Study title: Psychological Well-Being in Individuals With Chronic 
Fatigue Syndrome/ Myalgic Encephalomyelitis 
REC reference: 14/ES/0053 
Protocol number: NCT02094820 
IRAS project ID: 146565 
 
Thank you for your email of 16 April 2014, responding to the Proportionate Review  
Sub-Committee’s  request  for  changes  to  the  documentation  for  the  above  study. 
 
The revised documentation has been reviewed and approved by the sub-committee. 
 
We plan to publish your research summary wording for the above study on the NRES website, 
together with your contact details, unless you expressly withhold permission to do so.  Publication 
will be no earlier than three months from the date of this favourable opinion letter.  Should you wish 
to provide a substitute contact point, require further information, or wish to withhold permission to 
publish, please contact the Co-ordinator Mrs Lorraine Reilly, lorraine.reilly@nhs.net. 
 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the above 
research on the basis described in the application form, protocol and supporting documentation as 
revised. 
 
Ethical review of research sites 
 
The favourable opinion applies to all NHS sites taking part in the study, subject to management 
permission being obtained from the NHS/HSC R&D office prior to the start of the study (see 
“Conditions  of  the  favourable  opinion”  below). 
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Conditions of the favourable opinion 
 
The favourable opinion is subject to the following conditions being met prior to the start of the 
study. 
 
Management permission or approval must be obtained from each host organisation prior to the 
start of the study at the site concerned. 
 
Management  permission  (“R&D  approval”)  should  be  sought  from  all  NHS  organisations  involved  
in the study in accordance with NHS research governance arrangements. 
 
Guidance on applying for NHS permission for research is available in the Integrated Research 
Application System or at http://www.rdforum.nhs.uk.  
 
Where  a  NHS  organisation’s  role  in  the  study  is  limited  to  identifying  and  referring  potential  
participants  to  research  sites  (“participant  identification  centre”),  guidance  should  be  sought  from  
the R&D office on the information it requires to give permission for this activity. 
 
For non-NHS sites, site management permission should be obtained in accordance with the 
procedures of the relevant host organisation. 
 
Sponsors are not required to notify the Committee of approvals from host organisations.  
 
Registration of Clinical Trials 
 
All clinical trials (defined as the first four categories on the IRAS filter page) must be registered on 
a publically accessible database within 6 weeks of recruitment of the first participant (for medical 
device studies, within the timeline determined by the current registration and publication trees).   
 
There is no requirement to separately notify the REC but you should do so at the earliest 
opportunity e.g when submitting an amendment.  We will audit the registration details as part of the 
annual progress reporting process. 
 
To ensure transparency in research, we strongly recommend that all research is registered but for 
non clinical trials this is not currently mandatory. 
 
If a sponsor wishes to contest the need for registration they should contact Catherine Blewett 
(catherineblewett@nhs.net), the HRA does not, however, expect exceptions to be made. Guidance 
on where to register is provided within IRAS. 
 
You should notify the REC in writing once all conditions have been met (except for site 
approvals from host organisations) and provide copies of any revised documentation with 
updated version numbers.  The REC will acknowledge receipt and provide a final list of the 
approved documentation for the study, which can be made available to host organisations 
to facilitate their permission for the study. Failure to provide the final versions to the REC 
may cause delay in obtaining permissions. 
 
It is the responsibility of the sponsor to ensure that all the conditions are complied with 
before the start of the study or its initiation at a particular site (as applicable). 
 
Approved documents 
 
The documents reviewed and approved by the Committee are: 
  
Document    Version    Date    
Evidence of insurance or indemnity    02 September 2013  
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Investigator CV – Hannah Jackson      
Investigator CV – Any MacLeod      
Other: Hannah Jackson - Approval    14 March 2014  
Other: email covering letter     16 April 2014  
Participant Consent Form  1  31 March 2014  
Participant Information Sheet  2  16 April 2014  
Protocol  1  31 March 2014  
Questionnaire: Demographics Questionnaire  1  31 March 2014  
Questionnaire: Meaning of Life Questionnaire       
Questionnaire: Multimensional fatigue Inventory       
Questionnaire: Psychological Well-Being Scale       
Questionnaire: Scale of Positive and negative Experience       
REC application  146565/590635/1/460  03 April 2014  
Response to Request for Further Information       
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for Research 
Ethics Committees and complies fully with the Standard Operating Procedures for Research Ethics 
Committees in the UK. 
 
After ethical review 
 
Reporting requirements 
 
The  attached  document  “After  ethical  review  – guidance  for  researchers”  gives  detailed  guidance  
on reporting requirements for studies with a favourable opinion, including: 
 
Notifying substantial amendments 
 Adding new sites and investigators 
 Notification of serious breaches of the protocol 
 Progress and safety reports 
 Notifying the end of the study 
 
The NRES website also provides guidance on these topics, which is updated in the light of 
changes in reporting requirements or procedures. 
 
Feedback 
 
You are invited to give your view of the service that you have received from the National Research 
Ethics Service and the application procedure.  If you wish to make your views known please use 
the feedback form available on the website. 
 
Further information is available at National Research Ethics Service website > After Review 
 
 
 
 
14/ES/0053:    Please quote this number on all correspondence 
 
We  are  pleased  to  welcome  researchers  and  R  &  D  staff  at  our  NRES  committee  members’  training  
days – see details at http://www.hra.nhs.uk/hra-training/  
 
Yours sincerely 
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pp 
Mrs Sandra Forbes 
Vice-chair 
 
eosres.tayside@nhs.net 
 
Enclosures: “After  ethical  review  – guidance  for  researchers” 
 
Copy to:  Gary Brown, Royal Holloway, University of London 
Gerry  Leonard, Barts Health NHS Trust 
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EoSRES 
 
 
                         Research Ethics Service 
 
East of Scotland Research Ethics Service (EoSRES) REC 1 
      Tayside Medical Sciences Centre (TASC) 
Residency Block C, Level 3 
Ninewells Hospital & Medical School 
George Pirie Way 
Dundee  DD1 9SY 
 
 
Miss Hannah Jackson 
Trainee Clinical Psychologist 
Camden & Islington NHS Foundation Trust 
Royal Holloway University, Department of Clinical 
Psychology   
Egham Hill 
Egham  
TW20 0EX 
 
 
Date: 15 August 2014 
Your Ref:  
Our Ref: LR/14/ES/0053 
Enquiries to: Mrs Lorraine Reilly 
Direct Line: 01382 383878 
Email: eosres.tayside@nhs.net 
 
Dear Miss Jackson 
 
Study title: Psychological Well-Being in Individuals With Chronic 
Fatigue Syndrome/ Myalgic Encephalomyelitis 
REC reference: 14/ES/0053 
Protocol number: NCT02094820 
Amendment number: AM01 (for REC reference only) 
Amendment date: 24 July 2014 
IRAS project ID: 146565 
 
The above amendment was reviewed by the Sub-Committee in correspondence.  
 
Ethical opinion 
 
The members of the Committee taking part in the review gave a favourable ethical opinion of the 
amendment on the basis described in the notice of amendment form and supporting 
documentation. 
 
The Committee commented on method for recruiting NHS patients currently receiving treatment by 
the clinician.  They asked that the researcher ensure that the participants did not feel they had to 
take part in the study as the clinician had given them the questionnaire pack. 
 
Approved documents 
 
The documents reviewed and approved at the meeting were: 
 
Document   Version   Date   
Notice of Substantial Amendment (non-CTIMP)  AM01  24 July 2014  
Other [Cover email]    27 July 2014  
Participant consent form  2  18 July 2014  
Participant information sheet (PIS) [People for treatment]  3  04 July 2014  
 
	  	   174	  
	  	  	  
	  	  	  
 
 
Participant information sheet (PIS) [Support Groups ]  4  18 July 2014  
Research protocol or project proposal  2  16 April 2014  
 
Membership of the Committee 
 
The members of the Committee who took part in the review are listed on the attached sheet. 
 
R&D approval 
 
All investigators and research collaborators in the NHS should notify the R&D office for the relevant 
NHS care organisation of this amendment and check whether it affects R&D approval of the 
research. 
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for Research 
Ethics Committees and complies fully with the Standard Operating Procedures for Research Ethics 
Committees in the UK. 
 
We are pleased to welcome  researchers  and  R  &  D  staff  at  our  NRES  committee  members’  
training days – see details at http://www.hra.nhs.uk/hra-training/  
 
14/ES/0053:  Please quote this number on all correspondence 
 
Yours sincerely 
 
 
pp 
Dr Carol Macmillan 
Chair 
 
E-mail: eosres.tayside@nhs.net 
 
Enclosures: List of names and professions of members who took part in the 
review 
 
Copy to:  Gerry  Leonard, Barts Health NHS Trust 
Gary Brown, Royal Holloway, University of London 
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East of Scotland Research Ethics Service REC 1 
 
Attendance at Sub-Committee of the REC meeting on 11 August 2014 
 
 Committee Members:  
 
Name   Profession   Present    Notes   
Dr Carol Macmillan  Consultant Anaesthetist  Yes  Chair 
Dr Gary Lyon  Retired  Yes     
  
Also in attendance:  
 
Name   Position (or reason for attending)   
Mrs  Lorraine Reilly  Senior Co-ordinator  
  
Written comments received from:  
 
Name   Position  
Dr Carol Macmillan  Consultant Anaesthetist, Chair  
Dr Gary Lyon  Retired  
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Appendix III: LPFT Letter of Access for Research 
	   
                               
Chairman: Eileen Ziemer                                              
Chief Executive: Chris Slavin 
 
 
   
                 
                  
 
 
 
 
 
 
 
 
 
 
 
EGHAM 
Surrey 
 
 
 
 
 
 
 
Dear Miss Jackson 
 
Letter of access for research – Psychological well-being in individuals with chronic fatigue 
syndrome 
 
As an existing NHS employee you do not require an additional honorary research contract with this NHS 
organisation. We are satisfied that the research activities that you will undertake in this NHS organisation 
are commensurate with the activities you undertake for your employer.  Your employer is fully responsible 
for ensuring such checks as are necessary have been carried out.  Your employer has confirmed in writing 
to this NHS organisation that the necessary pre-engagement check are in place in accordance with the role 
you plan to carry out in this organisation. This letter confirms your right of access to conduct research 
through Lincolnshire Partnership NHS Foundation Trust (LPFT) for the purpose and on the terms and 
conditions set out below. This right of access commences on 25 April 2014 and ends on 2 March 2015 
unless terminated earlier in accordance with the clauses below.  
 
You have a right of access to conduct such research as confirmed in writing in the letter of permission for 
research from this NHS organisation. Please note that you cannot start the research until the Principal 
Investigator for the research project has received a letter from us giving permission to conduct the project. 
 
You are considered to be a legal visitor to Lincolnshire Partnership NHS Foundation Trust premises. 
You are not entitled to any form of payment or access to other benefits provided by this organisation to 
employees and this letter does not give rise to any other relationship between you and this NHS 
organisation, in particular that of an employee.  
 
While undertaking research through Lincolnshire Partnership NHS Foundation Trust, you will remain 
accountable to your employer University College London Hospitals NHS Foundation Trust but you are 
required to follow the reasonable instructions of your nominated manager Dianne Tetley Assistant 
Director of Research and Effectiveness in this NHS organisation or those given on her/his behalf in 
relation to the terms of this right of access. 
 
Where any third party claim is made, whether or not legal proceedings are issued, arising out of or in 
connection with your right of access, you are required to co-operate fully with any investigation by this NHS 
organisation in connection with any such claim and to give all such assistance as may reasonably be 
required regarding the conduct of any legal proceedings. 
 
You must act in accordance with Lincolnshire Partnership NHS Foundation Trust policies and 
procedures, which are available to you upon request, and the Research Governance Framework.  
 
Ref  Research Innovation and Effectiveness Team 
Date:  25 April 2014   Trust Headquarters Unit 9 
  The Point, Lions Way 
  SLEAFORD 
Miss Hannah Jackson  Lincolnshire 
Royal Holloway University of London  , NG34 8GG 
Department of Clinical Psychology   
Egham Hill   
TW20 0EX  Tel: 01529 222206 
  Fax: 01529 222226 
  Email: Research@lpt.nhs.uk 
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Chairman: Eileen Ziemer                                              
Chief Executive: Chris Slavin 
 
 
   
You are required to co-operate with Lincolnshire Partnership NHS Foundation Trust in discharging its 
duties under the Health and Safety at Work etc Act 1974 and other health and safety legislation and to take 
reasonable care for the health and safety of yourself and others while on Lincolnshire Partnership NHS 
Foundation Trust premises. Although you are not a contract holder, you must observe the same standards  
of care and propriety in dealing with patients, staff, visitors, equipment and premises as is expected of a 
contract holder and you must act appropriately, responsibly and professionally at all times.  
 
You are required to ensure that all information regarding patients or staff remains secure and strictly 
confidential at all times. You must ensure that you understand and comply with the requirements of the 
NHS Confidentiality Code of Practice (http://www.dh.gov.uk/assetRoot/04/06/92/54/04069254.pdf) and the 
Data Protection Act 1998. Furthermore you should be aware that under the Act, unauthorised disclosure of 
information is an offence and such disclosures may lead to prosecution.  
 
Lincolnshire Partnership NHS Foundation Trust will not indemnify you against any liability incurred as a 
result of any breach of confidentiality or breach of the Data Protection Act 1998. Any breach of the Data 
Protection Act 1998 may result in legal action against you and/or your substantive employer. 
 
You should ensure that, where you are issued with an identity or security card, a bleep number, email or 
library account, keys or protective clothing, these are returned upon termination of this arrangement. Please 
contact R&D office before visiting Trust premises to agree arrangements for the issue of ID Badge. 
Please also ensure that while on the premises you wear your ID badge at all times, or are able to prove 
your identity if challenged. Please note that this NHS organisation accepts no responsibility for damage to 
or loss of personal property. 
 
We may terminate your right to attend at any time either by giving seven days’ written notice to you or 
immediately without any notice if you are in breach of any of the terms or conditions described in this letter 
or if you commit any act that we reasonably consider to amount to serious misconduct or to be disruptive 
and/or prejudicial to the interests and/or business of this NHS organisation or if you are convicted of any 
criminal offence. Where applicable, your substantive employer will initiate your Independent Safeguarding 
Authority (ISA) registration in-line with the phasing strategy adopted within the NHS (as from 26th July 2010 
at the earliest).  Once you are ISA-registered, your employer will continue to monitor your ISA registration 
status via the on-line ISA service.  Should you cease to be ISA-registered, this letter of access is 
immediately terminated. Your substantive employer will immediately withdraw you from undertaking this or 
any other regulated activity and you MUST stop undertaking any regulated activity. 
 
Your substantive employer is responsible for your conduct during this research project and may in the 
circumstances described above instigate disciplinary action against you.  
 
If your circumstances change in relation to your health, criminal record, professional registration or ISA 
registration, or any other aspect that may impact on your suitability to conduct research, or your role in 
research changes, you must inform the NHS organisation that employs you through its normal procedures. 
You must also inform your nominated manager in this NHS organisation. 
 
 
 
Yours sincerely 
 
 
 
Dianne Tetley 
Assistant Director Research Innovation & Effectiveness 
On behalf of HR Department 
Lincolnshire Partnership NHS Foundation Trust 
 
cc:  HR department of the substantive employer - Ian Sawyer, HR Office Manager Ian.Sawyer@candi.nhs.uk   
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Appendix V: Participant Information Sheet    	  
Participant Information Sheet             
   
Study title: Well-Being in Individuals Diagnosed with Chronic 
Fatigue Syndrome/ Myalgic Encephalomyelitis (CFS/ ME). 
 
You are being invited to take part in a research study. Before you decide to take part, 
it is important for you to understand why the research is being done and what it would 
involve. Talk to others about the study if you wish and please ask me, the researcher, 
if there is anything that is not clear or if you would like more information. You can 
contact me by emailing hannah.jackson.2012@live.rhul.ac.uk or by leaving a message 
on the following answer phone number 01784 414012 (Please quote “Hannah 2012” 
and clearly leave your name and contact details). Take time to decide whether or not 
you wish to take part.  
 
What is the purpose of the study?  
This study is interested in finding out about a variety of aspects of quality of life, 
specifically psychological well-being, in people experiencing Chronic Fatigue 
Syndrome/ Myalgic Encephalomyelitis (CFS/ ME). At present we do not have a 
detailed profile of which aspects of well-being and quality of life are affected and 
which are unaffected by the experience of CFS/ ME. Building such a profile could 
help us better understand the experiences of people with CFS/ ME and develop more 
effective interventions. 
 
Why have I been chosen?  
You have been invited to take part in this study because you are currently being seen 
by a Chronic Fatigue Syndrome Service and are believed to be experiencing the 
condition. The study is hoping to recruit at least 60 participants to take part.  
 
Do I have to take part?   
No, it is up to you to decide whether or not you would like to take part in this study. If 
you do take part you are still free to withdraw at any time, without giving a reason. A 
decision to withdraw or a decision not to take part, will not affect the standard of care 
you receive. 
 
What will I have to do if I take part? 
If you decide to take part, please sign the consent form, complete the questionnaires 
and return them both to the researcher, using the prepaid self-addressed envelope 
provided. In total, the questionnaire pack should take approximately 30 minutes to 
complete. The questionnaires are made up of multiple choice questions and you will 
be required to tick boxes to choose your response. The questionnaires will ask about 
your well-being, physical symptoms related to CFS/ ME (e.g. fatigue, pain) and your 
experience of a range of emotions (positive and negative).  You will be asked to return 
the questionnaires at the earliest convenience to the researcher via post, using the 
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prepaid, self-addressed envelope provided. If you wish, you can also return the 
questionnaires to the CFS team at your next therapy session.   
 
What are the possible disadvantages and risks in taking part? 
There are no foreseen risks or disadvantages of taking part in this study. However, if 
you feel distressed at any time, then you are free to withdraw without giving a reason. 
If you feel you need to talk to someone, please contact your GP or, if more urgent, go 
to the nearest Accident and Emergency Department. The Samaritans are available 24 
hours a day, 7 days a week. Telephone: 08457 909090 email: jo@samaritans.org 
 
 
 
What are the possible benefits of taking part? 
This study was not designed to offer any direct benefits to those taking part. However, 
participating in this study will hopefully enable us to gain a better understanding of 
the psychological well-being of individuals with CFS.  This information will 
hopefully inform interventions for CFS/ ME that enhance individuals’ quality of life. 
 
What if there is a problem? 
It is unlikely that there will be any problems, but if you are unhappy with any aspect 
of the study, then you should speak to the researcher, Hannah Jackson, who will do 
her best to answer any questions. Hannah can be contacted by emailing 
hannah.jackson.2012@live.rhul.ac.uk or leaving a message on the following answer 
phone number 01784 414012 (Please quote “Hannah 2012” and clearly leave your 
name and contact details). You are free to withdraw from the study at any time and 
you also have the right to make a formal complaint about the way you have been dealt 
with, throughout the course of the study. 
 
If you wish to complain, or have any concerns about any aspect of the way you have 
been approached or treated during the course of this study, then you can also contact 
your local Patient Advice and Liaison Service (PALS). 
Lincolnshire Partnership Foundation Trust on 01529 222265 or by email: PALS@lpft.nhs.uk 
Royal London Hospital for Integrated Medicine on 020 3447 3042 or by email: 
PALS@uclh.nhs.uk. 
 
Will my taking part in the study be kept confidential? 
Yes. All information collected will be strictly confidential. The only exception to this 
is if you tell the researcher something that could put yourself or someone else at risk, 
then they will be obliged to pass this information on to a clinician at your CFS service. 
A unique identifier code will be allocated to you and you name will not be put on any 
of the questionnaires or data collected about you. Furthermore, all completed 
questionnaires will be stored securely in a locked cupboard, and will only be 
accessible to people who are involved in the study. The data will be kept for five years 
and then destroyed. 
 
What will happen if I don’t want to carry on with the study? 
You are free to withdraw at any time and without giving a reason. This will not affect 
your treatment in any way. If you choose to withdraw, then you may consent to the 
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data that has already been collected from you to be used within the study. 
Alternatively, you can request for all the data to be destroyed. 
 
What will happen to the results of the research study? 
The results of the study will form part of a dissertation for a Doctorate in Clinical 
Psychology from Royal Holloway, University of London. The results may also be 
published in a scientific journal. You will not be identifiable in any of these reports. 
Findings will be presented as group averages and there will be no information to 
identify participants. If you would like to be notified of the results please indicate this 
on the consent form and then the researcher is happy to send a summary of them to 
you. 
 
Who has reviewed this study? 
This research has been looked at by an independent group of people, called a Research 
Ethics Committee, to protect your safety, rights, well-being and dignity. This study 
has been reviewed and given favourable opinion by Royal Holloway, University of 
London Research Ethics Committee. The East of Scotland Research Ethics Committee 
REC 1, which has responsibility for scrutinising all proposals for medical research on 
humans in Tayside, has also examined the proposal and has raised no objections from 
the point of view of medical ethics. It is a requirement that your records in this 
research, together with any relevant records, be made available for scrutiny by 
monitors from Royal Holloway, University of London and participating NHS Trusts, 
whose role is to check that research is properly conducted and the interests of those 
taking part are adequately protected. 
 
 
The researcher will be supervised by Professor Andrew MacLeod, Director of Clinical 
Psychology training at Royal Holloway University of London. 
 
Thank you for taking the time to read this information sheet.  
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Appendix VI: Participant Consent Form  
 
Project ID: 146565  
 
Centre Number: 
Patient Identification Number: 
CONSENT FORM 
Title of Project: Well-Being in Individuals Diagnosed with Chronic Fatigue 
Syndrome/ Myalgic Encephalomyelitis (CFS/ ME). 
 
Name of Researcher: Hannah Jackson 
                                                                                                                 Please initial or tick all boxes  
1. I confirm that I have read and understand the information sheet for the above study.  I 
have had the opportunity to consider the information, ask questions and have had them 
answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any 
time without giving any reason, without my medical care or legal rights being affected. 
 
3. I agree to take part in the above study  
 
4. I would like to receive a summary of the results (Please provide contact details below) 
 
If you would like to receive a summary of the results please write your email address or postal 
address below: 
Email:        
Postal Address:           
 
Please Sign Below: 
 
                                                                        
Name of Participant   Date                      Signature          
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Appendix VII: Participant Questionnaires 
 
!!!!!!!!!!!!!!!Centre!Number:!
!!!!!!!!!!!!!!!!!!!Participant!Number:!
 
 
 
 
Psychological+Well.being+in+Chronic+Fatigue+
Syndrome/+Myalgic+Encephalomyelitis+(CFS/+ME)+!
+
THE+QUESTIONNAIRE+
+
+!
!
 
 
 
 
 
          PLEASE WRITE YOUR NAME BELOW: 
 
 
 
 
 
         First name                                 Surname 
 
  
 
        DATE OF COMPLETION 
 
 
 
      
Please+complete+all+of+the+questionnaires+enclosed.+Pages+are+double+sided.+
Try+to+answer+every+item,+even+if+you+are+unsure+and+be+careful+not+to+skip+
any.+Please+remember+that+there+are+no+right+or+wrong+answers.+
+
Thank+you+for+taking+part+in+this+study.+
 
 
Please+return+using+the+freepost+envelope+provided+(no+stamp+needed)+
 
This!study!is!interested!in!finding!out!about!a!variety!of!aspects!of!quality!of!life,!specifically!psychological!well9being,!in!people!experiencing!Chronic!Fatigue!Syndrome/!Myalgic!Encephalomyelitis!(CFS/!ME).!At!present!we!do!not!have!a!detailed!profile!of!which!aspects!of!well9being!and!quality!of!life!are!affected!and!which!are!unaffected!by!the!experience!of!CFS/!ME.!Building!such!a!profile!could!help!us!better!understand!the!experiences!of!people!with!CFS/!ME!and!develop!more!effective!interventions.!
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Demographics Questionnaire 
 
1. Age (to the nearest month):                                      years                 months 
 
2. Gender (Please tick):                                 Male    or    Female 
 
3. Ethnicity (Please tick):         White British                     Indian 
                                                 White Other                      Pakistani 
                                                 Black African                    Bangladeshi 
                                                 Black British                     Other Asian 
                                                 Black Caribbean               Chinese 
                                                 Black Other                      Other (please state)             .          
 
 
4. Marital Status (Please tick):                        Single  
                                                                        Married/ Living with partner 
                                                                        In a Relationship 
                                                                        Divorced/ separated 
                                                                        Widowed 
 
3. Employment (Please tick):                          Unemployed 
                                                                        Student 
                                                                        Employed full-time 
                                                                        Employed part-time 
                                                                        Retired 
 
4. How many hours a week do you work?                          hours        
 
 
5. Highest Level of Educational Attainment:    No qualifications           
    (Please tick)                                                 GCSE/ O’levels 
                                                                         A’ levels 
                                                                         Vocational training/ college 
                                                                         University/ professional qualification 
           
 
6. Do you have a diagnosis of Chronic Fatigue Syndrome or Myalgic Encephalomyelitis 
(CFS/ ME)?   Yes/ No 
 
7. How long have you had CFS/ ME?               years              months 
 
8. From the onset of symptoms, how long did it take for you to be diagnosed with CFS/ 
ME?               years              months 
          
9. Have you received treatment for CFS/ ME before?  Yes/ No 
 
10. Since being referred to your current CFS service, how many sessions of treatment 
(individual or group) have you received? 
 
11. Do you have a diagnosis of Fibromyalgia?    Yes/ No 
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Scale of Positive and Negative Experience (SPANE) 
 
Please think about what you have been doing and experiencing during the past 
four weeks. Then report how much you experienced each of the following 
feelings, using the scale below. For each item, select a number from 1 to 5, 
and indicate that number on your response sheet. 
 
!!
1. 
Very rarely or 
Never 
2. 
 
Rarely 
3. 
 
Sometimes 
4. 
 
Often 
5. 
Very often 
or Always 
Positive           
Negative            
Good            
Bad            
Pleasant            
Unpleasant            
Happy            
Sad            
Afraid            
Joyful            
Angry            
Contented            
 
 
 
 
 
 
 
 
 
 
 
Pain Visual Analog Scale (VAS) 
 
Directions: Indicate on the line how severe your physical pain is in relation to 
the two extremes.  
 
 
 
No Pain                                                                                         Pain as bad  
                                                                                        as it could    
                                                                                        possibly be 
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Multidimensional fatigue inventory (MFI-20) 
 
We would like to get an idea of how you have been feeling recently. For example, the 
statement: 
"I FEEL RELAXED" 
If you think that this is entirely true, that you have been feeling relaxed lately, please 
place an X in the extreme left box like this: 
 
 
                   yes, that is true                                        no  that is not true 
 
The more you disagree with the statement, the more you can place an X in the 
direction of "no, that is not true". Please, do not miss out a statement and place one X 
next to each statement. 
    
1. I feel fit 
                                 yes, that is true                                                             no  that is not true 
 
2. Physically I feel only able to do a little  
 
                               yes, that is true                                                                 no  that is not true 
3. I feel very active 
 
                             yes, that is true                                                                    no  that is not true 
4. I feel like doing all sorts of nice things 
 
                             yes, that is true                                                                 no  that is not tru 
 
 
 
 
X     
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5. I feel tired 
 
                            yes, that is true                                                                  no  that is not true 
6. I think I do a lot in a day 
 
                                 yes, that is true                                                           no  that is not true 
 
7. When I am doing something, I can keep my thoughts on it  
 
                                yes, that is true                                                            no  that is not true 
8. Physically I can take on a lot 
 
                                yes, that is true                                                            no  that is not true 
9. I dread having to do things 
 
 
                                yes, that is true                                                            no  that is not true 
10. I think I do very little in a day 
 
 
                                yes, that is true                                                            no  that is not true 
11. I can concentrate well 
 
 
               yes, that is true                                                             no  that is not true 
 
 
12. I am rested 
 
               yes, that is true                                                             no  that is not true 
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13. It takes a lot of effort to concentrate on things 
 
 
              yes, that is true                                                               no  that is not true 
 
 
14. Physically I feel I am in a bad condition 
 
 
               yes, that is true                                                                no  that is not true 
 
15. I have a lot of plans 
 
 
                yes, that is true                                                             no  that is not true 
 
16. I tire easily 
 
                 yes, that is true                                                            no  that is not true 
 
17. I get little done 
 
 
                yes, that is true                                                              no  that is not true 
 
18. I don’t feel like doing anything 
 
 
              yes, that is true                                                               no  that is not true 
 
 
19. My thoughts easily wander 
 
 
            yes, that is true                                                                  no  that is not true 
 
 
20. Physically I feel I am in an excellent condition 
 
 
            yes, that is true                                                                  no  that is not true 
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Hospital Anxiety and Depression Scale (HADS) 
Please choose one response from the four possible answers given that 
best describes the way you are currently feeling. Please tick only one in 
each section!
A" I"feel"tense"or"'wound"up':" ""
"" Most of the time ""
"" A lot of the time ""
""
From time to time, 
occasionally ""
"" Not at all ""!!
D" I"still"enjoy"the"things"I"used"to"enjoy:" ""
"" Definitely as much ""
"" Not quite so much ""
"
Only a little ""
"" Hardly at all ""!!
A"
I"get"a"sort"of"frightened"
feeling"as"if"something"
awful"is"about"to"happen:" ""
""
Yes definitely and quite 
badly ""
"" Yes, but not to badly ""
""
A little, but it doesn’t worry 
me ""
"" Not at all ""!!
D" I"can"laugh"and"see"the"funny"side"of"things:" ""
"" As much as I always could ""
"" Not quite so much now ""
"
Definitely not so much now ""
"" Not at all ""!!
A" Worrying"thoughts"go"through"my"mind:" ""
"" A great deal of the time ""
"" A lot of the time ""
""
From time to time, but not 
too often ""
"" Only occasionally ""
!
D" I"feel"cheerful:" ""
"" Not at all ""
"" Not often ""
"
Sometimes ""
"" Most of the time ""!!!
A" I"can"sit"at"ease"and"feel"relaxed:" ""
"" Definitely  ""
"" Usually ""
"
Not often ""
"" Not at all ""!!
D" I"feel"as"if"I"am"slowed"down:" ""
"" Nearly all the time ""
"" Very often ""
"
Sometimes ""
"" Not at all ""!!
A"
I"get"a"sort"of"frightened"
feeling"like"butterflies"in"
the"stomach:" ""
"" Not at all ""
"" Occasionally ""
"" Quite often ""
"" Very often ""!!
D" I"have"lost"interest"in"my"appearance:" ""
"" Definitely  ""
""
I don’t take as much care 
as I should ""
"
I may not take quite as 
much care ""
""
I take as much care as 
ever ""
	  	   194	  
	  
	  
!!
A" I"feel"restless"as"I"have"to"be"on"the"move:" ""
"" Very much indeed ""
"" Quite a lot ""
"" Not very much ""
"" Not at all ""!!
D" I"look"forward"with"enjoyment"to"things:" ""
"" As much as I ever did ""
"" Rather less than I used to ""
"
Definitely less than I used 
to ""
"" Hardly at all ""!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
!!
A" I"get"sudden"feelings"of"panic:" ""
"" Very often indeed ""
"" Quite often ""
"" Not very often ""
"" Not at all ""!!
D" I"can"enjoy"a"good"book"or"radio"or"TV"program:" ""
"" Often ""
"" Sometimes ""
"
Not often ""
"" Very seldom ""!
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Psychological Well-Being Scale 
 
The following set of questions deals with how you feel about yourself and your life.  
Please remember that there are no right or wrong answers. 
 
Circle the number that best describes your present agreement or disagreement with 
each statement 
 
Circle the number that best 
describes your present 
agreement or disagreement 
with each statement 
 
 
Strongly 
Disagree 
 
Disagree 
Somewhat 
 
Disagree 
Slightly 
 
Agree 
Slightly 
 
Agree 
Some-
what 
 
Strongly 
Agree 
1. Most people see me as loving 
and affectionate. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
2. In general, I feel I am in charge 
of the situation in which I live. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
3.  I am not interested in activities 
that will expand my horizons. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
4. When I look at the story of my 
life, I am pleased with how things 
have turned out. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
5. Maintaining close relationships 
has been difficult and frustrating 
for me. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
6.  I am not afraid to voice my 
opinions, even when they are in 
opposition to the opinions of most 
people. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
7. The demands of everyday life 
often get me down. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
8. I live life one day at a time and 
don’t really think about the future. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
9. In general, I feel confident and 
positive about myself. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
10. I often feel lonely because I 
have few close friends with whom 
to share my concerns. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
11. My decisions are not usually 
influenced by what everyone else 
is doing. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
12. I do not fit very well with the 
people and the community 
around me. 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
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13.  I tend to focus on the 
present, because the future 
nearly always brings me 
problems. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
14. I feel like many of the people 
I know have gotten more out of 
life than I have. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
15. I enjoy personal and mutual 
conversations with family 
members or friends. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
16.  I tend to worry about what 
other people think of me. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
17.  I am quite good at managing 
the many responsibilities of my 
daily life. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
18.  I don’t want to try new ways 
of doing things - my life is fine the 
way it was. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
19.  Being happy with myself is 
more important to me than 
having others approve of me. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
20.  I often feel overwhelmed by 
my responsibilities. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
21.  I think it was important to 
have new experiences that 
challenge how you think about 
yourself and the world. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
22.  My daily activities often 
seem trivial and unimportant to 
me. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
23.  I like most aspects of my 
personality. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
24. I don’t have many people 
who want to listen when I need to 
talk. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
25.  I tend to be influenced by 
people with strong opinions. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
26.  When I think about it, I 
haven’t really improved much as 
a person over the years. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
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27.  I don’t have a good sense of 
what it is I’m trying to accomplish 
in life. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
28.  I made some mistakes in the 
past, but I feel that all in all 
everything has worked out for the 
best. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
29.  I would generally do a good 
job of taking care of my personal 
finances and affairs. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
30.  I used to set goals for 
myself, but that now seems like a 
waste of time. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
31.  In many ways, I feel 
disappointed about my 
achievements in life. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
32.  It seems to me that most 
other people have more friends 
than I do. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
33.  I enjoy making plans for the 
future and working to make them 
a reality. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
34.  People describe me as a 
giving person, willing to share my 
time with others. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
35.  I have confidence in my 
opinions, even if they are 
contrary to the general 
consensus. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
36.  I am good at juggling my 
time so that I can fit everything in 
that needs to be done. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
37.  I have a sense that I have 
developed a lot as a person over 
time. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
38.  I am an active person in 
carrying out the plans I set for 
myself. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
39.  I don’t experience many 
warm and trusting relationships 
with others. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
40.  It is difficult for me to voice 
my own opinions on controversial 
matters. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
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41.  I don’t enjoy being in new 
situations that require me to 
change my old familiar ways of 
doing things. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
42.  Some people wander 
aimlessly through life, but I am 
not one of them. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
43.  My attitude about myself is 
probably not as positive as most 
people feel about themselves. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
44.  I often change my mind 
about decisions if my friends or 
family disagree. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
45. For me, life has been a 
continuous process of learning, 
changing, and growth. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
46.  I sometimes feel as if I’ve 
done all there is to do in life. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
47.  I know that I can trust my 
friends, and they know they can 
trust me. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
48.  The past had its ups and 
downs, but in general, I wouldn’t 
want to change it. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
49.  I have difficulty arranging my 
life in a way that is satisfying to 
me. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
50.  I gave up trying to make big 
improvements or changes in my 
life a long time ago. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
51.  If I compare myself to friends 
and acquaintances, it makes me 
feel good about who I was. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
52. I judge myself by what I think 
is important, not by the values of 
what others think is important. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
53.  I am able to build a home 
and a lifestyle for myself that is 
much to my liking. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
54.  There is truth to the saying 
that you can’t teach an old dog 
new tricks. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
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variables for the CFS Sample (N= 60) 
	  
	  
	  
	  
	  
	  
	  
	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Symptoms Age (years) 
 
 
 
Years with 
CFS 
Years taken to 
receive a 
diagnosis of CFS 
 
General Fatigue .000 
(p = .999) 
 
.053 
(p = .688) 
-.104 
(p = .430) 
Physical Fatigue .008 
(p = .954) 
-.209 
(p = .109) 
-.185 
(p = .158) 
 
Mental Fatigue -.087 
(p = .511) 
 
-.032 
(p = .808) 
-.051 
(p = .699) 
Reduced Activity .070 
(p = .596) 
-.181 
(p = .166) 
-.156 
(p = .234) 
 
Reduced Motivation .027 
(p = .836) 
 
-.053 
(p = .688) 
-.035 
(p = .788) 
Pain1 -.040 
(p = .764) 
 
-.072 
(p = .591) 
-.129 
(p = .333) 
 
Anxiety -.170 
(p = .194) 
 
.013 
(p = .924) 
-.010 
(p = .942) 
 
Depression .112 
(p = .392) 
-.057 
(p = .667) 
.004 
(p = .977) 
1 N= 58 
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Appendix IX: Means and standard deviations on the self-report scales of 
symptoms for CFS participants who were in a relationship versus those who 
were not in a relationship, and the significance of difference between the groups. 
 
 
Symptom In a relationship 
(N= 34) 
Mean (SD) 
Not in a 
relationship 
(N= 26) 
Mean (SD) 
t(58) p 
General 
Fatigue 
 
17.82 (2.50) 18.19 (1.50) .075 .940 
Physical 
Fatigue 
 
17.12 (3.25) 16.73 (3.57) .555 .581 
Mental 
Fatigue 
 
15.68 (4.22) 15.15 (3.36) .766 .447 
Reduced 
Activity 
 
14.35 (4.03) 14.42 (4.66) .062 .950 
Reduced 
Motivation 
 
13.12 (3.99) 12.65 (3.45) .472 .638 
Pain 
 
4.53 (2.98)a 4.74 (2.10)b .295c .769 
Anxiety 
 
10.50 (5.11) 8.54 (4.08) 1.605 .114 
Depression 
 
8.94 (4.19) 9.12 (4.07) .162 .872 
aN= 32, b N= 24, cdf= 56 
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Appendix X: Means and standard deviations on the self-report scales of 
symptoms for CFS participants who were unemployed versus those who were not 
unemployed, and the significance of difference between the groups. 
 
 
Symptom Unemployed 
 
(N= 25) 
Mean (SD) 
 
Not 
unemployed 
(N= 35) 
Mean (SD) 
t(58) p 
General Fatigue 18.64 (2.08) 
 
17.51 (2.05) 2.493 .016 
Physical Fatigue 17.72 (3.25) 
 
16.40 (3.39) 2.254 .028 
Mental Fatigue 15.84 (4.37) 
 
15.17 (3.47) 1.324 .193 
Reduced Activity 15.40 (4.30) 
 
13.66 (4.17) 1.576 .120 
Reduced Motivation 13.40 (4.08) 
 
12.57 (3.50) .843 .403 
Pain 5.10 (2.75) 
 
4.27 (2.46) 1.213 .230 
Anxiety 9.76 (5.46) 
 
9.57 (4.27) .150 .881 
Depression 9.56 (5.03) 8.63 (3.32) .865 .391 
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Appendix XI: Non-­‐significant	  ANOVAs	  examining	  the	  effect	  of	  treatment	  
stage	  (assessment	  vs.	  in	  treatment	  vs.	  not	  in	  a	  service)	  on	  symptoms	  	  
 Symptom	   F	  (2,	  55)	   P	  value	  	  General	  Fatigue	   2.650	   .080	  Physical	  Fatigue	   1.670	   .198	  Mental	  Fatigue	   .711	   .496	  Reduced	  Motivation	   2.705	   .076	  Pain	   .845	   .435	  Anxiety	   .137	   .872	  Depression	   .848	   .434	  
 
